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ABSTRACT
DECIPHERING PROTEIN HIGHER-ORDER STRUCTURE AND INTERACTIONS
VIA DIETHYLPYROCARBONATE LABELING-MASS SPECTROMETRY

FEBRUARY 2022
XIAO PAN
B.Eng. (Pharm), EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Richard W. Vachet
The study of protein higher-order structures is vital because it is closely related to the
investigation of protein folding, aggregation, interaction and protein therapeutics. Consequently,
numerous biochemical and biophysical tools have been developed to study protein higher-order
structures in many different situations. The combination of covalent labeling (CL) and mass
spectrometry (MS) has emerged as a powerful tool for studying protein structures and offers many
advantages over other traditional techniques, such as better structural coverage, high throughput,
high sensitivity, and the ability to study proteins in mixtures.
This dissertation focuses on diethylpyrocarbonate (DEPC) as an effective CL reagent that
can label N-termini and the side chains of several nucleophilic residues, providing information for
about 30% of the residues in the average protein. In contrast to hydroxyl radical foot printing, it
does not require expensive laser apparatus. The reaction only generates a single type of product,
which facilitates the data interpretation. The overarching goal of this dissertation is to continue the
development and application of DEPC-based CL-MS studies of protein structure and assembly.
Specifically, the first part of my dissertation concentrates on the kinetic study of DEPC labeling
and the second part focuses its applications to a set of biologically important systems.
ix

We first established a quantitative correlation between general protein structural factors
and DEPC reaction rates. Our results show that the solvent accessible surface areas of histidine
and lysine residues in proteins are the primary factors that determine a protein’s reactivity towards
DEPC. This model can be used to predict the reactivity of a protein based on its structure and
sequence, allowing the optimal DEPC concentration to be chosen for a given protein. In addition,
we determined that the overall reaction of DEPC with peptides was second order and measured
the intrinsic rate coefficients of nucleophilic residues and the N-terminus from the dose-response
plots. The histidine reactivity in peptides is primarily impacted by the number of charged residues
and peptide net charge, while histidine reactivity in proteins is weakly correlated with their SASA,
indicating more complicated factors control their reactivity. Moreover, we use DEPC labeling
together with LC-MS/MS analysis to distinguish the two sidechain tautomers of histidine residues
in peptides by distinct dissociation patterns and LC retention times. The tautomer ratios of several
histidine residues in myoglobin are in good agreement with previous 2D nuclear magnetic
resonance (NMR) data. The ability of DEPC labeling/MS to determine histidine tautomeric state
will help us to better understand histidine residue structure and function in proteins.
Furthermore, we applied CL-MS to study the structures of membrane-associated proteins,
an important class of proteins that are difficult to investigate by other techniques. We chose
chemotaxis A (CheA) as a model system to study the structural and binding interactions of this
protein in a membrane-associated chemoreceptor complex system. The DEPC labeling changes of
20 residues in the complex were monitored. While the results for 17 of these sites are consistent
with the current structural model of the chemoreceptor complex, the labeling results for several
sites are inconsistent with the model, suggesting that the model may need to be further refined.
Last but not the least, we demonstrated that DEPC CL-MS could probe surface interactions in

x

polymer-protein complexes and provided residue-level structural information for polymeric
protein transduction domain mimics (PTDM)-protein interactions for the first time. In particular,
our results show that, with the increase of polymer concentrations, residues near negativelycharged and hydrophobic patches on superfolder green fluorescent protein decrease in labeling,
which is consistent with a model in which PTDM binding is mediated via electrostatic and
hydrophobic interactions on the protein surface.
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CHAPTER 1
STUDY STRUCTURES AND INTERACTIONS OF SOLUBLE PROTEIN AND
MEMBRANE PROTEIN FROM COVALENT LABELING COUPLED WITH MASS
SPECTROMETRY
Majority of this chapter is part of a review article published as: Arden, B. G.; Pan, X.; Kirsch,
Z. J.; Vachet, R. W., Methods | Covalent Labeling and Chemical Cross-Linking Coupled With
Mass Spectrometry for Studying Protein Amyloid Formation. In Encyclopedia of Biological
Chemistry III (Third Edition), Jez, J., Ed. Elsevier: Oxford, 2021; pp 742-756. and Pan, X., &
Vachet, R. W. (2020). Membrane Protein Structures and Interactions from Covalent Labeling
Coupled with Mass Spectrometry. Mass spectrometry reviews, 10.1002/mas.21667. Advance
online publication. https://doi.org/10.1002/mas.21667
1.1 Introduction of Soluble Protein Study
In the postgenomic era, researchers from both academia and industry are enthusiastic
to study protein primary and higher-order structures, post-translational modifications (PTMs),
dynamics and protein complexes due to the vital roles that they play in living organisms.
Among them, the study of higher-order structures is closely related to the investigation of
protein folding, aggregation, interaction and protein therapeutics. Proteins function properly
after they fold into specific three-dimensional structures. Deciphering protein folding pathways
and discovering the mechanisms of misfolding are necessary to understand biochemical
processes and to search for therapeutics against disorders.1-2 In some pathological
circumstances, some proteins will form insoluble aggregates called amyloids. The formation
of fibrils in vivo is closely related to several human diseases such as Parkinson’s, Alzheimer’s,
dialysis-related amyloidosis (DRA) and some immunodeficiency illnesses.3 Researchers have
some breakthroughs in investigating the mechanism of fibril formation in vitro but more efforts
are still needed in this area. The study of ligand-protein or protein-protein interactions is
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important as well because they regulate signal transduction, cell metabolism and other
biochemical reactions. On the other hand, the past several decades have witnessed increased
development of protein therapeutics in the pharmaceutical industry. Biological drugs have
many advantages over small molecules such as higher specific binding and more complex
functions.4 In order to guarantee their safety, high efficacy and low immunogenicity,
developing analytical techniques which are routinely utilized to characterize higher-order
structures of therapeutic proteins is essential. Hence, the more that we know about protein
topology, function and dynamics, the more benefits that it will bring to us.

1.2 Soluble Protein Structural Analysis Techniques
Current protein structural analysis techniques can be classified into three categories.
The first category is low resolution but fast techniques such as circular dichroism (CD),
fluorescence spectroscopy, infrared spectroscopy and dynamic light scattering (DLS). These
techniques are only able to provide ensemble averages of protein conformation. Fluorescence
spectroscopy is only sensitive to the regions of protein with aromatic residues, particularly
tryptophan. In the second class, X-ray crystallography, nuclear magnetic resonance (NMR),
and cryo-electron microscopy (cryo-EM) are three powerful ways to investigate protein
structures and interactions with atomic-level resolution. However, X-ray crystallography
requires highly purified crystals, and the results indicate protein structure in the solid state, not
in aqueous solution. NMR needs large amount of samples and can only be used to study small
proteins. Cryo-EM requires controlled protein concentrations and has low signal-to-noise ratio.
The third category is moderate structural resolution techniques such as mass spectrometry (MS).
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MS is emerging as a powerful way to study protein structure due to its high sensitivity,
good structural resolution, relatively high-throughput, and ability to study proteins in mixtures.
A variety of approaches have been combined with MS to provide more information about
protein higher-order structures and interactions. One label-free technique is called ion mobility
(IM)-MS which is able to investigate protein conformational changes in the gas phase by
measuring the collisional cross section (CCS) and comparing the CCS of analytes with the CCS
of standard samples.5 However, this method is limited by low structural resolution and only
directly provides information about the gas-phase structure of proteins, which may or may not
be related to solution-phase structure. Among other MS approaches are intra- and
intermolecular cross-linking (XL), hydrogen/deuterium exchange (HDX), covalent labeling
(CL) and noncovalent labeling. Cross-linking approaches often use chemical linkers to form
new covalent bonds between close residues in the tertiary structure.6 However, the
identification of cross-linked sites is challenging because of the complicated data interpretation.
In the course of HDX, when exposed to D2O, backbone amide hydrogens on the surface of
proteins are more readily replaced by deuterons in contrast to amide hydrogens buried in the
proteins. By monitoring the increase in mass, HDX-MS is able to provide information about
secondary structure and track protein dynamics such as conformational changes of protein
backbone or protein movements. Hydrogens on many side chains may experience exchange as
well but they are too quick to be measured by MS. HDX-MS is a sensitive and fairly robust
technique that can be automated. Disadvantages of HDX-MS like back- exchange and labeling
scrambling are obvious too.7-8
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The combination of covalent labeling of amino acid residues and MS has been a
valuable tool to study higher-order structure of proteins due to good structural coverage, high
sensitivity and simplicity.9 Even though it was first introduced in 1999,10 CL-MS has only
recently been developed into a useful tool for protein surface mapping,11 probing interfaces in
protein complexes,12 discovering protein folding pathways13 and characterizing therapeutic
proteins.14 Unlike HDX, CL is generally not subject to the back exchange and label scrambling.
In CL techniques, chemical reagents are utilized to irreversibly modify the side chains of
residues exposed on the protein surface. The extent of modification on intact proteins can be
detected by direct infusion into MS. Furthermore, acquiring the labeling percentages at
individual residues can be accomplished in a straightforward way if proteins are digested and
LC-MS/MS is conducted (Figure 1.1). CL encodes structural information of residue’s side
chains into the increase of protein mass. Up to now, there are several commonly used reagents
in CL field. The most widely-used one is hydroxyl radicals for oxidative modification of
proteins.15

Figure 1.1. Experimental workflow of CL-MS and its applications
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1.3 Covalent Labeling Reagents
Hydroxyl radicals are one of the most widely-used reagents for CL. They are valuable
footprinting reagents because they are able to label almost all amino acid side chains in proteins,
although they do produce over 50 different product types, which can make the resulting MS
analysis more challenging.15 The oxidative modification of aliphatic side chains (Ala, Val, Leu,
and Ile) typically involves the addition of a hydroxyl group with a mass shift of +16 Da or a
carbonyl group with a mass shift of +14 Da, whereas aromatic side chains (Phe, Tyr, and Trp)
are usually modified by one or more hydroxyl groups on the ring.16 Acidic side chains (Asp
and Glu) can undergo oxidative decarboxylation with a mass loss of 30 Da. The reactions of
basic side chains (Lys, Arg, and His) with hydroxyl radicals lead to the addition of a hydroxyl
group or a carbonyl group as well as ring opening for His residues and deguanidination of Arg
residues. The modification of sulfur-containing side chains (Cys and Met) primarily results in
the formation of sulfonic acid (+48 Da) for Cys residues and sulfoxide (+16 Da), sulfone (+32
Da), or cleavage products (-32 Da) for Met residues. The reaction of •OH with side chains is
very fast (~ µs to ms timescale),17-18 meaning that the reagent can often modify proteins before
any structural changes can occur.13 The sulfur-containing residues have the highest intrinsic
reactivity towards hydroxyl radicals, followed by aromatic residues. Other residues such as His,
Leu, Ile, Arg, Lys, Val, Ser, Thr, Pro, Gln, and Glu have moderate reactivity while Asp, Asn,
Ala, and Gly are the least reactive.16
Hydroxyl radicals for CL experiments are generated mainly through synchrotron water
radiolysis or UV laser photolysis of hydrogen peroxide.19 In synchrotron-based hydroxyl
radical footprinting (HRF), •OH can be produced from water molecules without the addition of
5

any other reagents.20 Because synchrotron sources are not available for routine use, however,
a more readily accessible means of generating hydroxyl radicals via laser (248 nm or 266 nm)
photolysis of H2O2 has been developed.17, 21 Gross and co-workers have pioneered the design
of a hydroxyl radical footprinting platform (Figure 1.2), which they have termed fast
photochemical oxidation of proteins (FPOP).22-23 By controlling sample flow, laser pulse width,
and irradiation frequency, protein oxidative labeling can happen on the µs timescale when
combined with a radical scavenger.13, 24 Because synchrotron HRF and FPOP produce hydroxyl
radicals everywhere in solution, the extent of oxidative labeling in these methods tends to be
related to the solvent accessible surface area (SASA) of amino acid side chains, allowing
oxidative labeling to provide information about protein structural changes and protein
interactions.25-27
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Figure 1.2. (a) Scheme illustrating an FPOP platform. (b) A photo of an FPOP setup from Li
et al. 201823
Another way that hydroxyl radicals can be produced is using Fenton and Fenton-like
chemistry, which involves the redox cycling of a transition metal in the presence of H2O2.
Transition metals that can undergo one-electron redox processes can also generate radicals
when they are reduced in the presence of other oxidants such as O2 or S2O82- (Scheme 1.1),
allowing even more selective oxidation of amino acids. Indeed, when the transition metal is
bound to a peptide or protein, the resulting radicals are produced site specifically at the metal
center, providing a unique way to oxidize only amino acid residues that are bound to or near
the metal center.28-30 Such oxidation events contrast to the synchrotron HRF or FPOP
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approaches that produce radicals wherever solvent is present. These metal-catalyzed oxidation
(MCO) reactions have been used together with MS to identify metal-binding sites in peptides
and proteins that bind Fe, Cu, Co, Mn, and Ni.31

Scheme 1.1: Metal-catalyzed oxidation reactions can be used to site-specifically oxidize amino
acids (e.g. His in this example) that are bound to redox active metals such as Cu(II). The
transition metal undergoes rapid reduction and re-oxidation in the presence of reducing and
oxidizing agents, producing reactive oxygen species that react with nearby amino acids. The
sites of oxidation, and therefore the metal binding sites, can then be determined after proteolytic
digestion and LC-MS/MS analysis of the resulting peptide fragments.

Other covalent labeling reagents that can modify many different amino acid residues
include carbenes, trifluoromethyl radicals (•CF3) and diethylpyrocarbonate (DEPC).19
Carbenes and •CF3 are able to label multiple amino acids by inserting themselves into X-H
bonds (where X stands for C, O, N or S). More importantly, •CF3 reacts with Gly, Ala, Ser, Thr,
Asp, and Glu, which are relatively unreactive to hydroxyl radicals. For DEPC, it can label Ntermini and side chains of several nucleophilic residues such as free Cys, His, Lys, Tyr, Ser and
Thr (Figure 1.3), which can be performed in regular chemistry lab without the need of complex
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and expensive setup such as a laser apparatus, which is required for hydroxyl radical, carbene,
and trifluoromethyl radical labeling. DEPC probes up to 30% of the protein sequence on
average. Compared to hydroxyl radical footprinting, it generates a single type of product,
simplifying the identification of labeled sites. Owing to the advantages of DEPC labeling-MS,
it is essential to continue the study and understand this technique.

Figure 1.3. DEPC structure and reaction of His, Lys, Tyr, Ser and Thr with DEPC
1.4 Introduction of Membrane Protein Study
Membrane proteins, comprising 30% of the proteome, perform numerous cellular
functions in living organisms, such as cell signaling, transport, cell adhesion, catalysis and
more. They are incredibly important biomolecules because they mediate interactions between
9

a cell’s external and internal environment. Their importance is further emphasized by the fact
that more than 60% of FDA-approved drugs target membrane proteins,32 with a remarkable 19%
of these drugs directed toward ion channels.33 However, compared to water-soluble proteins, it
is difficult to characterize their higher order structures and to study their binding interactions
owing to their partially hydrophobic surfaces, flexibility and lack of stability.34 Moreover, when
the natural lipid bilayer is removed, the exposure of hydrophobic surfaces usually results in
protein denaturation and/or aggregation. Several approaches have been developed to overcome
these hurdles. One common approach is to study only the soluble domain of the protein. This
method enables the use of all the tools that have been developed for soluble proteins, but it
limits structural information and does not represent the full three-dimensional context of the
protein or its membrane environment. An alternative method is to embed the protein into an
artificial membrane, such as micelles, bicelles, amphipols, or lipid nanodiscs, which mimic cell
membrane environments. This approach allows the full membrane protein to be studied in the
context of a lipid environment, even though it does not always fully account for diversity of
components that are present in real cell membranes.
Techniques

for

membrane

protein

structure

investigations

include

X-ray

crystallography,35 cryo-electron microscopy (cryo-EM),36 solution or solid-state nuclear
magnetic resonance (NMR),37 and single-molecule tracking with fluorescence spectroscopy.3840

However, despite these techniques, the number of membrane protein with known structures

is 2488 or 1.5% of the 165422 structures in Protein Data Bank. This relatively low number of
structures is due to the significant challenges associated with applying traditional structural
analysis methods to membrane proteins. For example, co-crystallization of membrane protein
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with artificial membranes is difficult, limiting the use of X-ray crystallography. NMR is
typically more applicable, but molecular weight restrictions and difficulties with analyzing
mixtures limits its broad usage for membrane proteins. Cryo-EM has great promise for
membrane protein structural analysis, although its resolution for intact cell studies is currently
limited.
The popularity of utilizing mass spectrometry (MS) to study membrane proteins is on
the rise because of its high sensitivity, good structural resolution, relatively high-throughput,
and ability to study proteins in complex mixtures.41 In native MS, protein non-covalent
interactions can be maintained upon ionization so that it can provide protein structural
information and binding stoichiometries. Amphipols, nanodiscs, and bicelles are often used to
directly analyze membrane proteins in native MS because they solubilize the full protein and
are compatible with electrospray ionization. Ion mobility (IM)-MS, coupled with collisioninduced dissociation (CID), collision-induced unfolding (CIU), or surface-induced dissociation
(SID) can then report protein structural information, albeit with low resolution.
Hydrogen/deuterium exchange (HDX)-MS can provide more highly resolved information for
membrane proteins and yields insight into solvent accessible regions of the protein main chain
and backbone dynamics that can reflect conformational changes upon interactions with
ligands.42-44 Similarly, chemical cross-linking (XL)-MS provides structural information at the
residue level for protein regions that are adjacent to one another. XL-MS also can be applied
to study subunit connectivity of membrane protein complexes and protein interactions.45-46
Covalent labeling (CL)-MS is also emerging as a complementary technique to HDX
and has some advantages over XL-MS in terms of measurement simplicity. CL-MS has been
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used study membrane protein structure and interactions due to some of its inherent advantages.
In CL-MS, a reagent covalently modifies solvent exposed side chains on a protein or protein
complex. The resulting modification is typically very stable, allowing the use of optimized
proteomics techniques to facilitate its localization. Because the reagent leads to essentially a
‘dead-end’ modification, analysis of the resulting MS and MS/MS data is simpler than in XLMS methods. A variety of labeling chemistries are available, and they fall into two general
categories – residue non-specific reagents (e.g. hydroxyl radical) and residue specific reagents
(e.g. N-ethylmaleimide for Cys residues).15,

47

When CL-MS methods are used to study

membrane proteins, the covalent modification readily withstands the purification steps
necessary to facilitate membrane protein analysis. The typical steps involved are illustrated in
Figure 1.4. After the labeling reaction, the membrane components are removed, the proteins
are digested, and the resulting fragments are separated by liquid chromatography (LC) and
analyzed by tandem mass spectrometry (MS/MS) to identify the modified residues. Comparing
modification percentages of a given protein under one condition (e.g. without ligand) to that of
the same protein under another condition (e.g. with ligand) can reveal conformational changes,
ligand binding sites, and protein-protein interfaces often with residue-level resolution. CL-MS
is not subject to back exchange and label scrambling, and data interpretation is typically more
straightforward.
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Figure 1.4. In covalent labeling-mass spectrometry (CL-MS) techniques, a chemical reagent
modifies solvent accessible side chains of membrane proteins, followed by lipid removal,
enzymatic digestion, and LC-MS/MS analysis to determine modification sites. Comparing
modification levels under one condition (e.g. without ligand) to another (e.g. with ligand) can
reveal interactions sites or conformational changes.
While several excellent reviews on hydroxyl radical footprinting and CL-MS of soluble
proteins have appeared elsewhere,19, 47-51 no review solely focused on CL-MS of membrane
proteins has appeared recently. In this review, we focus on the chemistry and methods that are
unique to membrane proteins. In particular, we highlight the technical challenges and
innovations associated with conducting CL experiments on membrane protein both in vitro and
in vivo. We also describe several ways in which CL-MS has been applied to understand better
membrane protein structures as well as membrane protein-ligand or protein-protein interactions.
Proximity-dependent labeling methods,52-54 such as those that use horseradish peroxidase
(HRP), ascorbate peroxidase (APEX), or biotin ligase (BioID), are not included in this review
because we focus on direct labeling techniques that do not require molecular biology on the
proteins of interest.

1.5 Residue Non-specific Labeling
1.5.1 Labeling Reagents
Residue non-specific reagents are able to simultaneously modify a wide variety of
13

amino acid side chains in CL experiments. Among those reagents for membrane protein studies,
hydroxyl radical is the most commonly used because they can label almost all amino acid side
chains in proteins. Hydroxyl radicals (•OH) can be generated through synchrotron water
radiolysis or UV laser photolysis of H2O2 (248 nm or 266 nm),20, 22-23 and when used to
oxidatively modify proteins, the process has been termed synchrotron-based hydroxyl radical
footprinting (HRF) or fast photochemical oxidation of proteins (FPOP), respectively (Figure
1.5). The labeling reactions usually occur on the ~ µs to ms timescale,13, 17-18 which helps avoid
labeling-induced structural changes during the course of the experiment, as proteins are labeled
faster than they can typically undergo structural changes. Although the reactions of proteins
with hydroxyl radical produce over 50 different product types, which can complicate MS
analyses,15 the predominant products are the addition of a hydroxyl group with a mass shift of
+16 Da or a carbonyl group with a mass shift of +14 Da.16 Sulfur-containing residues and
aromatic residues have the highest intrinsic reactivity. Because the amount of •OH generated
in solution during HRF or FPOP is in large excess, the extent of oxidative labeling tends to
correlate with the solvent accessible surface area (SASA) of amino acid side chains, which can
provide insight about protein structure and their interactions.25-27 In contrast to synchrotron
HRF and FPOP, which produce hydroxyl radical everywhere in solution, •OH can also be
produced site specifically at a transition metal center via Fenton and Fenton-like chemistry.
These metal-catalyzed oxidation (MCO) reactions selectively oxidize residue side chains that
are bound or near the metal center.28-30
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Figure 1.5. (a) Scheme illustrating the main reactions during synchrotron-based hydroxyl
radical footprinting (HRF). Activated water (H2O*), hydrated electrons (eaq-) and •OH radical
are generated via radiolysis of bulk water. Then, •OH radical can be quenched by buffer, selfassociate to form peroxide, or label protein surface residues. (b) Scheme illustrating an FPOP
platform. Figures used with
10.1021/acs.chemrev.9b00815.

permission

from

Liu

et

al.,

2020,

DOI:

Carbenes are another residue non-specific labeling reagent that has been used for
membrane protein analysis. Carbenes are generated from the photolysis of diazirine derivatives
using near-UV light (~ 350 nm). This labeling reagent can irreversibly insert into any X-H bond
(X stands for C, O, N, or S) and generate a variety of products, which can lead to some
difficulties in getting residue-level information.19,

55

The challenge of pinpointing carbene

labeling sites requires a different approach to data analysis than is typically used in HRF or
FPOP.56-57 Most recently, labeling methods based on trifluoromethyl radicals (•CF3) have been
reported. Trifluoromethyl radicals can be generated by laser or synchrotron irradiation of
triflinate anions,58 and these radicals can insert into X-H bonds of amino acid side chains.
Trifluoromethyl radicals tend to label all amino acid residues, except Met and Cys, which
makes the reagent complementary to hydroxyl radical which has the highest reactivity with
these sulfur-containing residues.51
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1.5.2 Technical Challenges of Residue Non-specific Labeling Experiments on
Membrane Proteins
Covalent labeling of membrane proteins relies on many of the same approaches used
for soluble proteins, but additional considerations and steps in the digestion and separation
procedures are typically necessary due to inherent properties of membrane proteins. Moreover,
the presence of lipids, which are necessary to solubilize and stabilize membrane proteins, can
affect the experimental procedures and labeling results. Below we indicate the technical
challenges associated with non-specific labeling reagents, but it should be recognized that
many of these same challenges are present when using residue specific labeling reagents. For
example, the same challenges associated with the choice of the artificial membrane system,
artificial membrane removal, and membrane protein digestion are common to both residue nonspecific labeling experiments and residue specific labeling experiments.
1.5.2.1 Choice of Artificial Membrane
Artificial membranes are a common way to solubilize, enclose and stabilize membrane
proteins in aqueous solutions (Figure 1.6). Detergents that form micelles when used at
concentrations above their critical micelle concentration (CMC) are commonly used artificial
membranes. In principle, detergent micelles mimic natural lipid bilayers and ensure the native
conformations of both the membrane-embedded and soluble domains of the protein, while at
the same time allowing the protein to interact with other molecules. However, in practice,
micelles do not have ideal shapes to match the proper curvature of real cell membranes, and
their sizes can vary even in the same sample.59 Moreover, if a given membrane protein has two
soluble domains with an intervening transmembrane domain, micelles cannot properly
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recapitulate the structure of such membrane proteins. Another option is amphipols, which are
amphiphilic polymers capable of embedding membranes proteins. They are more stable than
simple detergents but have some of the same limitations as micelles. In bicelles, membrane
proteins can be encapsulated by a lipid bilayer in a manner that better mimics the native cellmembrane environment, especially for proteins with transmembrane domains.60 Other
important membrane components, such as cholesterol and cardiolipin, can be doped into
bicelles to further mimic the diversity of biological membranes. However, one challenge with
bicelles is that there morphology can change at low lipid concentrations,61 which can be
limiting in some applications. Nanodiscs have grown in popularity recently for their ability to
solubilize membrane proteins. They use not only a lipid bilayer to stabilize the membrane
protein but also membrane scaffold proteins to encircle the bilayer. Nanodiscs are well defined
in size and more stable than micelles and bicelles at low concentrations.62 Liposomes can also
be used to reconstitute and solubilize membrane proteins. They have a lipid bilayer that can
form a spherical shape that is morphologically analogous to cells, thereby allowing proteins
with transmembrane domains to be properly structured. A challenge, however, is that most
membrane proteins have a proper orientation, and ensuring that each soluble domain presents
itself on the appropriate side of the liposome typically proves difficult.
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Figure 1.6. Scheme illustrating some artificial membranes that are used to solubilize and
stabilize membrane proteins. a) micelles, b) amphiphols, c) bicelles, d) liposomes, e) nanodiscs.

1.5.2.2 Choice of Labeling Reagents
An important characteristic of membrane proteins is the presence of large hydrophobic
domains, which typically embed or span the membrane, and large soluble domains that orient
outside or inside the cell. A unique feature of CL, as opposed to HDX, is the ability to use
reagents that can target one domain or the other. Depending on the goals of the experiment,
water-soluble reagents are used to probe solvent exposed side chains, whereas lipophilic
reagents are used to probe residues that are buried in membrane regions. For example, hydroxyl
radical has been used to label soluble domains of the membrane protein while some carbenes
can modify residues in hydrophobic transmembrane regions due to their amphipathic
properties.55 Although trifluoromethyl radicals are hydrophobic, they do not readily diffuse into
the membrane and thus only modify extra-membrane domains.63 This inability to penetrate the
membrane may result from the well-known poor interactions between fluorocarbons and
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hydrocarbons.
1.5.2.3 Reagent Concentrations and Reaction Time Optimization
Optimizing reaction conditions is necessary to ensure detectable and reproducible
levels of labeling while at the same time maintaining a protein’s conformation integrity during
the CL experiments. Structural perturbations are minimized when a protein’s exposure to the
residue non-specific reagents (e.g. •OH) is kept on the µs timescale. In FPOP, this is achieved
by tuning sample flow rate, laser pulse width, and irradiation frequency, so that proteins in
solution are only illuminated once. Radical scavengers such as the amino acid Glu or adenine
are also added to minimize the •OH lifetime, which not only prevents over-labeling but
improves reproducibility.51 In HRF, dose-response plots that measure labeling kinetics are often
used to provide additional assurance that a protein’s structural integrity has been maintained.
Reproducible labeling in both FPOP and HRF is necessary to properly compare proteins under
different conditions (e.g. with ligand vs. without ligand), and dosimetry methods have been
described to maximize method reproducibility. Typically, reproducible labeling in FPOP is
accomplished by measuring the effective hydroxyl radical concentrations via the UV
absorbance of adenine at 265 nm upon oxidation.64 In synchrotron-based HRF, the dose of •OH
is reported by monitoring the radiolytic degradation of the Alexa 488 fluorophore.65 As long as
the dose of hydroxyl radical is controlled properly, it appears then that membrane proteins can
be studied by HRF and FPOP in a manner analogous to soluble proteins.
1.5.2.4 Scavenging Effects of Membrane Components and Other Molecules
One concern that could arise when studying membrane proteins is the potential for the
membrane components and other molecules to react with the labeling reagents. Often, the
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decreased modification levels caused by sample components can be addressed by simply
increasing the concentration of the labeling reagent. For example, to compensate for the •OH
scavenging effects of artificial membranes, the X-ray exposure time in HRF of membrane
proteins is increased, while still controlling •OH levels by radical dosimetry approaches.66
Because hydroxyl radical is usually present in excess to the protein and membrane components
in FPOP and HRF experiments, the presence of these additional components are not expected
to significantly affect overall reactivity as long as the proper radical levels are maintained.
Similarly, the reaction of carbenes with detergents decreases the modification events at residue
side chains, and the diazirine precursor reagent concentrations need to be increased
accordingly.55 A more challenging situation arises when other molecules are added to change
the structure or conformation of the membrane protein. For example, Chance and co-workers
used HRF to study the open and closed states of a potassium channel, and used EDTA, a wellknown radical scavenger, to achieve the open state.67 By conducting the radical dosimetry
approaches, the authors found that 1 mM EDTA reduces the hydroxyl radical dose by a factor
of 2.5. Consequently, they normalized the measured residue rate constants in the open state by
a factor of 2.5 to allow a better comparison to the closed state. While this normalization factor
seems reasonable, this simple approach may not work for every labeling reagent, and so such
a correction should be approached with caution.
In addition, the lipid components of the membrane system can be oxidized, and lipid
oxidation is a very complicated process. Lipid oxidation starts with the reaction of double
bonds in polyunsaturated fatty acids with free radicals (e.g. hydroxyl radical). The resulting
lipid hydroperoxides that are generated decompose to form multiple secondary compounds
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such as alcohols, aldehydes, and ketones.68 Several studies have pointed out that lipid oxidation
has a significant impact on membrane physical properties. In brief, lipids will reorganize their
packing due to the change of their structures after oxidation. For example, Jacob et al. and
Ayuyan et al. have found the formation of large cholesterol rafts that decrease the width of lipid
bilayers.69-70 Bonneau and coworkers observed the shape transition of giant unilamellar
vesicles after oxidation.71 These changes influence membrane fluidity, permeability, its
thermodynamics properties, and how membrane proteins are embedded in lipids. Hence, HRF
approaches could oxidize lipids, causing the deformation of the lipid bilayer and subsequently
influencing membrane protein structures. Typically HRF experiments are conducted in such a
way that oxidation only occurs on the micro- to millisecond timescale, which should minimize
changes in membrane properties that could influence protein conformation, but possible
membrane changes should not be ignored. Moreover, radicals could propagate from oxidized
lipids to membrane proteins on a longer timescale (> ms) via free-radical mediated chain
reactions,72-73 giving rise to the possibility of indirect modifications to the protein of interest.
While we are not aware that such a phenomenon has been described during HRF experiments,
it is possible that researchers have not investigated this possibility. If such radical propagation
reactions do occur, the correlation of modification extent with residue solvent accessibility
would likely decrease, as membrane embedded regions could be oxidized.
1.5.2.5 Artificial Membrane Removal
After labeling experiments, the sample components that solubilize the membrane
protein (e.g. lipids in the artificial membrane) usually must be removed to facilitate the
subsequent digestion and LC-MS/MS analysis. Several approaches are used to achieve this
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purification. In one approach a mixture of methanol, water, and chloroform are used to separate
the proteins from the lipids. In this approach, proteins precipitate and remain at the interface of
the aqueous and organic layers, while the lipids dissolve in the organic phase. In another
approach, trichloroacetic acid (TCA) and acetone are used for precipitation. In this solvent
system, lipids dissolve in acetone but proteins do not. Then, the lipids are removed easily
through centrifugation. More sophisticated approaches rely on expressing membrane protein
with affinity tags that bind to spin columns, while lipids are washed away before later eluting
the bound proteins. Lipids can also be separated from proteins/peptides via reverse phase (RP)
liquid chromatography columns either before enzymatic digestion or during LC/MS analyses
due to the differences in the retention of lipids and proteins.
1.5.2.6 Membrane Protein Digestion
In most cases, membrane proteins can be digested by commonly used proteolytic
enzymes, such as trypsin, chymotrypsin, Lys-C, etc. These enzymes usually provide high
sequence coverage for the soluble domains of the membrane protein after protein denaturation;
however, it can be difficult to digest hydrophobic transmembrane and membrane-embedded
domains owing to their hydrophobicity and lack of residues recognized by proteases. Using
multiple enzymes to digest the protein is one way to overcome this challenge. A second method
is to perform in-gel protease digestions. In this approach, the protein bands of interest are
excised, disulfide bonds are reduced and alkylated, the protein is destained and then
enzymatically digested all in the gel where the protein had been previously solubilized by
sodium dodecyl sulfate (SDS).74 Another common challenge in analyzing membrane proteins
is the poor sequence coverage that results in LC/MS analyses because of the poor LC separation
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of highly hydrophobic peptides. Often, mobile phase and gradient conditions that are normally
used for soluble proteins are unsuitable. A common solution is to use a shallower gradient of
the organic mobile phase to better separate the many hydrophobic peptides that can be produced
during enzymatic digestion.
1.5.3 Applications of Residue Non-specific Labeling to Membrane Proteins
1.5.3.1 Structural Characterization
Because the extent of labeling is related to the solvent accessibility of amino acid side
chains, CL-MS techniques can provide information about a protein’s higher-order structure.
An early example of using non-specific labeling reagents to study membrane proteins was by
Konermann and co-workers, who utilized FPOP to characterize the structure of
bacteriorhodopsin (BR) in Halobacterium salinarum purple membrane suspensions.75 Only
Met residues in the protein were labeled owing to their high intrinsic reactivity and the relative
high percentage of this residue in BR. Three Met residues in solvent-exposed loops were found
to have higher extents of modification than the remaining six Met residues that are in
transmembrane helices, indicating that FPOP can identify residues in the soluble domain of
membrane proteins. The conformational changes of BR under semi-denaturing conditions (low
pH, SDS exposure, and heat) were studied as well.76 Surprisingly, the labeling pattern of BR
at low pH is similar to the protein in native state, indicating that unlike other proteins, BR does
not have large conformational changes at low pH. When BR was heated or treated with SDS,
two additional Met residues are labeled, indicating that partial unfolding of some helices is
necessary to oxidize these residues.
The refolding of SDS-denatured BR in the presence of bicelles and free retinal
23

molecules was also studied by producing •OH in ~1 μs increments at various time points after
mixing with the artificial membranes.77 The fraction of unmodified M20 in transmembrane
helix A increases significantly from 0 to 20 ms, showing the residues in this region are
protected by the refolding of helix A. In this early stage of folding, BR forms an intermediate,
I1, and then it refolds to the intermediates I2 and IR after binding with the retinal chromophore.
The interaction between the retinal chromophore and the protein reduces the solvent
accessibility of M118, as revealed by the declining oxidation level of M118 on helix D from
0.5 s until 4 s. Finally, BR folds into IR* at 4 s, IR** at 10 s, and native state. These early FPOP
experiments on a well-studied membrane protein demonstrated the great potential of oxidative
labeling for understanding membrane protein structure and folding.
When structural changes are significant enough, HRF can be used to identify
physiologically relevant conformational changes in membrane proteins. One of the first
examples of such studies was work by Chance and co-workers in which the open and closed
states of the potassium channel KirBac3.1 in the detergent n-tridecyl-b-D-maltopyranoside
were investigated with millisecond HRF.67 From modification rate constant measurements of
residues in the open and closed states, it was found that L122 and L124 on one of the
transmembrane helices, M94 near the pore cavity, and T84, D85, F88, P107, and N110 at the
selectivity filter react faster with hydroxyl radical during channel opening (Figure 1.7). The
residues near the selectivity filter that have increased labeling rates were consistent with prior
postulations that an additional gating mechanism could exist. Importantly, changes in
modification rates for some residues at the slide-helix/N-terminal linker region and G-loop/CDloop region were some of the first direct experimental evidence for the role of the G-loop as a
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gate in the cytoplasmic domain of the protein.

Figure 1.7. Crystal structure of potassium channel KirBac3.1 in the closed state. Oxidatively
modified residues are shown as sticks. The magnitudes of the changes in modification rate
constants from the closed to open state are color-coded. Figure used with permission from
Gupta et al., 2010, DOI: 10.1016/j.str.2010.04.012

Synchrotron HRF has also been used to study solvent exposed regions in the
photosystem II (PS II) membrane protein, including presumed water channels.78 The PS II
protein consists of four subunits (CP47, CP43, D1, and D2), and two other subunits from
cytochrome b559. Around 75% of the residues that are oxidatively modified sit on the surface
of PS II. More interesting is the fact that some residues located in the interior of the protein
complex were labeled as well, including M331, E333, R334, and E323, which map to a putative
water channel. These experimental results complemented prior computational studies by
identifying residues involved in transporting water to the active metal center that then convert
water to oxygen. The HRF results in this study also led the authors to posit that another channel
existed that functions as an O2 or ROS exit pathway. The ability to identify water channels or
25

structural water molecules in transmembrane regions appears to be a unique capability of
synchrotron HRF because it can dissociate water molecules into hydroxyl radical that directly
oxidize Phe, Cys, Met, and Tyr residues, which are often found in transmembrane segments.
An example of HRF being used to examine the role of structurally important water
molecules in integral membrane proteins is the work on the G protein-coupled receptor (GPCR)
rhodopsin (Rho) by Chance and co-workers.66 Rho, which is a light-activated membrane
protein essential for vision, was studied by HRF in its ground state, photo-activated state, and
inactive state to understand the role of crystallographically observed water molecules on the
structure and function of this important protein. By rapidly mixing H218O into the samples and
performing HRF, the researchers were able to show that residues in the transmembrane helical
bundle were labeled with 16O from localized structural H216O that had limited exchange with
bulk H218O, whereas residues in the soluble domain were modified with 18O from bulk H218O.
The 16O labeling, and lack of 18O labeling, only in the transmembrane regions was independent
of the protein state, indicating that the structural waters in the transmembrane segments do not
exchange with bulk solvent even upon activation or inactivation. Instead, Rho activation
changed the sites of oxidation in the transmembrane helical bundle, suggesting that protein and
water dynamics are an important part of the mechanism controlling Rho activity. Overall, the
structural and dynamic information obtainable by HRF provides a valuable complement to Xray crystallography and NMR studies of membrane proteins.
Since the level of covalent labeling reflects the solvent accessibility and intrinsic
reactivity of modifiable residue side chains, oxidative modification by hydroxyl radical can be
used to assess the accuracy of computational protein structure prediction.79 WaaL, a membrane26

bound O-antigen ligase from E. coli with unknown higher order structure, was studied by
oxidative footprinting. High modification extents on M19, M291, and M316 and the lack of
modification on other Met and Cys residues were consistent with an algorithm that predicts
transmembrane helices in protein sequences. However, one Met residue, M151, that was
predicted to reside in a transmembrane helix was modified as well. This result led to a refined
structural model for WaaL that placed this residue closer to the periplasmic interface.
Complementary to hydroxyl radical, •CF3, which can label 18 of the 20 common amino
acid residues, has been used to investigate membrane proteins. Gross and co-workers used this
reagent to characterize the structure of vitamin K epoxide reductase (VKOR).63 Ten residues
on the extra-membrane regions were found to be labeled, including Ala and Gly residues, which
show low reactivity towards •OH. Surprisingly, •CF3 did not modify any transmembrane
regions despite its hydrophobicity. We speculate that the poor interactions between
fluorocarbons and hydrocarbons prevent the diffusion of trifluoromethyl radicals into the
membrane.
Covalent labeling with hydroxyl radical can also be used in a complementary fashion
with HDX/MS to obtain greater insight into the conformational changes undergone by
membrane proteins. As an example, the glycerol facilitator (GF) from E. coli, which is a
homotetramer where each monomer contains a transmembrane channel allowing the selective
permeation of glycerol and water, was interrogated by HDX-MS and FPOP.80 Each monomeric
unit in the protein consists of six helices and two half-helices that cross the membrane bilayer
and two extra-membrane helices (EM1 and 2) that make up the soluble domain. Upon
performing FPOP experiments on n-dodecyl-D-maltoside (DDM)-solubilized GF, Konermann
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and co-workers monitored the labeling extents of 13 Met, Cys, and Trp residues. They observed
that the completely or partially solvent exposed residues were primarily labeled (red in Figure
1.8), and the buried residues were generally not labeled (blue in Figure 1.8). Surprisingly, C134
and M237, which are found buried in the crystal structure of GF, were modified by •OH,
suggesting that the half-helical transmembrane segment in which these residues are found is
only marginally stable. HDX-MS results were consistent with this observation, showing
moderate conformational dynamics in this region. From these results, the authors postulated
that the flexibility of this transmembrane helix is necessary to strike a balance between
selectivity and efficient transport of glycerol and water.

Figure 1.8. Structure of the glycerol facilitator (GF). The transmembrane segment, TM7, is
shown in orange. Modified residues are shown in red while unmodified ones are shown in blue.
The dashed line represents the region of the protein near the N-terminus that is not resolved in
the crystal structure. Figure used with permission from Pan, Piyadasa, O'Neil, & Konermann,
2012, DOI: 10.1016/j.jmb.2011.12.052
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1.5.3.2 Protein-ligand and Protein-protein Interactions
The interactions between proteins and ligands and proteins with other proteins lead to
buried surfaces and conformational changes, both of which lead to changes in residue solvent
accessibility. Thus, CL-MS can be a powerful way to map binding interfaces and discover
structural changes by comparing the differences in labeling extent with and without
ligand/protein. A common class of membrane proteins that undergo conformational changes
upon protein or ligand binding are GPCRs, and they have been the focus of several CL-MS
studies. In addition to using HRF to study the role of structural waters in the GPCR Rho,
Chance and co-workers examined the conformational changes associated with photoactivation
of Rho and the subsequent interactions of this activated state with the G protein transducin
(Gt).81 By comparing the modification rate constants of residues in the ground state, photoactivated state, and the complex of activated Rho and Gt, it was found that Gt binding causes
the formation of a structural state in Rho that is different from the ground state or
photoactivated uncomplexed state. Specifically, the researchers found that the oxidation rates
of residues A346, M86, P303, and M288 significantly change in Rho-Gt complex compared to
Rho and activated Rho, allowing some molecular details about this new structural state to be
revealed.
Du et al. have demonstrated the merits of time-resolved HRF together with rapid
mixing in their CL-MS studies of the β2 adrenergic receptor (β2AR), which is another GPCR.82
In this work, the early conformational changes of β2AR forming a complex with the G protein
Gαsβ1γ2 (Gs) were studied by pulse-labeling of hydroxyl radical at various time points ranging
from 20 ms to 30 s after mixing (Figure 1.9). The duration of X-ray exposure (~ 50 µs) and the
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inherently fast reactivity of hydroxyl radical allowed the researchers to capture early
conformational changes. These conformational changes revealed transient intermediates that
seem to be important as selectivity filters and are states that are not evident from crystal and
cryo-EM structures. The residue-specific information possible with HRF pinpointed the
conformational changes to specific α-helices and β strands that likely explain GDP release,
which is important for eventual GTP binding and activation.

Figure 1.9. A) The oxidation levels of ICL2 on β2AR decrease over time because this region
forms an α-helix from an unstructured loop upon binding. B) The change of labeling extent of
M386 reveals that the interactions of C-terminus of Gαs with β2AR exposes its side chain and
then forms a stabilized α-helix. C) The rise in oxidative modifications of M221 and V375/F376
is explained by the conformational rearrangement after GDP release. When these residues have
new interactions with other hydrophobic residues, the labeling level drops. Figure used with
permission from Du et al., 2019, DOI: 10.1016/j.cell.2019.04.022
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A proton-coupled Zn(II) transporter YiiP was labeled by hydroxyl radical in both apoand Zn- form to unravel the structural differences in two conformations as a way to reveal the
mechanism of Zn(II) transport.83 Again, the fast reactivity of hydroxyl radical and the ability
to do time-resolved experiments yielded insight inaccessible to other methods. In these
experiments, the labeling rate of the region around V48/D49/I50 drops after Zn(II) binding
because D49 coordinates the ion. Furthermore, the energy released from the binding leads to
the reorientation of the transmembrane helix TM5, which is reflected by a drop in the labeling
rates of L152 and M197 and the increase in labeling of M151, M159, and M160. Time-resolved
CL experiments were carried out by rapid mixing of apo-YiiP with Zn(II) followed by pulsed
•OH labeling to capture structural dynamics in millisecond range. Averaging the labeling rates
of four modified residues on TM5 provided the approximate rate of TM5 motion, which is on
the same order of the macroscopic transport rate.
HRF can also be used to provide structural insight into the conformational changes
caused by ligand binding to a membrane protein in the absence of any crystallographic
information. As an example, the binding of one type of serotonergic receptor 5-HT4, with one
of its antagonists, GR125487, was characterized by HRF and compared to homology models.84
Upon binding of the antagonist, changes in the oxidation rates of several residues provide
insight into the ligand-binding site, structural changes caused by antagonist binding, and the
presence and movement of several structural waters that are likely located in transmembrane
regions as was seen in other GPCRs. Even though no high-resolution structural data existed to
compare to the HRF data, confidence in the results came from the fact that most of the changes
in oxidative labeling matched docking calculations, and the data shared ligand-binding
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characteristics that are typical of other GPCRs in the same class. Moreover, most of the labeled
residues were found to be located either at the solvent accessible sites or in transmembrane
regions known to have integral structural water molecules. The study demonstrates the power
of CL-MS in revealing binding sites and structural changes after ligand binding to membrane
proteins with no other direct structural data.
The sensitivity of HRF rates to the solvent accessibility of protein sites makes the
technique very valuable for studying protein-protein interactions in membrane protein
complexes. The interactions of photosystem II (PS II) with PsbP and PsbQ, which are two
water-soluble extrinsic proteins in higher plants that play essential roles in oxygen evolution
under physiological conditions, is a good example.85 The organization of the 20-protein PS II
system, particularly the locations of PsbP and PsbQ, is unclear, even though individual highresolution structures of these water-soluble proteins exist. In studies by Bricker and co-workers,
HRF revealed that regions on the surfaces of these proteins were resistant to oxidative
modification when in contact with components of PS II, indicating that these two proteins
define buried regions within the larger PS II system. While relatively few HRF studies of
membrane protein-protein interactions in artificial systems have been reported, the large buried
interfaces associated with protein-protein binding would seem to make CL-MS a powerful tool
for mapping such sites.
While HRF can provide insight into membrane protein binding, it primarily reports on
soluble domain sites unless the transmembrane segments already have structural waters or
water channels. Manzi et al. have investigated the capability of photoactivatable aryl diazirines,
which are precursors to highly reactive carbenes, as a complementary means of labeling
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transmembrane regions of a protein.55 Using an aryl diazirine (Figure 1.10), these researchers
were able to label the micelle-embedded regions of the outer membrane porin, OmpF, a
homotrimeric membrane protein. In contrast to hydroxyl radical, the aryl diazirine can insert
into the micelles, and upon laser irradiation at 349 nm, carbenes can be generated that modify
hydrophobic transmembrane regions. Interestingly, most of the extracellular regions of the
protein were unlabeled, suggesting this diazirine precursor is particularly suited for membraneembedded regions. Moreover, most of the modified residues in the artificial membrane are
located on one side of the β-barrel structure, revealing the other side to be the trimeric interface
of OmpF. More water-soluble diazirines, such as photoleucine (Figure 1.10) were unable to
label membrane-embedded regions of OmpF. Not surprisingly, the carbenes generated by the
aryl diazirine react extensively with the detergent used to solubilize OmpF. This observation
means higher concentrations of labeling reagent are needed. These necessary higher
concentrations also raise concerns about how the diazirine precursors might influence
membrane structure and fluidity, thereby also negatively affecting membrane protein structure.
Assuming the precursor concentrations are kept as low as possible, then membrane perturbation
is probably not a large concern.

Figure 1.10. Structures of aryl diazirine (left) and photoleucine (right).

1.5.3.3 Impact of Different Lipids on Proteins
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CL-MS has also been used to examine the interactions between different lipids and
membrane proteins. Gross and colleagues investigated the different impact of the detergent
DDM and nanodiscs on the topology of light-harvesting complex 2 (LHC 2) from B850
bacteriochlorophyll a using FPOP.59 To compare the extent of oxidation at the residue level in
the two membrane environments, leucine enkephalin was added as a reporter peptide to
normalize LHC 2 reactivity due to the differences in reactivity of DDM and nanodiscs with
hydroxyl radical. The researchers found that LHC 2 residues were oxidized to a greater extent
in DDM, perhaps due to the higher mobility of this detergent. However, nanodiscs provided
better protection for the membrane-embedded regions of the proteins suggesting that the
protein higher-order structure in the nanodiscs were more native like than in the simple
detergent. In addition to providing some insight into how different detergents affect protein
reactivity with hydroxyl radical, this study also indicates that nanodiscs might be a better
artificial membrane system for some proteins than the commonly used DDM detergent.
In an analogous study, Watkinson et al. studied the interactions of DDM and amphipols
(A8-35) with the membrane protein OmpT via FPOP.86 Some previous studies had shown that
polymeric amphipols can be more effective than detergent micelles at maintaining the native
structure of membrane proteins, and FPOP was used to compare the solvent accessibility of
OmpT in these two artificial membrane systems. The group found that oxidation levels were
different for key residues when DDM and amphipols were used, suggesting that the artificial
membranes interact differently with OmpT. Moreover, the site-specific differences in the
modification extents indicate greater intermolecular contacts between the amphipols and OmpT,
providing a molecular-level rationale for the greater stability of OmpT in amphipols.
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1.5.4 Residue Non-specific Labeling in Cells and in vivo
The integration of CL with MS to investigate membrane proteins in cells or in vivo is a
relatively new and exciting area of research. In contrast to CL-MS of proteins in vitro,
experiments conducted in cells or in vivo seek to study native proteins in their normal cellular
environment. Studying proteins under these conditions provides a more relevant setting in
which to understand a membrane protein’s structure and interaction. For example, in a cellular
context, membrane proteins may have competing interactions with multiple different molecules
and the presence of clusters of lipids, ions, and small and large molecules, which could all
influence their structure. Although in cell and in vivo labeling are relatively new areas that have
primarily used FPOP, researchers have made a lot of promising progress in the last five years.
There are numerous technical issues to consider when using non-specific reagents to conduct
CL-MS experiments on living cells or organisms, including the following.
1.5.4.1 Reagent Toxicity
An important aspect to consider when performing CL-MS experiments on cells or in
vivo is the effect of the reagent on cell or organism viability. To minimize toxicity, optimization
of reagent concentrations and reaction time are necessary. Often, the viability of cells are
reported by measuring ATP concentrations 87 while fluorescence from propidium iodide, which
inserts into the DNA of dead cells, is used to indirectly reflect the viability of organisms, such
as C. elegans, at different reagent concentrations.88
1.5.4.2 Chemical Penetration Enhancers (CPEs)
Reagent access to the cells or organisms is one of the more challenging aspects of CL35

MS experiments, yet it is essential to control as it largely determines the labeling efficiency,
especially for the intracellular side of membrane proteins and for multicellular organisms.
Jones and co-workers have found that the addition of CPEs can increase the uptake of labeling
reagents via mild disruption to the lipid bilayer.89 These CPEs should not be toxic to the cell or
organism within the working concentrations and ideally should not interfere with the labeling
reagent. The addition of 1% 1-dodecylazacycloheptan-2-one, known by its registered
trademark name Azone®, for FPOP experiments has been found to increase the number of
modified proteins and their oxidation extents in the nematode C. elegans. Azone is capable of
increasing the penetration of the H2O2, which is needed for FPOP experiments, while exhibiting
low toxicity itself. CPE use is far from optimized in such labeling experiments, so searching
for other CPE compounds that can be compatible with reagents and facilitate even higher
labeling efficiencies is still required.
1.5.4.3 Choice of Quench/Scavenger Reagents
Not only is it important to consider the penetration of the labeling reagent, cell
permeability of the quenching/scavenging reagent is vital as well. Because cells have high
concentrations of proteins, the radical scavengers that are used in hydroxyl radical labeling
experiments (i.e. Gln or Phe) are typically not required in cell labeling experiments. Quenching
reagents are still needed to consume H2O2, and Jones and co-workers have found that N’dimethyl-thiourea (DMTU) and N-tert-butyl-α-phenylnitrone (PBN) are better than catalase
and methionine owing to their good cell permeability properties.87
1.5.4.4 Labeling Platform
Labeling cells and organisms introduces additional logistical challenges that are absent
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in simple solution-based experiments. Consequently, Jones and co-workers have developed a
novel microflow system for IC-FPOP to increase labeling efficiency and to improve
modification reproducibility during the experiments.90 By adding two sheath flows besides the
central cell flows with relatively high velocity, optimal laser irradiation of single cells at a time
allows for increased oxidation extents (Figure 1.11a). To increase the throughput of their initial
system, they designed a Platform Incubator with XY movement (PIXY) in which FPOP in cell
or in vivo (i.e. C. elegans) can be done on an optical bench (Figure 1.11b).91 Four pumps control
the flow of reagents or buffers automatically while laser pulses occur at each well. By utilizing
this improved platform, the number of modified proteins further increases, and some proteins
have more modified residues compared to their initial microflow system. Precursor isotopic
labeling with isobaric tagging is also integrated into their FPOP system to greatly reduce
analysis time and to increase biological reproducibility in vivo.92
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Figure 1.11. a) Scheme illustrating the IC-FPOP microflow system created by Jones and coworkers. b) Scheme illustrating the Platform Incubator with XY movement. Figure used with
permission from Rinas, Mali, Espino, & Jones, 2016, DOI: 10.1021/acs.analchem.6b02357 and
Johnson,
Punshon-Smith,
Espino,
Gershenson,
&
Jones,
2020,
DOI:
10.1021/acs.analchem.9b04933.

1.5.4.5 Protein Purification and Enrichment
Just as with artificial membrane systems, non-protein molecules are removed after the
modification experiment by precipitation, SDS-PAGE, and/or affinity columns, as indicated
earlier. Given the complexity of the samples, however, the use of affinity tags linked to the
proteins of interest often needs to be considered to improve detectability, especially for
membrane proteins that are underrepresented in proteomics experiments on cells and tissues.
An important consideration is that the affinity tag should ideally not react with the labeling
reagents, thereby reducing enrichment efficiency. The broad reactivity of •OH makes affinity
enrichment for challenging when FPOP or synchrotron HRF is used.

In cell FPOP (IC-FPOP) has been applied to study protein structure.87 After optimizing
the H2O2 concentrations and cell culture volumes to ensure moderate cell viability, many
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proteins in different cellular compartments, including membrane proteins, with a variety of
abundances can be modified. MS measurements show that 17 different types of residues can
be labeled, with Met, Glu, and Asp being the most frequently detected. In one of the first
examples of IC-FPOP on cells, the extent of modification of residues in the protein actin were
found to have the same trend as when the protein is labeled in vitro. The in-cell labeling showed
a stronger correlation with the open state of actin as compared to the close state, indicating
most of the actin was in open state in Vero cells during the FPOP experiments.
The conformational changes of epidermal growth factor receptor (EGFR) upon binding
with EGF were characterized by nanosecond laser photolysis protein footprinting in HEK 293K cells.93 The majority of the modified residues that were detected are solvent accessible with
and without EGF activation. Upon EGF binding, five peptides showed increased levels of
oxidation, whereas only two peptides showed decreased oxidation. These regions that increase
in labeling span across some subdomains in the extracellular regions, demonstrating that the
binding of EGF triggers these regions to be more extended. The decreasing oxidation of two
peptides reflects that they are more buried causing by the conformational changes after EGF
binding.
An exciting recent development by the Jones group is the application of FPOP to
investigate protein structure in vivo.88 The nematode C. elegans was mixed with 200 mM H2O2
immediately before photolysis, and then the UV laser was fired at 50 Hz, resulting in 545
modified proteins from the nervous, alimentary, muscle, and epithelial systems. Among them,
membrane proteins from the transmembrane 9 superfamily, the TWiK family of potassium
channels, the KvQLT family of potassium channels, and olfactory channels were found to be
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oxidized. The authors found that the oxidation levels of the modified residues from the heat
shock protein 90 (Hsp90) correlate with their SASA values acquired from the protein’s crystal
structure. Likewise, the oxidation levels of the protein actin were found to be consistent with
its oxidation levels in cells. The ability to perform FPOP on live organisms opens up many
possibilities for characterizing membrane protein structures and interactions in vivo.
Oxidative labeling of membrane proteins in live cells was also conducted by Zhu et al.
to study the structure and dynamics of trimeric OmpF under different physiological
conditions.94 In this case, •OH were generated through an in situ Fenton reactions rather than
laser photolysis of H2O2 because the E. coli culture medium interfered with the transmission
of light. The modification extent of the residues in loops L1, L3 and L6, which are at or close
to extracellular domains, are higher than the oxidation levels of residues in the internal β-barrels
that comprise the transmembrane regions. There were no modifications of loops L2 and L4
located at the trimer interfaces. Interestingly, when OmpF is subjected to low pH, low ionic
strength, or both, the oxidation extent of residues in the internal β strands significantly drops.
This lower oxidation extent was interpreted as being caused by the closure of OmpF channel
preventing Fe(II) ions from initiating the Fenton reactions inside the channel.
Metal-catalyzed oxidation (MCO) reactions have also been used to identify proteins
binding to cell surface glycoproteins in three cell lines (PNT2, Caco-2, and A549).95 In this
work, azido groups were incorporated into sialylated glycoproteins followed by click chemistry
to link Fe(II) complexes to the glycoproteins (Figure 1.12). The addition of H2O2 to the samples
catalyzed the production of hydroxyl radical at the Fe center, causing proteins that were close
to the functionalized sialic acids to be oxidatively modified (Figure 1.12). MS was then used
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to identify the oxidized proteins, and they were found to fall into three categories: 1) sialylated
glycoproteins having transmembrane domains, 2) non-sialylated membrane proteins having
interactions with sialic acid, and 3) extracellular proteins without transmembrane domains but
having interactions with sialic acid.

Figure 1.12. Scheme illustrating protein oxidation near cell surface glycoproteins as generated
by Fenton chemistry. Fe(II) complexes are incorporated into glycoproteins via click chemistry,
and then proteins are oxidized through metal-catalyzed oxidation reactions. Figure used with
permission from Li, Xie, Xu, & Lebrilla, 2019, DOI: 10.1039/C9SC01360A.

Oxidative labeling of membrane protein labeling in cells can also been conducted using
H2O2 alone without the addition of metals or irradiation with light. In such cases, the extent of
labeling is often too low to be confidently identified, but some structural insight can be obtained
by quantifying the levels of unmodified peptides, as a way to reveal indirectly which solvent
exposed sites are oxidized. As an example, Yao and co-workers used such an approach to study
the cystic fibrosis transmembrane conductance regulator (CFTR), which is a chloride ion
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channel on the surface of epithelial cells.96 To improve the quantification accuracy of the
unmodified peptides, internal standards were added, and measurements were conducted using
multiple reaction monitoring (MRM). The researchers found that unmodified peptides from the
loop regions on CFTR decreased in abundances as H2O2 concentrations were increased, while
unmodified peptides from transmembrane regions changed less.
1.6 Residue Specific Labeling
1.6.1 Labeling Reagents
In contrast to non-specific reagents that probe the topology of a variety of residues
altogether, residue-specific reagents only modify one or a few residue side chains in a given
protein. Residue-specific reagents are easy to use, as they are typically just added to solution,
and their limited modification scope actually simplifies the resulting MS analysis. However,
they generally provide lower structural resolution, and some prior structural information about
the protein of interest is often needed to apply them most effectively. A wide variety of residuespecific labeling reagents have been created and used in CL-MS experiments,47, 51 but the ones
most commonly used for membrane protein studies are: the combination of 1-ethyl-3-(3(dimethylamino)propyl)carbodiimide (EDC) and glycine ethyl ester (GEE) for Asp/Glu
labeling, butane-2,3-dione (BD) for Arg, diethylpyrocarbonate (DEPC) for nucleophilic
residues such as Lys, His, Tyr, Ser, and Thr, N-ethylmaleimide (NEM) for Cys, and
sulfosuccinimidyl acetate for Lys. The polar residues that are targeted by these reagents are
often either located on the extra- or intra-cellular segment of membrane proteins, and they often
are involved in protein-ligand and protein-protein interactions. Thus, residue specific labeling
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can unravel the important roles of these residues in regulating protein structures or mediating
protein interactions. Moreover, as alluded to earlier, experiments that use these reagents can be
conducted without a complex setup (e.g. laser), and the data interpretation is much simpler than
with oxidative labeling. An additional aspect of residue-specific labels is that these reagents
can be isotopically encoded. By analyzing together proteins that are labeled with a ‘light’
isotopically encoded reagent under one condition and proteins that are labeled with a ‘heavy’
reagent under another condition, detection time can be dropped in half. In addition, the
quantification accuracy is improved because the isotopically labeled peptides from the two
conditions are detected at the same time and have the same ionization efficiency.97
1.6.2 Technical Challenges of Residue-Specific Labeling Experiments
Many of the technical challenges for membrane protein analysis that were described in
section II.B. for non-specific labeling reagents are also present when using residue specific
labeling reagents. These include the choice of the artificial membrane, the removal of the
membrane components before analysis, and protein digestion. In the process of using residuespecific labeling reagents, one must also consider a protein’s structural integrity during the
labeling reaction. In sharp contrast to non-specific reagents such as hydroxyl radical, residuespecific reagent react more slowly, and it is possible that proteins change their structure during
the longer reaction times (i.e. seconds to minutes) that are required for a protein to obtain
adequate modification extents. To avoid these structural changes, reagent concentrations and
reaction times must be optimized to avoid overlabeling the protein. In addition, often a
complementary technique such as circular dichroism (CD), fluorescence spectroscopy or
activity assays must be used to confirm that the protein’s structure has not been significantly
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changed. However, all of these techniques are only able to detect significant conformational
changes and are not sensitive to local structural perturbations.19 A more reliable, but more
experimentally involved way, to monitor the structural integrity of the protein during these
labeling reactions is to measure the labeling reaction kinetics, as deviations in kinetic plots are
a very sensitive way to identify structural perturbations. Alternatively, restricting the extent of
labeling to one label per protein on average is a safe way to obtain reliable information, but
this approach also limits the number of labeled peptides that will be detected, leading to less
structural information.
1.6.3 Applications of Residue Specific Labeling to Membrane Proteins
1.6.3.1 Structural Characterization
Like CL with non-specific reagents, CL with residue-specific reagents is affected by
the solvent accessibility of residue’s side chains, and so it can be used to monitor the topology
of membrane proteins. As an example, Schmidt et al. used DEPC labeling data and
computational modeling to study an F-type ATP synthase (cATPase).98 The structure
information about this assembly is limited, and CL-MS was able to provide solvent
accessibility information of residue side chains to facilitate structure prediction. The protein
was subjected to DEPC labeling, and modified residues were identified through LC-MS/MS
analysis. Using the DEPC labeling results as modeling constraints and applying a customized
scoring algorithm together with native MS and cross-linking data, the authors were able to
assemble a structural model for cATPase. Based on this model, they were able to conduct MD
simulations to investigate the dynamics of this nanomotor.
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1.6.3.2 Protein-ligand and Protein-protein Interactions
Residue-specific reagents have been more commonly used with MS to study membrane
protein-ligand or protein-protein interactions. One example was work by Knapp and colleagues,
who studied photo-activated Rho (Rho*) and its binding interactions with α subunit of the Gprotein transducin (Gtα) in the detergent DDM.99 Ground-state Rho, Rho*, Rho with the Gtα
peptide 340-350, and Rho* with the Gtα peptide 340-350 were separately incubated with the
Lys-specific reagent sulfosuccinimidyl acetate followed by enzymatic digestion and LCMS/MS measurements. Most of the residues labeled by this reagent were found to be on the
cytoplasmic side of the protein. The acetylation levels of K66/K67 on one soluble loop and
K141 on another soluble loop slightly dropped after light activation, while the reactivity of
K325 at the C-terminus declined dramatically, providing some insight into the structural
changes induced by light. After binding with the Gtα peptide fragment, the extents of
modification of K66/K67 and K311 on another soluble loop decreased due to interactions with
the peptide, while K141 was less impacted by Gtα peptide binding. This work represents one
of the earliest examples of CL-MS confirming structural changes of Rho after photoactivation
and Gtα peptide binding.
The value of lysine specific reagents to study membrane proteins is also seen in the
work on N-methyl-D-aspartate receptors (NMDARs), which are glutamate receptors and ion
channel proteins in the central nervous system (CNS).100 Binding regions of three ligands
(Ro25-6981, gavestinel and UBP710) and associated conformational changes of NMDARs
were studied using dimethyl labeling of Lys residues using formaldehyde followed by sodium
cyanoborohydride (NaBH3CN) reduction. According to the researchers, this CL method is
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highly efficient and does not deactivate the membrane protein complex. Ro25-6981 and
gavestinel were found to bind to two different regions on the receptor based on labeling
decreases at Lys residues in different domains, whereas UBP170 shielded some of the same
Lys residues in both regions, indicating that this molecule binds at the dimer interface created
by these two different regions.
Residue-specific labeling reagents have also been used to reveal the conformational
changes of β2-adrenergic receptor (β2AR) after binding with nine different ligands separately
in DDM.101 The nine ligands included full agonists, partial agonists, weak partial agonists,
antagonists, and inverse agonists. Lefkowitz and coworkers used isotopically-encoded NEM
and succinic anhydride to modify Cys and Lys residues at various time points after the addition
of ligands.102 The reactivity of each modified residue in bound state versus unbound state were
used to compare with the classical Gα activation mechanism. The researchers found that two
Cys residues (C77 and C327) correlated with expected mechanism, whereas the reactivity of
other residues were quite variable, indicating that the conformational changes of β2AR that are
induced by binding are ligand dependent.
Even though free Cys residues appear much less frequently in proteins than Lys residues,
Cys-specific labeling reagents can still be used to provide useful binding information for
membrane proteins. One example is from studies of the D-galactose-H+ symport protein (GalP)
and its structural changes upon binding D-glucose.103 NEM was used to modify the three Cys
residues in this protein. Two of the Cys residues decreased in labeling, while one residue’s
reactivity remained unchanged. The decreased labeling of one of the residues (C374) could be
explained by previous information about the glucose-binding site, but the unexpected decrease
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in C19 labeling could only be attributed to protein conformational changes. Analogous insight
into conformational changes were obtained for Mhp1, which is a sodium dependent transport
protein for 5-aryl-substituted hydantoins.104 One Cys residue, C327, was found to exhibit high
reactivity in the inward-facing state of this membrane protein (Figure 1.13). Upon incubation
with Na+ and 5-benzyl-L-hydantoin (L-BH) together, Mhp1 switches from the more
predominant inward-facing state to an outward-facing state in which C327 is mostly buried,
which lowers the NEM modification percentage of this residue (Figure 1.13). Upon titrating LBH concentrations and measuring changes in the modification levels of this Cys residue at
different Na+ concentrations, Michaelis-like constant (Km) values could be acquired for both
Na+ and L-BH.

Figure 1.13. Cartoon illustrating the Mhp1 transport mechanism between outward-facing and
inward-facing conformations. Yellow stars are the residue C327; green dots represent Na+, and
red dots represent the L-BH molecule. Figure used with permission from Calabrese et al., 2017,
DOI: 10.1021/acs.analchem.7b01310.

Wen et al. used EDC/GEE to identify the binding interactions of the membrane-bound
Fenna-Matthews-Olson (FMO) antenna protein, which links the large peripheral chlorosome
complex to the reaction center in photosynthetic bacteria.105 The isolated FMO protein, FMO
from chlorosome-depleted membranes of Chlorobaculum tepidum, and FMO from native
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membrane isolates were reacted with EDC/GEE to discover the binding interfaces (Figure
1.14). A comparison of the labeling sites and extents from these three constructs were able to
reveal the orientation of the FMO protein in the larger photosystem complex. The researchers
noted that their results were consistent with theoretical predictions about the architecture of the
photosystem, but noted that the relatively small size of the reagent, and presumably its
relatively slow reactivity, might cause it to miss some more weakly interacting sites.

Figure 1.14. Experimental workflow for discovering the interactions of FMO with chlorosome
and the reaction center. FMO alone, chlorosome-depleted complex, and the complex are
labeled by EDC/GEE followed by enzymatic digestion and LC-MS/MS analysis to compare
the modification extent of peptides in three cases. Figure used with permission from Wen,
Zhang, Gross, & Blankenship, 2009, DOI: 10.1073/pnas.0901691106.

The binding interfaces of substrates with lactose permease (LacY), which is a
membrane protein that facilitates lactose transport across cell membranes, were also
investigated using carbodiimide chemistry
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and the arginine specific reagent BD.107 The

studies using carbodiimides are particularly important for demonstrating the value of residuespecific reagents. In the presence of p-nitro-phenyl-α-D-galactopyranoside (p-NPGal), which
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is a high-affinity ligand, the modification level of E269 in LacY was dramatically reduced,
indicating this Glu as a key residue that binds the substrate. Combining the modification profile
of LacY with other p-NPGal derivatives that have deoxy and methoxy functional groups at
different positions on the galactopyranosyl ring, Weinglass et al. proposed that E269 interacts
with the C-3 OH of the ring. These observations are intriguing, as they suggest that proper
experimental design can provide even higher resolution information than would be predicted
based on the size and reactivity profile of the reagent. Moreover, the higher observed reactivity
of E269 towards more hydrophobic carbodiimide labeling reagents suggested a more
hydrophobic environment around the binding sites. This latter observation highlights another
potential advantage of residue-specific labeling reagents. They can be sensitive to the local
microenvironment in ways that non-specific reagents are not, allowing them to provide deeper
molecular-level information.108
1.6.4 Residue Specific Labeling in vivo
Like non-specific CL coupled with MS to study membrane proteins in vivo, the
combination of residue-specific CL with MS can provide insight into protein structure and
interactions in cellular environments. Despite some technical challenges that must be
considered, the past few years have witnessed several successful studies of membrane protein
topology and their interactions with ligands by residue-specific CL techniques.
Technical Challenges of Residue Specific Labeling Experiments on Membrane Proteins
in vivo
1.6.4.1 Reagent Permeability
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We have mentioned some challenges of CL labeling in vivo such as reagent toxicity, the
choice of quench reagent, labeling platform and protein enrichment. For residue specific CL,
we need to pay special attention to reagent permeability. Given the variability in their sizes,
hydrophobicities, and charges at physiological pH, different reagents will have different
abilities to pass through the cell membrane and thus different abilities to provide structural
information for extra-cellular or intra-cellular regions of membrane proteins. In general, small
molecules with no charge or hydrophobic molecules can pass through cell membrane whereas
large polar or ionic molecules cannot.
1.6.4.2 CPEs
CPEs have been applied to increase the cellular uptake of residue-specific reagents.
Digitonin, a non-ionic detergent, is often used to facilitate the delivery of small molecules into
cells by permeabilizing cell membrane. Li et al. pre-treated mammalian cells with digitonin to
increase the labeling efficiency of EDC/GEE without affecting functional integrity. Other CPEs,
such as Azone®, could conceivably be used as well.109
1.6.4.3 Peptide Abundance
Membrane proteins consist of some hydrophobic transmembrane segments that have
low solubility and poor ionization efficiencies. In addition, membrane proteins and their
proteolytic fragments are often underrepresented in traditional proteomics experiments, further
affecting the detection of covalently labeled proteins and influencing the accuracy of their
quantitation. One advantage of residue-specific labeling reagents is that functional groups such
as biotin groups can be added to the reagent to facilitate enrichment of the modified peptides.
Some researchers have also mixed ‘light’ and ‘heavy’ versions of labeling reagents as a means
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of enhancing relative quantitation during MS detection.109

Only a few examples of using residue-specific labeling reagents for CL-MS of
membrane protein in cells have appeared in the literature. In one example, EDC/GEE labeling
of Asp and Glu residues in human glucose transporters (hGLUTs) was used to identify key salt
bridge interactions in two conformations.109 When hGLUT1 is not bound to a ligand, it has an
equilibrium between outward-facing and inward-facing conformations. The binding of Dglucose or D-maltose shifts the equilibrium towards outward-facing conformation in which
E329 forms a salt bridge with R333, and decreased modification of E329 allowed this to be
determined. In contrast, when the mycotoxin cytochalasin B is bound, hGLUT1 favors an
inward-facing conformation. Labeling with EDC/GEE identified that E299 decreases in
labeling under this condition because of the formation of a salt bridge with K38. Key salt
bridges in different conformations of another transporter, GLUT5, which is a fructose specific
binding protein, have been characterized by EDC/GEE-based CL-MS as well.
In another example, a two-step modification procedure involving EDC/Nhydroxysulfosuccinimide activation and a biotinyl cystamine reaction to label Asp/Glu residues
has been used to identify soluble regions in the extracellular domains of membrane proteins in
human HL60 cells (Figure 1.15), and this labeling data was used to help refine computational
models of membrane proteins from this organism.110 The use of a biotinylated reagent along
with an avidin-based enrichment column enhanced the detection of membrane protein
proteolytic fragments after cell lysis and protein digestion. In total, 135 residues from 38
different transmembrane proteins were modified, and the majority of the labels were found in
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predicted extracellular regions, meaning that CL-MS is likely to be more broadly applicable
for improving the accuracy of membrane protein topology predictions.

Figure 1.15. Scheme illustrating covalent labeling of Asp and Glu residues by EDC/sulfo-NHS
activation and the subsequent biotinyl cystamine reaction. After cell lysis and protein digestion,
peptides from membrane proteins are enriched via the binding between biotinylated Asp/Glu
and neutravidin column. The addition of dithiothreitol (DTT) was applied to elute the peptides
followed by iodoacetamide (IAM) alkylation. Figure used with permission from Müller et al.,
2019, DOI: 10.1038/s41598-019-52188-4.

Alkylation of Cys residues by NEM has been also applied for investigating the higher
order structure and binding interactions of human vitamin K epoxide (hVKOR), an enzyme in
the endoplasmic reticulum (ER) membrane in HEK 293 cell line.97, 111 To monitor the redox
status of multiple Cys residues in hVKOR, the reduced form was first labeled by NEM in cells.
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After cell lysis, the oxidized form was reduced and labeled by d5-NEM. By calculating the
apparent oxidized fraction from the ratio of NEM labeling extent with the light and heavy
reagent, the researchers were able to identify which Cys residues formed disulfide bonds and
which did not. When hVKOR was labeled in the presence of warfarin, a known binder of this
protein, it was also demonstrated that certain disulfide bonds and a free Cys were crucial for
warfarin binding, facilitating the construction of warfarin-hVKOR model from molecular
dynamics (MD) simulations.

1.7 Outlook
The past 10 years have witnessed the rapid development of CL-MS techniques for
membrane protein structural analysis. Since membrane proteins are common drug targets,
knowledge about their higher order structures and interactions can facilitate the research and
development of new therapeutics. We predict that more researchers will begin to use CL-MS
techniques to study the wide range of membrane protein systems given their immense
importance. Moreover, because there is a dearth of structural information about membrane
proteins in live cells, CL-MS methods have the potential to have a huge impact on the field in
the future. From a technique standpoint, one need is the development of new reagents with
different chemical properties that can separately react with exposed or membrane-buried region
of the protein. For studies of intact cells or organisms, the cell penetration efficiency of reagents
will also need to be further enhanced by identifying reagents that can pass through cell
membranes or by finding better chemical penetration enhancers. The effect of the lipid
membrane itself and components in real cell membranes need more study as well.
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Improvements in the analysis of proteins by LC-MS/MS are always emerging, and these
improvements will undoubtedly increase the structural resolution possible in CL-MS
experiments, as better detection efficiency is achieved. However, approaches to selectively
enrich membrane proteins will also likely be needed to access the full potential of the method.
As CL-MS methods continued to be used more broadly, they will likely be combined more and
more with computational modeling to predict and refine membrane protein structures. Overall,
we feel that CL-MS is poised to improve our understanding of cellular biochemistry by
revealing membrane structure and interactions that are currently not accessible by other
techniques.
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CHAPTER 2
HIGHER-ORDER STRUCTURE INFLUENCES THE KINETICS OF
DIETHYLPYROCARBONATE COVALENT LABELING OF PROTEINS
This chapter is part of a research article published as: Pan, X.; Limpikirati, P.; Chen, H.; Liu,
T.; Vachet, R. W., Higher-Order Structure Influences the Kinetics of Diethylpyrocarbonate
Covalent Labeling of Proteins. Journal of the American Society for Mass Spectrometry 2020,
31 (3), 658-665.
2.1 Introduction
Analyzing protein higher-order structure (HOS) is important in a variety of contexts
including investigations of protein folding, aggregation, interactions and function. Covalent
labeling-mass spectrometry (CL-MS) is being developed as a protein HOS analysis technique
due to good structural coverage, high sensitivity, robustness, and simplicity.1-4 In CL techniques,
chemical reagents are utilized to modify the side chains of residues exposed on the protein
surface. Determining the labeling at individual residues allows site-specific information to be
obtained, and protein digestion followed by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) measurements typically are used to identify specific modification sites. Unlike
hydrogen-deuterium exchange,5-6 CL is generally not subject to the back exchange and label
scrambling, allowing standard proteomics workflows to be used. CL-MS has been successfully
used for protein surface mapping,7 probing interfaces in protein complexes,8-11 discovering
protein-folding pathways,12-14 and characterizing therapeutic proteins.15-18
CL reagents can be classified into two general categories: residue-specific reagents and
non-specific reagents.1-2,

19

Non-specific CL reagents have the advantage of modifying

numerous residues in proteins, providing better structural resolution. Non-specific reagents
include hydroxyl radicals, carbenes, trifluoromethyl radicals (•CF3), and diethylpyrocarbonate
62

(DEPC). Our group has been investigating DEPC labeling for studying protein HOS because
of the simplicity of using this reagent.20-23 DEPC labels N-termini and the side chains of several
nucleophilic residues, including His, Lys, Tyr, Ser, Thr, and free Cys (Scheme 2.1). DEPC can
probe up to 30% of the sequence of the average protein and generates a single type of product,
facilitating subsequent MS analysis. For comparison, hydroxyl radicals can label almost all the
amino acid side chains in proteins but produce over 50 different product types, sometimes
complicating data interpretation.3 Moreover, hydroxyl radicals, like carbenes and •CF3, require
more expensive and sophisticated equipment, such as a laser, while DEPC labeling can be
performed by simple sample mixing.

Scheme 2.1. DEPC reactions with different nucleophilic residue side chains

When DEPC is used to label proteins to get HOS information, the proper reagent
concentration must be chosen to control the extent of labeling and prevent modificationinduced structural changes. Unlike carbenes and radical reagents that are thought to react faster
than the proteins can change structure, DEPC reacts more slowly, so one DEPC modification
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could conceivably cause structural changes such that subsequent modifications no longer probe
the correct structure. Previously, our work has shown that limiting the extent of DEPC
modification to 1 to 1.2 labels per protein on average helps ensure the structural integrity of
the protein during DEPC labeling, while at the same time getting enough labeling to sensitively
monitor protein structure.20 However, when studying a new protein, it can be time consuming
to optimize the DEPC concentration to ensure about 1 to 1.2 labels per protein. Thus, we
decided to explore whether there are structural features that can quantitatively predict the
reactivity of proteins with DEPC, so that the proper DEPC concentration can be chosen without
time-consuming empirical optimization.
To achieve this goal, we have measured the DEPC reaction rates of numerous model
proteins with known structures and have attempted to establish a quantitative correlation
between their structural features (e.g. number of modifiable residues, solvent accessibility of
modifiable residues) and DEPC modification rates. Based on previous work, we know that the
trend in DEPC reactivity is His > Lys > Tyr, Ser, Thr and have learned recently that the
reactivity of Tyr, Ser, and Thr are affected by nearby hydrophobic groups.23 These insights
provide a good starting point for developing a quantitative relationship between protein
structural features and DEPC reaction rate coefficients, which would allow us to predict
optimal DEPC labeling conditions. Furthermore, our quantitative measurements of protein
reactivity with DEPC provide new insights into the protein structural features that affect their
reactivity, thereby deepening our understanding of this useful reagent.

2.2 Experimental Section
2.2.1 Materials
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The model proteins that were used in this study include ubiquitin, -2 microglobulin
(β2m), equine cytochrome c, chicken egg white lysozyme, myoglobin, carbonic anhydrase, α1 antitrypsin (α1AT), and transferrin. Several additional proteins, including bovine cytochrome
c, human lysozyme, ΔN6-β2m, human growth hormone (hGH), and maltose binding protein
(MBP), were also studied. Ubiquitin from bovine erythrocytes (#U6253), cytochrome c from
equine heart (#C7752), cytochrome c from bovine heart (#C3131), lysozyme from chicken
egg white (#L6876), human lysozyme (#L1667), myoglobin from equine skeletal muscle
(#M0630), carbonic anhydrase from bovine erythrocytes (#C7025), α-1 antitrypsin from
human plasma (#A9024), human transferrin (#T8158), diethylpyrocarbonate (DEPC)
(#D5758), imidazole (#I5513), 3-morpholinopropane-1-sulfonic acid (MOPS) (#M1254),
MOPS sodium salt (#M9381), guanidine hydrochloride (GuHCl) (#G4505), sodium chloride
(NaCl) (#S5886), phenylmethylsulfonyl fluoride (PMSF) (#10837091001), and arabinose
(#A3256) were all bought from Sigma-Aldrich (St. Louis, MO). Human full-length -2
microglobulin (2m) were purchased from Lee Biosolutions (Maryland Heights, MO).
Recombinant human growth hormone (hGH) (#4769), and maltose binding protein (MBP)
(#MBS203159) were ordered from BioVision (Milpitas, CA), and MyBioSource (San Diego,
CA), respectively. Sodium phosphate dibasic anhydrous (#S374), ammonium acetate (#A639),
Tris base (#BP152), acetic acid (#A38C-212), formic acid (#A117), water (#W7), and
acetonitrile (#A998) were obtained from Fisher Scientific (Fair Lawn, NJ). Sodium phosphate
monobasic monohydrate (#S0710) was bought from EM Science (Darmstadt, Hesse, Germany).
Tris hydrochloride (#10812846001) was from Roche Diagnostics GmbH (Mannheim,
Germany). Amicon centrifugal filters (#UFC500396 and #UFC501096) were from Millipore
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Sigma (Burlington, MA).
ΔN6-β2m preparation
ΔN6-β2m was sub-cloned into an arabinose induction pBAD33 expression plasmid for
native expression in E. coli. The vector was constructed through isothermal assembly by adding
molar ratios of the product of primer pair OPC 1287/1288 with NdeI/KpnI digested pBAD33,
and transformed into TOP10 E. coli cells. After culturing overnight, the cells were back-diluted
1:100 into 3 L of media and allowed to grow for an additional 3.5 h. Arabinose was added to a
final concentration of 2 g/L, and the cells were grown for another 2 h.
The cell solution was pelleted at 5500x g for 10 minutes, and resulting cell pellet was
suspended in 20 mL 100 mM Tris pH 8 supplemented with 5 mM PMSF. The pellet was
ruptured by passing through (4X) a Microfluidics M-110 L Microfluidizer at 18k psi. The cell
slurry was then centrifuged at 10k g in 4 °C for 20 min, resulting in a loose pellet. The
supernatant was removed and the loose pellet remnant was re-suspended in 100 mM Tris pH 8,
6 M GuHCl (~12 mL), then ultracentrifuged (6 x 2 ml) at 100k g at 4 °C for 1 h. The supernatant
underwent Sephacryl S300 size exclusion column (GE Healthcare, Chicago, IL) where the
purest fractions containing ΔN6-β2m were pooled together and dialyzed against 10 mM Tris
pH 8 overnight. The dialysate was then concentrated and further purified through Mono QTM
5/50 GL ion exchange column (GE Healthcare, Chicago, IL) as outlined in Esposito et al.24 The
purest fractions of ΔN6-β2m were eluted at ~130 mM NaCl with a linear gradient from 0-0.5
M NaCl. Individual fractions were then aliquoted and lyophilized for later use.
2.2.2 DEPC Labeling Reactions
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Proteins (10 μM) were prepared in a MOPS buffer (pH 7) or phosphate buffered saline
(PBS, pH 7) at different buffer concentrations, depending on the experiment. DEPC stock
solutions were freshly prepared for each experiment in dehydrated acetonitrile. Protein labeling
was initiated by adding DEPC at various molar excesses ranging from 2 to 50. After 1 min at
37°C, the DEPC labeling reactions were quenched by adding imidazole at a 50:1 imidazole to
DEPC molar ratio. The final amount of acetonitrile in the protein solution was 1% or less.
Before MS detection of the intact proteins, samples were desalted either by Amicon®
centrifugal filters or via liquid chromatography (LC).
2.2.3 Liquid Chromatography
Online LC-MS detection was performed on a HP1100 (Agilent, Wilmington, DE)
HPLC system or a Thermo Scientific Dionex Ultimate 3000 HPLC (Waltham, MA) with an
OPTI-TRAPTM MICRO column (1 mm x 12 mm, Optimize Technologies Inc., Oregon City,
OR). The mobile phases were water and acetonitrile both containing 0.1% formic acid. The
desalting gradient started at 5% acetonitrile during the first 5 min and then was increased to
70% within 2 min at a flow rate of 50 μL/min. Twenty percent of the LC effluent flowed into
the mass spectrometer, and the rest was directed to waste.
2.2.4 Mass Spectrometry
Mass spectra of intact proteins were acquired on either a Bruker Esquire quadrupole
ion trap mass spectrometer, a Bruker SolariX FT-ICR mass spectrometer, or a Thermo Orbitrap
Fusion Tribrid mass spectrometer. All of the parameters were adjusted to acquire maximum
intensity in each experiment. Data processing was performed on Bruker Compass™ data
analysis 4.0 or Thermo Xcalibur.
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2.2.5 Determination of Weighted Average Number of Labels on Protein
The weighted average number of labels on a given protein was calculated as follows
(Eq. 1).
Weighted average number of labels on protein =

𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑
∑𝑛
𝑥=1 𝑥𝐼𝑥
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑
𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑
∑𝑛
+𝐼0
𝑥=1 𝐼𝑥

(1)

where x is the number of modification, Ix is the intensity of labeled peaks, I0 is the intensity of
unlabeled peaks.

2.2.6 Solvent Accessible Surface Area (SASA) Calculations
The protein structures used for the SASA calculation were obtained from the Protein
Data Bank (PDB). The following PDB codes were used for the indicated proteins: ubiquitin
(1UBQ), β2m (1JNJ), ΔN6-β2m (2XKU), cytochrome c from equine heart (1HRC),
cytochrome c from bovine heart (2B4Z), lysozyme from chicken egg white (1DPX), human
lysozyme (1REX), myoglobin (1WLA), carbonic anhydrase (1V9E), α-1 antitrypsin (3NE4),
transferrin (3QYT), human growth hormone (1HGU), and maltose binding protein (1PEB).
Solvent accessible surface area values were calculated by GETAREA.25 A probe radius of 5.6
Å was used in the calculations, which represents half the length of a DEPC molecules. The
calculated SASA was compared to the surface area of the side chain in a Gly-X-Gly tripeptide
and a percent ratio was generated (%SASA).
2.2.7 Principal Component Analysis (PCA)
The software R was used for the statistical analyses to establish the quantitative
correlation between protein structural factors and DEPC modification rate coefficients.
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2.3 Results and Discussion
2.3.1 DEPC Labeling of the Model Proteins
Eight model proteins, including ubiquitin, -2 microglobulin (2m), equine
cytochrome c, chicken egg white lysozyme, myoglobin, carbonic anhydrase, α-1 antitrypsin
(α1AT), and transferrin were reacted with a range of DEPC concentrations, and the number of
modifications on each protein increases as the DEPC concentration is increased (Figure 2.1).
In general, smaller proteins, such as ubiquitin (8.6 kDa) and 2m (11.7 kDa), are modified to
a lesser extent at a given DEPC concentration than larger proteins like α-1 antitrypsin (51.1
kDa) and transferrin (79.6 kDa) (Figure 2.1b and Figure 2.2). The modification extent and the
maximum number of DEPC modifications, however, are not strongly correlated with protein
molecular weight. For example, carbonic anhydrase with a molecular weight of 29.0 kDa reacts
less extensively with DEPC than myoglobin, which has a molecular weight of 17.0 kDa.

Figure 2.1. a) Example mass spectrum showing an expanded view of DEPC labeled and
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unlabeled ions for different charge states of 10 μM myoglobin after labeling with 0, 40, 80, and
500 μM DEPC. The peak labels 1’, 2’, 3’, etc. refer to the number of DEPC modifications. b)
The weighted average number of DEPC labels for each of the model proteins after reaction
with different DEPC concentrations.
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Figure 2.2. A summary of the DEPC labeling data for the eight model proteins. a) ubiquitin, b)
β-2 microglobulin, c) cytochrome c, d) lysozyme, e) myoglobin, f) carbonic anhydrase, g) α-1
antitrypsin, and h) transferrin.

To establish a correlation between protein structural factors and DEPC modification
rates, we determined the DEPC reaction rate coefficients for each of the model proteins. The
reaction of DEPC with a given protein is a second-order reaction, and the rate coefficient can
be determined by applying equation 1.
[𝑋] [𝑃]

0
𝑙𝑛( [𝑋][𝑃]
) = −𝑘𝑡[𝑋]0 + 𝑘𝑡[𝑃]0 (1)
0

In this equation, [P]0 is the initial concentration of unmodified protein, [X]0 is the initial
concentration of DEPC, [P] is the unmodified protein concentration at time t, [X] is the DEPC
concentration at time t, and k represents the second-order rate coefficient. Because DEPC
hydrolyzes over time in water, determining the reaction rate coefficient is best achieved by
varying the initial DEPC concentration (i.e. [X]0) while maintaining a constant reaction time,
[𝑋] [𝑃]

0
t. A plot of 𝑙𝑛( [𝑋][𝑃]
) as a function of [X]0, which we refer to as a dose-response plot, can be
0

used to determine the rate coefficient for the consumption of the unmodified protein. Because
the information from CL-MS is most useful when the structural integrity of the protein is
preserved, any rate information must be measured under conditions in which the protein’s
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structure is unperturbed. In previous work, we found that deviations from linearity in the doseresponse plots of the unmodified protein indicate a change in the reaction dynamics induced
by protein conformational changes.20 Applying a similar analysis here, we find on average that
the structural integrity of each protein is preserved up to DEPC molar excesses of 8 to 10 fold,
whereas deviations from linearity are significant at much higher concentrations (e.g. 50-fold
excess) (Figure 2.3).

Figure 2.3. Second-order reaction kinetic plots for the decrease in the unmodified proteins as
a function of DEPC concentration. The protein concentration in each case was 10 µM. These
plots remain linear for DEPC molar excesses of 8- to 10-fold, depending on the protein. The
fits of the linear portions of these kinetic plots are used to determine the reaction rate
coefficients that are shown in Table 2.2.

The structural integrity of each protein upon DEPC labeling can also be confirmed by
assessing if each DEPC labeling site reacts independently. If sites do react independently, the
labeling extents will follow a Poisson distribution. Such an analysis was previously used to
assess the reactivity of proteins with hydroxyl radicals.26 Poisson distributions are most
appropriate when the number of independent sites is greater than 20,27 so the labeling of all the
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proteins but ubiquitin could be assessed by this statistical modeling approach because the sum
of DEPC modifiable residues (i.e. H, K, Y, S, and T) is over 20 for each of the proteins except
ubiquitin. We find that Poisson distributions fit the labeling data for all the proteins very well
when the DEPC molar excess is 10-fold or less, whereas higher DEPC concentrations result in
poorer fits (Figure 2.4 and Table 2.1). Because good fits to the Poisson distributions and doseresponse plots are observed for DEPC concentrations below a 10-fold molar excess for the
proteins studied here, we used labeling data up to 10-fold DEPC to determine the modification
rate coefficients.

Figure 2.4. Poisson statistical modeling of lysozyme, β-2 microglobulin, carbonic anhydrase,
cytochrome c, α-1 antitrypsin, myoglobin and transferrin at (a) 100 μM DEPC and (b) 500 μM
DEPC.

Table 2.1. The adjusted R2 and reduced chi-square for the Poisson fits from Figure 2.4 for
protein labeling reactions through 100 μM or 500 μM DEPC.
adjusted R2
reduced chi-square × 10-3
Protein
100 μM DEPC 500 μM DEPC 100 μM DEPC 500 μM DEPC
β2m
0.98
0.72
1.30
6.78
Cytochrome c
0.98
0.76
0.87
4.05
Lysozyme
0.99
0.87
0.03
3.02
Myoglobin
0.93
0.68
1.74
4.51
Carbonic anhydrase
0.99
0.90
0.29
1.19
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α-1 antitrypsin
Transferrin

0.94
0.93

0.96
0.84

1.47
0.53

0.25
0.94

Fitting the protein labeling data for up to 10-fold excess DEPC using equation 1 results
in rate coefficients that range from around 2 x 10-5 to 4 x 10-4 µM-1s-1 (Table 2.2). For some
proteins (e.g. ubiquitin and lysozyme), the measured rate coefficients are lower if the time
between the end of the DEPC reaction and the MS measurement is delayed, although the effect
on the weighted average number of modifications at any given DEPC concentration is modest
(Figure 2.5a and Figure 2.6). The variation in modification rates for ubiquitin and lysozyme is
likely caused by hydrolysis of some DEPC labeled sites in these proteins, as such label loss
had been observed previously for some modified Tyr, Ser, and Thr residues.20 Indeed, among
all the proteins, ubiquitin and lysozyme have the highest ratio of Tyr, Ser, and Thr residues
relative to His, which is the most DEPC-reactive residue.

Table 2.2. Modification rate coefficients and structural factors for the eight model proteins
used in this study.
Modification Rate
SASA
Coefficients k (μM-1s-1)
SASA SASA of Y,
of Hb of Kb
S&
10-min
1-hour delay
a,b
T
delay

Model
Proteins

MW
(kDa)

H

K

Y,
S
&
Ta

Ubiquitin

8.6

1

7

9

34.0

470.0

356.7

β2m

11.7

4

8

19

122.6

700.0

628.4

Cytochrome
c

12.4

2c

19 11

0.5c

1460.5

141.6

Lysozyme

14.3

1

6

7.5

350.2

383.0

14
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2.3±0.1 ×
10-5
9.7±0.1 ×
10-5
1.5±0.1 ×
10-4
5.5±0.1 ×
10-5

4.3±0.7 ×
10-5
9.8±0.1 ×
10-5
1.40±0.04 ×
10-4
6.7±0.5 ×
10-5

a
b
c

Myoglobin

17.0

9c

19 13

321.6c 1222.4

451.1

Carbonic
anhydrase

29.0

8c

18 33

264.9c

997.1

522.9

α1AT

51.1

10 32 44

224.4

1614.1

535.0

Transferrin

79.6

17c 58 74c 478.6c 2538.1 923.4c

2.2±0.1 ×
10-4
1.1±0.1 ×
10-4
1.6±0.1 ×
10-4
3.79±0.04 ×
10-4

2.4±0.1 ×
10-4
1.35±0.03 ×
10-4
1.7±0.1 ×
10-4
3.2±0.2 ×
10-4

The number or SASA of Y, S, and T residues that have hydrophobic residues within 6 Å
The calculation of SASA is described in SI.
The number or SASA of metal-binding residues are not counted.

Figure 2.5. The effect of analysis delay time and buffer composition/concentration on protein
labeling by DEPC. a) Weighted average number of modifications on ubiquitin, lysozyme and
myoglobin after a 1-hour or 10-minute delay between reaction quenching and MS analysis. b)
Example protein data showing the minimal impact that buffer composition and concentration
have on DEPC labeling. The weighted average number of modifications on β2m does not
substantially change under different buffer conditions.
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Figure 2.6. Example mass spectra showing the results from proteins labeled by 80 μM DEPC
after different delay times before LC-MS analysis. a) ubiquitin, b) lysozyme, and c) myoglobin.
The peak labels 1’, 2’, 3’, etc. refer to the number of DEPC modifications.
76

As an important side note, the effect of buffer concentration and composition on DEPC
labeling rates was also evaluated. We find that buffer concentrations between 20 and 50 mM
have little effect on the labeling rates or extents, although buffer concentrations as high as 150
mM cause a measurable change in labeling extent (e.g. Figure 2.5b and Figure 2.7). In this
study, like in previous ones by our group,8,9,15,20 buffer composition also appears to have little
effect on DEPC labeling as long as the buffer does not contain functional groups (e.g. primary
amines) that can react with DEPC. Commonly used Tris buffers, for example, substantially
reduce DEPC reactivity with proteins due the presence of the free amino groups (data not
shown).

Figure 2.7. Example mass spectra showing of the results from β2m labeled with 100 μM DEPC
under different buffer condition. The peak labels 1’, 2’, 3’, etc. refer to the number of DEPC
modifications.
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2.3.2 Protein Structural Features Affecting DEPC Reaction Rates
To establish a quantitative correlation between DEPC reaction rates and protein
structural factors, principal component and regression analyses were performed. Based on the
previous work, H, K, Y, S, and T residues are known to be reactive with DEPC, and
modification extents in covalent labeling experiments are generally affected by residue solvent
accessible surface area (SASA).2 A recently study from our group, however, also demonstrated
that the DEPC reactivity of Y, S, and T residues are influenced just as much or more by a nearby
hydrophobic microenvironment.23 Thus, in considering the variables that might affect protein
reactivity with DEPC, we evaluated (i) protein molecular weight, (ii) the number of modifiable
residues, (iii) the SASA of H and K residues, and (iv) the SASA of Y, S, and T resides that have
hydrophobic residues within 6 Å (Table 2.2). To reduce the dimensions of multiple variables
and to minimize redundancy, principal component analysis (PCA) was used followed by
regression analysis. Equations in the following forms were used:
𝑘 = A𝑧1 + B𝑧2 + ⋯ + C𝑧𝑖 + D
𝑧𝑖 = 𝑎𝑉1 + 𝑏𝑉2 + ⋯ + 𝑐𝑉𝑖

(2)
(3)

where k is the experimentally measured modification rate coefficient, zi are principal
components, A, B, C, and D are coefficients of these principal components, Vi are variables
(e.g. number of H residues), and a, b, c, d are coefficients of these variables. Before PCA, all
of the variables were standardized by having mean values equal to 0 while their standard
deviations equal to 1. Rate coefficients were multiplied by 104 to avoid convergence problems
with small fractions.
A summary of the PCA and regression analyses, including all the different variables
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that were considered, is shown in Table 2.3. There are two primary conclusions that can be
drawn from these results. First, the number of H and K residues are a better predictor of protein
reactivity than the total number of modifiable residues (i.e. H, K, Y, S, and T). Indeed, 82% of
the variations in the reaction rate coefficients for all the proteins can be accounted for by simply
counting the number of H and K residues. If the sum of all the modifiable residues is considered,
only 62% of the variance can be explained, although this is still a better predictor than
molecular weight alone, which accounts for only 53% of the variability. The fact that the total
number of modifiable residues does not predict protein reactivity very well is somewhat
unexpected as DEPC modifications of Y, S, and T residues have been shown to be valuable for
identifying protein binding sites and changes in protein HOS.8-9, 15, 20, 28-29 For example, DEPClabeling studies of the monoclonal antibody rituximab showed that 13% of the information that
reveals sites of HOS changes in rituximab upon heat stress coming from the weakly
nucleophilic Y, S, and T residues.30 The disconnect between these residues being useful for
structural analysis but not influencing overall protein reactivity might be explained by their
typically low modification levels (< 1 %) and the requirement that they are near hydrophobic
groups. The fact that 82% of the variance can be accounted for from the number of H and K
residues means that overall protein reactivity with DEPC can be predicted fairly well with a
simple accounting of these residues and without any knowledge of its HOS.

Table 2.3. PCA and regression analysis results of 10-minute delay datasets
Variables and
Principal Components

Equation
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R2

a) Molecular weight (MW)
z1=MW

k=0.70z1+1.51

0.53

b) #H, & #K
z1=0.71 #H+0.71 #K

k=0.60z1+1.51

0.82

c) #H, #K, #Y, #S, & #T
z1=0.43 #H+0.46 #K+0.44 #Y+0.46 #S+0.44 #T

k=0.35z1+1.51

0.62

d) %SASAN, %SASAQ, & %SASAD
z1=0.56 %SASAN+0.52 %SASAQ+0.64 %SASAD

k=0.43z1+1.51

0.44

e) %SASAH
z1=%SASAH

k=0.81z1+1.51

0.76

f) %SASAH, & %SASAK
z1=0.71 %SASAH+0.71 %SASAK

k=0.66z1+1.51

0.91

g) %SASAH, %SASAK, %SASAY, %SASAS, & %SASAT
z1=0.50 %SASAH+0.51 %SASAK+0.02 %SASAY+0.49 %SASAS k=0.45z1+1.51
+0.51 %SASAT

0.75

h) %SASAH, %SASAK, & #YST
z1=0.57 %SASAH+0.58 %SASAK+0.59 #YST

k=0.51z1+1.51

0.79

i) %SASAH, %SASAK, & %SASAYST
z1=0.62 %SASAH+0.55 %SASAK+0.57 %SASAYST

k=0.53z1+1.51

0.77

A second important observation is that the total SASA of H and K is the best predictor
of protein reactivity with 91% of the variations accounted for. In contrast, only 75% of the
variance is explained when the total SASA of all the modifiable residues is included in the
analysis. For some context, if the SASA of typically solvent exposed but non-reactive residues,
such as N, Q, and D, are considered, very little of the variance (i.e. 44%) can be explained,
highlighting the importance of the reactive residues. When the SASA values of only Y, S, and
T residues near hydrophobic groups are considered along with H and K SASA totals, the
adjusted R2 is higher (i.e. 0.77) but still not as high as when only the SASA of H and K are
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included. Again, this trend is surprising since nearby hydrophobic groups have been found in
recent work to increase the reactivity of Y, S, and T residues.23 Considering the total number,
instead of the SASA values, of Y, S, and T residues near hydrophobic groups, improves the
result modestly (R2 = 0.79), but the results are still best explained by the total SASA values of
H and K residues. Presumably, other subtle features about the environment around Y, S, and T
residues are important for affecting their reactivity and the overall reactivity of a given protein.
The PCA-derived relationship between the protein reaction rate coefficients and H and K SASA
is shown in equations 4 and 5.
𝑘 = 0.66𝑧1 + 1.51
𝑧1 = 0.71𝑆𝐴𝑆𝐴𝐻 + 0.71𝑆𝐴𝑆𝐴𝐾

(4)
(5)

2.3.3 Predicting DEPC-protein Reaction Rates
Because one goal of this work is to predict protein reaction rates so that DEPC
concentrations can be chosen appropriately to avoid label-induced structural changes, we
explored two approaches to validate the predictability based on H and K SASA values. The
first was a cross-validation method that tests whether the PCA-derived equations (Table 2.3)
are able to predict data that are not used in the regression analysis. This approach prevents
overfitting and selection bias and provides insights into how accurate the predictive equations
will perform in practice. In this cross-validation method, PCA was performed on datasets from
7 of the model proteins, which served as the training datasets, and then the resulting equations
were tested on the dataset from an 8th protein that was left out of the training datasets and thus
served as the testing dataset. This approach was repeated so that each protein served as a testing
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dataset, and the experimentally measured rate coefficients (kactual) were compared to the
predicted rate coefficients (kpredicted) for each protein. When this cross-validation method is used,
we find that compared to any other model, the SASA of H and K correlates best with protein
reactivity (Figure 2.8).

Figure 2.8. Leave-one-out cross-validation to evaluate the regression equations. The indicated
variables of (a) molecular weight, (b) solvent accessible surface areas of His and Lys residues
plus the number of Tyr, Ser, and Thr residues near hydrophobic groups, (c) numbers of His and
Lys residues, and (d) the solvent accessible surface areas of His and Lys residues are used to
fit the 10-minute datasets.

The model summarized in equations 4 and 5 can be used to predict protein reaction rate
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coefficients, which could then be used to calculate the range of DEPC concentrations that
would lead to a weighted average of 1 to 1.2 labels per protein. This extent of labeling ensures
that label-induced structural changes are absent because the addition of a second DEPC label
is minimized. The predicted DEPC concentrations for this extent of labeling follow the trend
shown in Figure 2.9. The details of the calculation that lead to Figure 2.9 are shown in SI. The
range of DEPC concentrations for each of the model proteins was calculated based on their
predicted rate coefficients, and a concentration near this range was then used to react with each
protein. We find that the actual DEPC concentrations to get 1 to 1.2 labels per protein are close
to their predicted ones for most of the proteins (Table 2.4). For example, for β2m a DEPC
concentration range of 158 to 195 µM is predicted to give a labeling extent between 1 and 1.2,
and experimentally a DEPC concentration of 200 µM leads to a weighted average labeling
extent of 1.0.

Figure 2.9. The relationship between the DEPC concentrations needed to produce an average
of 1 to 1.2 labels on the proteins and the protein reaction rate coefficients. See the SI for details
of the calculations that produce this plot.

Table 2.4. Predicted DEPC concentrations, and experimentally measured number of DEPC
labels upon reacting model proteins with actual concentrations.
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Model Proteins

Predicted DEPC
Concentrations (μM)

Actual DEPC
Concentrations (μM)

Number of Labels

Ubiquitin

254~311

500

1.2

β2m

158~195

200

1.0

Cytochrome c

135~168

180

0.9

Lysozyme

331~403

270

1.2

Myoglobin

85~105

100

1.2

Carbonic anhydrase

100~125

100

1.1

α1AT

85~106

80

1.0

Transferrin

50~63

40

1.0

The second approach to validate the protein reaction rate predictions based on H and K
SASA values was to predict the reactivity of other proteins, including some that have high or
low sequence homology with the eight model proteins. Five additional proteins were evaluated,
including (1) cytochrome c from bovine heart, which has 98% sequence homology with equine
heart cytochrome c; (2) human lysozyme, which has 75% sequence homology with chicken
egg white lysozyme; (3) ΔN6-β2m, which is identical to β2m, except the first six residues are
missing; (4) human growth hormone (hGH), which has a relatively small number of His and
Lys residues (11) compared to Ser, Thr, and Tyr residues (41); and (5) maltose binding protein
(MBP), which has a relatively high percentage of Lys residues. We predicted the reaction rate
coefficients for these proteins based on the numbers and SASA values of H and K separately,
and then calculated the range of DEPC concentrations needed to get 1 to 1.2 labels on each
protein (Table 2.5 and Table 2.6). We then reacted each protein separately with a DEPC
concentration in the predicted range and determined the weighted average number of
modifications (Table 2.5). For all the proteins, the predicted DEPC concentrations result in
84

modification extents 1.3 or below, which means our predictions do not lead to overlabeling.
For example, 1.3 labels were measured on human lysozyme and ΔN6-β2m after reacting them
with 280 μM and 190 μM DEPC, respectively. Similarly, human growth hormone has a
weighted average modification extent of 1.1 after reacting with 230 μM DEPC. Bovine
cytochrome c has a lower extent of labeling (0.7), when reacted with the predicted
concentration, but its extent of labeling would certainly lead to useful structural information.
The very low level of labeling for MBP (i.e. 0.2), however, was unexpected. A likely
explanation for this low extent of labeling is the presence of 36 solvent exposed K residues and
only one solvent exposed H residue. This ratio of K/H solvent exposed residues vastly exceeds
this ratio for any other protein in this study, suggesting that using the SASA values for both H
and K residues might cause an inaccurate prediction. Indeed, if only the SASA of H is used to
predict the needed DEPC concentration for MBP, a labeling extent closer to 1 is obtained (Table
2.6). The other protein that has a similarly high ratio of K/H residues is bovine cytochrome c,
and when the SASA of only H is used to predict protein reactivity, a value of 1.1 is obtained
(Table 2.6). These results for MBP and bovine cytochrome c suggest that accurately predicting
DEPC concentrations for proteins with a large excess of K residues may require the use of only
the SASA of H residues.
Table 2.5. Proteins’ predicted rate coefficients and predicted DEPC concentrations based on
the SASA values of H and K
Test Proteins

H

K

Predicted Modification Rate
Coefficients k (μM-1s-1)

Predicted DEPC
Concentrations (μM)

Bovine cytochrome c
Human lysozyme

2a
1

18
5

1.1 × 10-4
7.0 × 10-5

151~186
236~290

85

ΔN6-β2m
hGH
MBP

4
3
3b

9.8 × 10-5
9.3 × 10-5
1.6 × 10-4

7
8
36

168~207
178~219
101~125

a

One His residue in bovine cytochrome c has an SASA values of 0.7 Å2. The other His
residue has a SASA value of 5.7 Å2.
b
Two of the His residues in MBP have SASA values of 0 Å2. The other His residue is very
exposed with an SASA value of 58.5 Å2.
Table 2.6. SASA values for H and K residues, predicted rate coefficients, predicted DEPC
concentrations, and experimentally measured number of DEPC labels upon reacting test
proteins with indicated concentrations.
Predicted
Predicted
Experimenta
Rate
Numb
SASA
DEPC
l DEPC
Test Proteins
SASAK Coefficient
er of
Concentratio Concentratio
H
-1 s k (μM s
Labels
ns (μM)
ns (μM)
1
)
1.1 × 10-4
149~184
170
0.7
Bovine
6.4a
1417.0
-5 b
cytochrome c
6.8 × 10
242~297
270
1.1
-5
Human lysozyme 100.0
279.6
6.5 × 10
254~311
280
1.3
-5
ΔN6-β2m
130.1
533.9
9.5 × 10
172~212
190
1.3
-5
hGH
111.4
275.3
7.3 × 10
224~275
230
1.1
-4
2.1 × 10
79~99
100
0.2
MBP
58.5
2521.2
-5 b
9.3 × 10
177~218
250
0.8
a
b

The SASA of metal-binding residues are not counted.
The predicted rate coefficients are calculated when only SASA of H is used.

2.4 Conclusions
Previous studies have shown that DEPC is a useful reagent in the context of CL-MS
experiments, and it can provide correct structural information as long as proteins can be labeled
without perturbations to their structure. Minimizing protein structural perturbations is best
achieved by controlling the extent of labeling. Here, we establish a quantitative correlation
between general protein structural factors and DEPC modification rate coefficients, allowing
us to predict the needed DEPC concentrations to optimize protein labeling. Notably, we find
that the total SASA of His and Lys residues, which are the most reactive residues with DEPC,
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primarily determine a protein’s reactivity with the reagent. Other residues that can be modified
by DEPC, including Tyr, Ser, and Thr, are not useful for predicting overall protein reactivity,
despite their proven utility for protein structure and binding analyses, as shown in previous
work.8-9, 15, 20, 28-29 The insignificant impact of Tyr, Ser, and Thr residues on overall protein
reactivity likely reflects (i) their low overall extents of modification and (ii) their exquisite
sensitivity to their local microenvironment, a feature that is not captured well in the simple
models used here. Future work will attempt to understand more deeply the effects of
microenvironment on Tyr, Ser, and Thr reactivity. The correlation between protein structural
features and DEPC reactivity that is reported here should allow researchers to more readily
choose appropriate DEPC concentrations to ensure reliable structural information without
time-consuming optimization of reaction conditions.

2.5 Example calculations for obtaining the predicted DEPC concentration
The reaction of a protein with DEPC is a second-order reaction,
[𝑋] [𝑃]

0
𝑙𝑛( [𝑋][𝑃]
) = −𝑘𝑡[𝑋]0 + 𝑘𝑡[𝑃]0 .
0

We assume that the distribution of modified protein peaks for a given charge state is a Poisson
[𝑃]

distribution. If the expected weighted average number of modification is 1, then[𝑃] = 0.37.
0

If the initial concentration of protein [𝑃]0 is 10 μM, then
[𝑋] = [𝑋]0 − 𝑤𝑒𝑖𝑔ℎ𝑡𝑒𝑑𝑎𝑣𝑒𝑟𝑎𝑔𝑒 ×  [𝑃]0 =  [𝑋]0 − 10.
The predicted rate coefficient 𝑘 of ubiquitin is 6.5 × 10-5 μM-1s-1, and t is 60 seconds.
Hence, 𝑙𝑛(

0.37×[𝑋]0
[𝑋]0 −10

) = −6.5 × 10−5 × 60 × [𝑋]0 + 6.5 × 10−5 × 60 × 10.

In order to get 1 label per protein, the initial concentration of DEPC ([𝑋]0 ) is predicted to be
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254 μM.
Similarly, when the weighted average number of modification is 1.2, the predicted DEPC
concentration would be 311 μM.
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CHAPTER 3
KINETIC STUDY OF DIETHYLPYROCARBONATE REACTION ON PEPTIDES
AND PROTEINS
3.1 Introduction
Due to the vital roles that proteins play in living organisms and their close connection
with many diseases, analyzing their higher-order structure (HOS) is important for
understanding their function. Mass spectrometry is being developed as a powerful technique to
study protein HOS due to its moderate structural resolution, high specificity, high sensitivity,
and analysis speed. Several approaches have been integrated with MS to enable studies of
protein HOS, such as hydrogen/deuterium exchange (HDX), chemical cross-linking (XL), and
covalent labeling (CL). Covalent labeling (CL) encodes protein structure information by
modifying the side chains of residues exposed on the protein surface with labeling reagents.
Modification sites can be detected and identified after enzymatic digestion by a mass shift via
liquid chromatography-tandem mass spectrometry (LC-MS/MS) measurements. This
technique has good structural coverage, high sensitivity, robustness, and simplicity. In contrast
to XL-MS, the data interpretation is simple. It is generally not subject to the back exchange
and label scrambling compared, which is a common problem in HDX. Up to now, CL-MS has
been successfully used for protein characterization,1-3 probing interfaces in protein
complexes,4-5 discovering protein folding pathways,6-7 and evaluating ligand binding sites and
affinities.8-9
CL reagents, in general, can be classified as residue non-specific ones (e.g., hydroxyl
radicals, carbenes and trifluoromethyl radicals) and residue specific ones (e.g., 2,3-butanedione,
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1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide coupled with glycine ethyl ester, and
diethylpyrocarbonate (DEPC)). DEPC modifies side chains of nucleophilic residues such as
Cys, His, Lys, Tyr, Ser, and Thr residues and the N-termini in proteins. It probes up to 30% of
the protein sequence on average. Compared to methods that use residue non-specific reagents,
the identification of DEPC labeled sites is simple. DEPC reactivity depends on protein
structural factors such as residue intrinsic reactivity, solvent accessibility and secondary and
tertiary structures.10 First and foremost, the intrinsic reactivity of residues towards DEPC relies
on the nucleophilicity of their side chain. Cys, His, Lys and the N-terminus have higher
reactivity than Tyr, Ser, and Thr because they are more nucleophilic. In addition, residue side
chains that have higher exposure to solvent tend to have better reactivity. Mendoza et al. found
a relationship between residue labeling extent and solvent accessible surface area (SASA).11-12
Finally, protein secondary and tertiary structure can influence residue reactivity by changing
the pKa values of side chain and thus changing its nucleophilicity.
In chapter 2, we demonstrated that the total SASA of His and Lys residues, which are
the most reactive residues with DEPC, primarily determine a protein’s reactivity with the
reagent. Other residues that can be modified by DEPC, including Tyr, Ser, and Thr, are less
useful for predicting overall protein reactivity. Moreover, our group has found that for weak
nucleophilic residues such as Tyr, Ser, and Thr, the presence of nearby hydrophobic residues
in the tertiary structure increases their reactivity due to higher local concentration of DEPC.13
In this work, we have further investigated the reaction order of DEPC with peptides,
quantitatively determined the intrinsic rate coefficients of nucleophilic residues and the Nterminus, and studied the correlation between His structural factors and their DEPC reactivity.
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Our results provide us greater insight about protein structural features affecting their reactivity
from different perspectives.

3.2 Experimental Section
3.2.1 Materials
Bradykinin (#B3259), myoglobin from equine skeletal muscle (#M0630), carbonic
anhydrase from bovine erythrocytes (#C7025), diethylpyrocarbonate (DEPC) (#D5758),
imidazole (#I5513), 3-morpholinopropane-1-sulfonic acid (MOPS) (#M1254), MOPS sodium
salt (#M9381), iodoacetamide (#I6125), tris(2-carboxyethyl)phosphine (TCEP) (#C4706),
were all bought from Sigma-Aldrich (St. Louis, MO). Model peptides (Fmoc-DGXGG-NH2,
where X = H, K, Y, S, and T) and DGGGW-NH2 were custom synthesized by GenScript USA
Inc (Piscataway, NJ). PierceTM sulfo-NHS-acetate (#26777) and immobilized TPCK-trypsin
(#20230) were obtained from Thermo Scientific (Waltham, MA). Urea (#424581000) was
bought from Acros Organics (Fair Lawn, NJ). Human full-length -2 microglobulin (2m) was
purchased from Lee Biosolutions (Maryland Heights, MO). Formic acid (#A117), water (#W7),
N,N-dimethylformamide (#D119), and acetonitrile (#A998) were obtained from Fisher
Scientific (Fair Lawn, NJ). Amicon centrifugal filters (#UFC501096) were from Millipore
Sigma (Burlington, MA).

3.2.2 DEPC Labeling Reactions
Lyophilized powders of the model peptides (Fmoc-DGXGG-NH2, where X = H, K, Y,
S and T) and DGGGW-NH2 was reconstituted in water or dimethylformamide to make a 1 mM
stock solution. DEPC stock solutions were prepared in dehydrated acetonitrile. For
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investigating the reaction order of DEPC with peptides, 250 μM bradykinin in 10 mM MOPS
buffer (pH 7) was reacted with DEPC concentrations ranging from 2 to 20 μM at 37 °C for 30
sec. The reactions were quenched by 5-fold MOPS buffer dilution. Then, 1 mM FmocDGYGG-NH2 was reacted with DEPC concentrations ranging from 10 to 30 μM at 37 °C for
1 min. Finally, they were quenched by adding 250 μM bradykinin at 37 °C for 30 sec. For
studying the intrinsic rate coefficients of nucleophilic residues and the N terminus, 1 mM model
peptides (Fmoc-DGXGG-NH2, where X = H, K, Y, S and T) and DGGGW-NH2 were diluted
in 10 mM MOPS buffer (pH 7) to make a final solution of 50 μM. Each model peptide was
reacted with DEPC at 37 °C for 1 to 10 min at different molar excesses from 2 to 500. The
reaction was then quenched by the addition of imidazole at a 1:50 DEPC to imidazole molar
ratio.
Model proteins (50 μM) were prepared in 10 mM MOPS buffer (pH 7). Protein labeling
was initiated by adding DEPC at molar excesses ranging from 2 to 8. After 1 min at 37 °C, the
DEPC labeling reactions were quenched by imidazole. The final amount of acetonitrile in the
protein solution was 2% or less.
For the DEPC labeling reactions on tryptic peptides, peptides from β2m, myoglobin,
and carbonic anhydrase were first generated via proteolytic digestion with trypsin (see
Proteolytic Digestion). N-termini blocking of the peptides was achieved by reacting NHSA for
1 h at a 10:1 molar ratio of reagent to the number of potential amine groups. The acetylated
tryptic peptides were then labeled by DEPC at 37 °C for 1 min at molar excesses ranging from
50 to 150 before being quenched by imidazole.
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3.2.3 Proteolytic Digestion
The proteins, before or after a DEPC reaction, were preconcentrated and desalted in
MOPS buffer via Amicon® centrifugal filters with 10 kDa molecular weight cutoff (MWCO).
Then, 10% (v/v) acetonitrile was added to β2m and myoglobin samples respectively followed
by incubation at 50 °C for 45 min to denature the proteins. The disulfide bond of β2m was
reduced by TCEP in a 40-fold molar excess. After 3 min at room temperature, iodoacetamide
was added in an 80-fold molar excess to alkylate the resulting free Cys residues. The samples
were kept in the dark at room temperature for 30 min. To unfold carbonic anhydrase, 8 M urea
was added to the samples. After 10 min, the samples were desalted and preconcentrated again
to ensure the concentration of urea was less than 2 M. Immobilized trypsin slurry was
prewashed 3 times with MOPS buffer. The digestion was performed for 16 hours at 37 °C by
adding immobilized trypsin at a 1:4 (v/w) enzyme to substrate ratio. Finally, the enzyme was
separated by centrifugation.

3.2.4 Liquid Chromatography
Online LC-MS/MS analyses were performed on a Thermo Scientific Dionex Ultimate
3000 HPLC system (Waltham, MA) with a Thermo Scientific Acclaim™ PepMap™ RSLC
C18 column (15 cm x 300 μm, 2 μm particle size, 100 Å pore size) at a flow rate of 4 μL/min.
The mobile phases were water and acetonitrile, both containing 0.1% formic acid. For model
peptides, the mobile phase started at 5% acetonitrile for the first 5 min and was then followed
by an isocratic elution at 40% acetonitrile for 25 min. For protein digests, the mobile phase
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started at 5% acetonitrile, and after 5 min, it was increased to 50% acetonitrile over 50 min
before being changed to and held at 95% to flush the column for 5 min.

3.2.5 Mass Spectrometry
Mass spectral data of the model peptides were acquired on a Bruker AmaZon
quadrupole ion trap (Billerica, MA). The electrospray needle voltage was kept at 4.1 kV with
the capillary temperature at 250 °C. To identify the modification sites, collisional-induced
dissociation (CID) was conducted with a ramp of voltages ranging from 0.9 to 2.7 V. Data
processing was performed on Bruker Compass™ data analysis 4.0.
Mass spectral data of the protein digests were acquired on a Thermo Scientific Orbitrap
Fusion mass spectrometer (Waltham, MA). The electrospray voltage was 4 kV, and the ion
transfer tube temperature was 275 °C. Tandem MS on peptides was conducted using CID. The
precursor ions (unmodified or modified peptide ions) were selected using a quadrupole mass
filter. CID was performed in the linear quadrupole ion trap with collision energy of 35%.
Product ions were detected by the orbitrap analyzer with a resolution of 30,000. Data
processing was performed using Thermo Xcalibur.

3.2.6 Molecular Dynamics (MD) Simulations
Crystal structures of β2m (PDB ID: 1JNJ)14, horse heart myoglobin (PDB ID:
1WLA),15 and bovine carbonic anhydrase (PDB ID: 1V9E)16 were used as the starting
structures for the molecular dynamics analyses. All water molecules and other ions were
removed from the structures using BioLuminate 3.5,17 and the proteins were then energy
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minimized using the OPLS3e force field.18 The complexed Zn2+ in carbonic anhydrase and the
heme group in myoglobin were retained. The proteins were minimized in vacuo using steepest
descent minimization for 10,000 steps prior to solvation using TIP3P water molecules. Counter
ions were added to neutralize the system charge by adding Na+ and Cl- ions to a total salt
concentration of 150 mM. Energy minimizations and later equilibration and production steps
were performed using the CHARMM36 force field19 in GROMACS 2020.4.20-21 After
solvation, the whole system was energy minimized using 10,000 steps of steepest descent
minimization.
Equilibration steps were then performed using position restraint, NPT, and NVT
conditions each for 50 ps with integration time steps of 2 fs. All bonds were constrained using
the LINCS algorithm,22 and electrostatic interactions were treated with the Particle-Mesh
Ewald algorithm.23 Under NPT conditions, the systems were then equilibrated at 300 K and 1
bar using a Berendsen thermostat. The systems were further equilibrated under NVT conditions
at 300 K with temperature coupling using velocity rescaling before starting a 100 ns production
simulation.
For the solvent accessible surface area (SASA) calculations, the trajectory output from
the production simulation was indexed to include only the protein, and every 5th frame was
written for a total of 10,000 frames sampling every 10 ps. Per-residue SASA values were
calculated over these 10,000 frames using MDTraj 1.9.524 and calibrated to a percent exposure
using the SASA values of fully exposed His residues. The fully exposed SASA of the His
residues were determined by simulating a Gly-His-Gly tripeptide for 5 ns with a similar

97

procedure. Per-atom SASA values were also calculated using MDTraj 1.9.5. pKa values of His
residues were calculated using PROPKA 3.4.0 using the starting frame of the trajectory.25-28

3.3 Results and Discussion
3.3.1 Reaction Order of DEPC with Peptides
In DEPC CL experiments, the reaction of DEPC with a given peptide or protein is
assumed to be a second-order reaction, and equation 1 can be used to determine the rate
coefficient by varying DEPC concentrations or varying time.
[𝑋] [𝑃]

0
𝑙𝑛( [𝑋][𝑃]
) = −𝑘𝑡[𝑋]0 + 𝑘𝑡[𝑃]0 (1)
0

In this equation, [P]0 is the initial concentration of unmodified protein, [X]0 is the initial
concentration of DEPC, [P] is the unmodified protein concentration at time t, [X] is the DEPC
[𝑋] [𝑃]

0
concentration at time t, and k represents the second-order rate coefficient. A plot of 𝑙𝑛( [𝑋][𝑃]
)
0

as a function of [X]0 is a dose-response plot in which deviations from linearity in the plots of
the unmodified protein indicate a change in the reaction dynamics induced by protein
conformational changes.12, 29-30 However, in many chemical reactions, the reaction order is not
determined by the stoichiometry of each reactant (equation 2), so we sought to confirm the
reaction order for the DEPC reaction with peptides.
Peptide (P) + DEPC → Carbethoxylated P + CH3CH2OH + CO2
𝑅𝑎𝑡𝑒 = −

𝑑[𝐷𝐸𝑃𝐶]
𝑑𝑡

=−

𝑑[𝑃]
𝑑𝑡

= 𝑘[𝐷𝐸𝑃𝐶]𝑎 [𝑃]𝑏

(2)

where 𝑎 and b are the reaction orders of DEPC and the peptide, respectively. Since DEPC
molecule is symmetric and has two reactive carbonyl groups, we felt that it was important to
measure a and b experimentally. Previous work by Limpikirati used the kinetic isolation
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method to determine the b value by reacting an excess amount of DEPC with varying
concentrations of the model peptide, Fmoc-DGYGG-NH2. The b value was found to be close
to 1, meaning that the reaction order of peptide is first order. A similar method was used to
acquire the 𝑎 value in equation 2 by reacting an excess amount of the model peptide with
varying DEPC concentrations. When the concentration of peptide in the samples is much
higher than DEPC concentration, equation 2 is reduced to
𝑅𝑎𝑡𝑒 = 𝑘𝑝 [𝐷𝐸𝑃𝐶]𝑎 , 𝑘𝑃 = 𝑘[𝑃]𝑏

(3)

Then

logRate =  log 𝑘𝑃 +𝑎 log [𝐷𝐸𝑃𝐶]

(4)

At t = 0 min,

logRate0 =  log 𝑘𝑃 +𝑎 log [𝐷𝐸𝑃𝐶]0 

(5)

When t → 0,

Rate0 = −

𝑑[𝐷𝐸𝑃𝐶]
𝑑𝑡

  −

[𝐷𝐸𝑃𝐶]

𝑡

(6)

When we plot log Rate0 as a function of different [DEPC]0, the 𝑎 value can be acquired from
curve fitting. In the experiments, a fixed excess amount of Fmoc-DGYGG-NH2 was reacted
with different DEPC concentrations for 1 min (t). Then, the reactions were quenched by a
fixed excess amount of bradykinin for 30 sec (Scheme 1). We assumed that after the reaction
with the Fmoc-DGYGG-NH2 peptide, the remaining DEPC would all be consumed by
bradykinin, providing a means to measure the leftover DEPC in solution. The concentration of
DEPC remaining in solution after reaction with Fmoc-DGYGG-NH2 could be determined from
an external calibration curve (Figure 3.1a) that considered the labeling extent of the bradykinin
that was added to solution after the reaction. Because the initial concentration of DEPC added
to the solution of Fmoc-DGYGG-NH2 was known, the amount of DEPC reacted with this
model peptide ([𝐷𝐸𝑃𝐶]) can be determined. Using this approach, the 𝑎 value can be obtained
from by plotting log(Rate)0 vs. log[DEPC]0 (Figure 3.1b) We find that the value is close to 1.
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Considering these data and previous measurements by Limpikirati, we can confirm that the
reaction between DEPC and peptides is a second-order reaction.

Scheme 3.1. Experimental workflow of determining the reaction order of DEPC

Figure 3.1. a) Extent of modification of bradykinin at various DEPC concentrations, which
acts a calibration curve to determine the DEPC concentration in solution after reaction with the
Fmoc-DGYGG-NH2. 250 μM bradykinin in 10 mM MOPS buffer (pH 7) was reacted with
DEPC concentrations ranging from 2 to 20 μM at 37 °C for 30 sec. The reactions were
quenched by 5-fold MOPS buffer dilution. b) Determination of the reaction order with regard
to DEPC using the kinetic isolation method (equation 2).
3.3.2 Intrinsic Rate Coefficients of Nucleophilic Residues and N-terminus
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The intrinsic reaction rates of DEPC with His, Lys, Tyr, Ser, Thr, and the N-terminus
were measured using model peptides (Fmoc-DGXGG-NH2, where X = H, K, Y, S and T and
DGGGW-NH2) to better understand the inherent DEPC reactivity of these residues. First, the
differences in ionization efficiency between unmodified and modified peptides had to be
determined. Using Lys as an example, different concentrations of unmodified Fmoc-DGKGGNH2 were injected into the LC-MS, and their peak areas were measured (Figure 3.2a). Then,
this peptide (50 μM) was labeled by 50-fold DEPC concentrations for 5 min in 10 mM MOPS
buffer (pH 7). After diluting the resulting samples to different peptide concentrations ranging
from 10 to 50 μM, the samples were injected into the LC-MS to get the peak areas of
unmodified and modified peptides, respectively. The peptides were all eluted at the same
mobile phase composition to ensure it did not impact peptide ionization efficiency. By using
Figure 3.2a as a calibration curve, the real concentrations of the unmodified and modified
peptides in the samples could be determined. Figure 3.2b presents the peak area of each species
at different concentrations. After fitting the data, we find that the modified peptide has a higher
inherent ionization efficiency by a factor of 2.3 ± 0.4. All the ionization efficiency differences
of other peptides were measured in the same way (Figure 3.3-3.6 and Table 3.1).
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Figure 3.2. a) Peak area of unmodified Fmoc-DGKGG-NH2 at different concentrations. b)
Peak area of unmodified and modified Fmoc-DGKGG-NH2 at different concentrations.
KUnmodified stands for the slope of the black line while KModified stands for the slope of the red
line.

Figure 3.3. a) Peak area of unmodified Fmoc-DGHGG-NH2 at different concentrations. b)
Peak area of unmodified and modified Fmoc-DGHGG-NH2 at different concentrations.
KUnmodified stands for the slope of the black line while KModified stands for the slope of the red
line.

Figure 3.4. a) Peak area of unmodified Fmoc-DGYGG-NH2 at different concentrations. b)
Peak area of unmodified and modified Fmoc-DGYGG-NH2 at different concentrations.
KUnmodified stands for the slope of the black line while KModified stands for the slope of the red
line.
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Figure 3.5. a) Peak area of unmodified Fmoc-DGSGG-NH2 at different concentrations. b) Peak
area of unmodified and modified Fmoc-DGSGG-NH2 at different concentrations. KUnmodified
stands for the slope of the black line while KModified stands for the slope of the red line.

Figure 3.6. a) Peak area of unmodified DGGGW-NH2 at different concentrations. b) Peak area
of unmodified and modified DGGGW-NH2 at different concentrations. KUnmodified stands for
the slope of the black line while KModified stands for the slope of the red line.

3.3.3 Dose-response Plot of DEPC Labeling on Model Peptides
Because the reaction of DEPC with peptides follows a second-order reaction (equation
1), the intrinsic rate coefficient of nucleophilic residues and N-terminus can be determined
from the dose-response plots after correcting the differences in ionization efficiency between
unmodified and modified peptides. For example, 50 μM Fmoc-DGKGG-NH2 was labeled by
various DEPC concentrations for 1 min in MOPS buffer. The rate coefficient of for the reaction
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of this Lys-containing peptide is found to be 1.6 ± 0.1 M-1s-1 (Figure 3.7). The rate coefficients
for the other residues and the N-terminus were determined in the same way (Figure 3.8 and
Table 3.1). The reactivity order is found to be His > N-terminus > Lys > Tyr > Thr > Ser, which
is consistent with the order of their nucleophilicity. In addition, Thr and Ser are around 10 3
times less reactive than His, suggesting that the high numbers of Thr and Ser residues that can
be labeled in proteins are very likely due to microenvironment effects, as decribed previously.13

Figure 3.7. Dose-response plot of Fmoc-DGKGG-NH2.
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Figure 3.8. Dose-response plot of a) Fmoc-DGHGG-NH2, b) Fmoc-DGYGG-NH2, c) FmocDGTGG-NH2, d) Fmoc-DGSGG-NH2, and e) DGGGW-NH2

Table 3.1. Intrinsic rate coefficients of nucleophilic residues and the N-terminus

a

Nucleophilic
residues

Uncorrected rate
coefficients k (M-1s-1)

/K

Corrected rate
coefficients k (M-1s-1)

H

68 ± 3

4.1 ± 0.4

24 ± 1

N-terminus

11.4 ± 0.4

0.9 ± 0.1

13 ± 1

K

3.4 ± 0.1

2.3 ± 0.4

1.6 ± 0.1

Y

4.6 ± 0.2×10-1

1.7 ± 0.2

2.7 ± 0.1×10-1

T

1.0 ± 0.1×10-1

/a

~1.0 ± 0.1×10-1

S

2.5 ± 0.2×10-2

0.8 ± 0.2

2.9 ± 0.2×10-2

K

Modified

Unmodified

Did not to acquire enough modified Thr for inherent ionization efficiencies calibration due
to its weak nucleophilicity.
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3.3.4 Investigating the Correlation Between Histidine Reactivity in Proteins and their
Nearby Structure
To study how structural factors around histidine residues determine their DEPC rate
coefficients, three intact proteins (β2m, myoglobin, and carbonic anhydrase) were separately
labeled by various concentrations of DEPC. After digestion, the labeling percentage of each
modified histidine was measured by LC-MS/MS analysis and its rate coefficient (𝑘𝑝𝑟𝑜𝑡𝑒𝑖𝑛 ) in
the protein context was acquired from the dose-response plots (Figure 3.9a-3.23a). For
comparison, tryptic peptides whose N-termini or lysine residues were acetylated, were also
reacted with various DEPC concentrations. Histidine rate coefficients (𝑘𝑝𝑒𝑝𝑡𝑖𝑑𝑒 ) in the peptide
context were calculated from dose-response plots as well (Figure 3.9b-3.23b and 3.24). All of
the 𝑘𝑝𝑟𝑜𝑡𝑒𝑖𝑛 and 𝑘𝑝𝑒𝑝𝑡𝑖𝑑𝑒 are listed in Table 3.2.

Figure 3.9. Dose-response plots of His13 from β2m. a) Residue labeled in protein. b) Residue
labeled in Ac-IQVYSRHPAENGK(Ac).
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Figure 3.10. Dose-response plots of His31 from β2m. a) Residue labeled in protein. b) Residue
labeled in SNFLNCYVSGFHPSDIEVDLLK(Ac).

Figure 3.11. Dose-response plots of His51 from β2m. a) Residue labeled in protein. b) Residue
labeled in VEHSDLSFSK(Ac).
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Figure 3.12. Dose-response plots of His84 from β2m. a) Residue labeled in protein. b) Residue
labeled in Ac-VNHVTLSQPK.

Figure 3.13. Dose-response plots of His25 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in Ac-VEADIAGHGQEVLIR.

Figure 3.14. Dose-response plots of His37 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in Ac-LFTGHPETLEK(Ac).
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Figure 3.15. Dose-response plots of His65 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in HGTVVLTALGGILK(Ac).

Figure 3.16. Dose-response plots of His82/His83 from myoglobin. a) Residue labeled in
protein. b) Residue labeled in Ac-GHHEAELK(Ac)PLAQSHATK(Ac).

Figure 3.17. Dose-response plots of His98 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in Ac-HKIPIK(Ac).

109

Figure 3.18. Dose-response plots of His114 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in YLEFISDAIIHVLHSK(Ac).

Figure 3.19. Dose-response plots of His117 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in YLEFISDAIIHVLHSK(Ac).

Figure 3.20. Dose-response plots of His120 from myoglobin. a) Residue labeled in protein. b)
Residue labeled in Ac-HPGDFGADAQGAMTK(Ac).
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Figure 3.21. Dose-response plots of His3/His4 from carbonic anhydrase. a) Residue labeled in
protein. b) Residue labeled in Ac-SHHWGYGK(Ac).

Figure 3.22. Dose-response plots of His10/His15/His17 from carbonic anhydrase. a) Residue
labeled in protein. b) Residue labeled in Ac-HNGPEHWHK(Ac).
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Figure 3.23. Dose-response plots of His64 from carbonic anhydrase. a) Residue labeled in
protein. b) Residue labeled in Ac-MVNNGHSFNVEYDDSQDK(Ac).

Figure 3.24. Dose-response plots of a) His94/His96/His97. Residue labeled in AcLVQFHFHWGSSDDQGSEHTVDR and b) His119/His122 from carbonic anhydrase. Residue
labeled in Ac-YAAELHLVHWNTK(Ac).

Table 3.2. Histidine rate coefficients in protein and peptides and its structural factors.
Protein

β2m

Residue

Peptide sequence

kpeptide
(M-1s-1)

#B#A1

Net
charge

#
HB2

kprotein
(M-1s-1)

%SASA3

pKa4

H13

Ac-IQVYSRHPAENGK(Ac)

0.073

1

-0.9

4

123

25.5

6.2

H31

SNFLNCYVSGFHPSDIEVDLLK(Ac)

0.045

-1

-3

9

1.0

19.7

6.0

H51

VEHSDLSFSK(Ac)

0.21

0

-1.9

3

1.6

18.9

6.5

H84

Ac-VNHVTLSQPK

0.050

2

0.1

3

26

0.0

6.3

H25

Ac-VEADIAGHGQEVLIR

0.15

-1

-2.9

7

0.92

0.0

5.5

H37

Ac-LFTGHPETLEK(Ac)

0.075

0

-1.9

3

7.3

8.6

6.3

H65

HGTVVLTALGGILK(Ac)

0.13

2

0.1

7

0.24

0.0

4.3

H82/H83

AcGHHEAELK(Ac)PLAQSHATK(Ac)

21.35

6.35

myoglobin

carbonic
anhydrase

0.87

2

-1.7

5

50

H98

Ac-HKIPIK(Ac)

1.3

2

0.1

2

5.8

1.6

5.5

H114

YLEFISDAIIHVLHSK(Ac)

0.12

1

-1.8

9

7.3

14.9

5.6

H117

YLEFISDAIIHVLHSK(Ac)

0.071

1

-1.8

9

9.8

15.2

6.9

H120

Ac-HPGDFGADAQGAMTK(Ac)

0.28

0

-1.9

5

2.2

1.1

5.2

H3/H4

Ac-SHHWGYGK(Ac)

0.71

2

-0.8

2

61

30.55

6.35

H10/H15/H17

Ac-HNGPEHWHK(Ac)

1.7

2

-1.7

1

47

21.45

6.15

1.3

-3

-4.9

5

19

0.0

3.0

0.94

0

-3.7

6

0.0

0.0

5.65

0.28

1

-1.8

7

0.0

0.0

6.35

H64
H94/H96/H107
H119/H122

AcMVNNGHSFNVEYDDSQDK(Ac)
AcLVQFHFHWGSSDDQGSEHTVDR
Ac-YAAELHLVHWNTK(Ac)

1

Number of basic residues minus the number of acidic residues in the tryptic peptides.
Number of hydrophobic residues in the tryptic peptides.
3&4
%SASA of each residue was calculated from molecular dynamics simulations. pKa
values were calculated using PROPKA 3.4.0.
2
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5

Because tandem MS is not able to resolve the exact modification sites, these structural
factors are the average values of each residue.
Based on previous observations,11-12 histidine reactivity is thought to primarily rely on
its solvent accessible surface area (SASA). Here, we used regression analyses to identify
correlations of various structural factors and the rate coefficients of several histidine residues
in proteins. Figure 3.25a shows that histidine rate coefficients have a weak positive correlation
with %SASA, with more exposed histidine residue reacting at higher rates than more buried
histidine residues. We also considered how the calculated pKa of histidine influence its
reactivity because the pKa value should be an indicator of the nucleophilicity of the residue,
with a lower pKa correlating with a higher nucleophilicity. The correlation with pKa is even
worse than %SASA (Figure 3.25b). Because the correlation of histidine reactivity and %SASA
is relatively weak, we then considered histidine residues having similar %SASA and plotted
their 𝑘𝑝𝑟𝑜𝑡𝑒𝑖𝑛 as a function of their calculated pKa values (Figure 3.26), hoping to find that both
factors might influence reactivity. Again, no strong correlations were found. These results
demonstrate that histidine reactivity in proteins is influenced by solvent accessibility, but other
more complicated factors also affect reactivity.
To get better understanding of how histidine reactivity might be affected by other
factors, we also measured the reactivity of the same histidine residues when they were present
in tryptic peptides (Table 3.2). Several variables were considered to understand how histidine
reactivity was influenced by primary sequence. The number of charged residues and peptide
net charge at pH 7 were considered as variables because nearby charged residue will affect the
histidine pKa values, and thus their nucleophilicity. In addition, we also considered the number
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of hydrophobic residues because the local microenvironment is known to influence the
reactivity of other DEPC-modifiable residues (i.e. Ser, Thr, and Tyr). We find that 𝑘𝑝𝑒𝑝𝑡𝑖𝑑𝑒 is
moderately correlated with these variables. Equation 7 is a regression analysis that summarizes
the influence of different peptide factors.
𝑘𝑝𝑒𝑝𝑡𝑖𝑑𝑒 = 0.69(#𝑏𝑎𝑠𝑖𝑐 − #𝑎𝑐𝑖𝑑𝑖𝑐) − 0.57(𝑁𝑒𝑡𝑐ℎ𝑎𝑟𝑔𝑒) − 0.11(#ℎ𝑦𝑑𝑟𝑜𝑝ℎ𝑜𝑏𝑖𝑐) +
0.11(#𝑏𝑎𝑠𝑖𝑐 − #𝑎𝑐𝑖𝑑𝑖𝑐) × (#ℎ𝑦𝑑𝑟𝑜𝑝ℎ𝑜𝑏𝑖𝑐) − 0.47

(7)

𝐴𝑑𝑗𝑢𝑠𝑡𝑒𝑑𝑅 2 = 0.71
The results of this regression analysis indicate that local sequence does influence the DEPC
reactivity of histidine residues. However, there is no strong correlation between 𝑘𝑝𝑟𝑜𝑡𝑒𝑖𝑛 and
𝑘𝑝𝑒𝑝𝑡𝑖𝑑𝑒 values (Figure 3.27), emphasizing further that a complicated set of factors influence
the reactivity of histidine residues in proteins.

Figure 3.25. a) Histidine rate coefficients as a function of %SASA from MD. b) Histidine rate
coefficients as a function of pKa.
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Figure 3.26. a) Rate coefficients of His31 and His51 from β2m, His82/His83 from myoglobin,
and His10/His15/His17 from carbonic anhydrase as a function of pKa. b) Rate coefficients of
His84 from β2m, His25, His65, His98, and His120 from myoglobin, and His64,
His94/His96/His107 and His119/His122 from carbonic anhydrase as a function of pKa.

Figure 3.27. Histidine rate coefficients in proteins and their corresponding rate coefficients in
tryptic peptides.
3.4 Conclusions
Based on previous studies, DEPC reactivity depends on a number of protein structural
properties. In this work, we measured the reaction order of DEPC with peptides and found that
the reaction order of both peptide and DEPC is 1, meaning that the overall reaction is second
order. Then, we determined the intrinsic rate coefficients of nucleophilic residues and the N-
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terminus from the dose-response plots after correcting the ionization efficiency differences of
unmodified and modified peptides. The reactivity order is consistent with the predicted
nucleophilicity of their side chain. Finally, we found that histidine reactivity in peptides is
primarily impacted by the number of charged residues and peptide net charge, while histidine
reactivity in proteins is weakly correlated with their SASA, indicating more complicated
factors control their reactivity. Further investigations are needed to more fully understand the
factors that influence histidine reactivity in proteins.
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CHAPTER 4
DIETHYLPYROCARBONATE MODIFIED HISTIDINE ISOMERS PROVIDE HIGH
RESOLUTION PROTEIN STRUCTURAL INFORMATION

4.1 Introduction
In the postgenomic era, researchers from both academia and industry are enthusiastic
to study protein higher-order structures because they are closely related to their functions in
living organisms. Protein structure information provides insights about their folding pathways,
aggregation, interactions with other components, and physicochemical properties. Mass
spectrometry (MS) is emerging as a powerful way to study protein structure due to its high
sensitivity, good structural resolution, relatively high-throughput, and ability to study proteins
in mixtures. A variety of approaches such as hydrogen/deuterium exchange (HDX), covalent
labeling (CL) or footprinting, and chemical cross-linking (XL) have been combined with MS
to provide information about protein higher-order structure and interactions in solution. Among
these techniques used together with MS, CL is emerging as a powerful tool, giving residuelevel structural information via reactions with solvent exposed residues on the protein surface.13

The method is simple, has high sensitivity and good time resolution. In contrast to chemical

XL, data interpretation is relatively straightforward. It also has many advantages over HDX
such as no back-exchange and no labeling scrambling. Up to now, this method has been
successfully applied for studying protein-protein interactions,4-5 probing protein aggregation,67

evaluating ligand binding sites and affinities,8-9 and monitoring protein folding/unfolding.10-

11

CL-MS is also being explored to analyze membrane proteins,12 for refining computer-based

119

structural predictions,13-14 as well as studying protein structure and interactions in cells and in
vivo.15-17
Covalent labeling reagents, in general, can be classified as residue non-specific ones
(e.g., hydroxyl radicals, carbenes and trifluoromethyl radicals) and residue specific ones (e.g.,
2,3-butanedione, 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide coupled with glycine
ethyl ester, and dimethyl(2-hydroxy-5-nitrobenzyl) sulfonium bromide). Other reagents, such
as diethylpyrocarbonate (DEPC), are pseudo-specific CL reagents. DEPC modifies side chains
of nucleophilic residues such as Cys, His, Lys, Tyr, Ser, and Thr residues and the N-termini in
proteins. Compared to methods that use residue non-specific reagents, such as hydroxyl radical
footprinting (HRF) that needs an expensive laser apparatus, DEPC labeling can be conducted
very readily. The reaction generates a single product with a mass shift of 72.02 Da, simplifying
the identification of labeled sites. Our lab and others have used this reagent to investigate
functional histidines,18 protein-protein interactions,19-20 protein-ligand interactions,21-22 and
antibody structure.23-25
DEPC reacts most readily with histidine residues, allowing the accessibility of this
residue to be effectively probed. In proteins, histidine exists in an equilibrium between two
tautomers, with the hydrogen on the ε nitrogen (Nε-H) being the preferred form over the
hydrogen on the δ nitrogen (Nδ-H) (Figure 4.1). Even though the Nε-H tautomer is preferred,
the Nδ-H form is preferentially populated in special cases in proteins, such as in the catalytic
His at the active site of serine proteases26-27 or other structural His residues that have unique
H-bonding in protein pockets.28 Exchange between these two tautomers is also a mechanism
by which proton transfer can be mediated in proteins.29-30 Distinguishing these two tautomers
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in proteins typically requires 2D nuclear magnetic resonance (NMR) experiments,31 usually
along with estimations of a given His residue’s pKa and thus its protonation state.32 Because
histidine residues have two tautomers, its side chain can be labeled by DEPC at two different
sites, producing two isomers (Figure 4.1). In this work, we have investigated whether DEPC
labeling and LC-MS analysis are able to distinguish these two tautomers. Moreover, we have
evaluated whether identifying the ratio of these isomers can provide deeper insight into His
residue structure and function, as well as protein higher resolution structural information in
general.
To achieve these goals, we conducted DEPC labeling on model peptides and tryptic
peptides and have analyzed the resulting products by LC-MS/MS. Using experimental
conditions that enable the two isomers to be distinguished, we then use DEPC labeling to
identify the histidine tautomers present in several proteins. These measurements provide
information about how the local structure around the histidine residues influences the formation
of a given tautomer, effectively yielding higher resolution structural information.
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Figure 4.1: DEPC structure and its reaction with the two different histidine tautomers.

4.2 Experimental Section
4.2.1 Materials
The model peptides are Fmoc-DGHGG-NH2, angiotensin II, and kinetensin, and the
model proteins that are studied include -2 microglobulin (β2m), myoglobin, and carbonic
anhydrase. Human angiotensin II (#A9525), myoglobin from equine skeletal muscle (#M0630),
carbonic anhydrase from bovine erythrocytes (#C7025), diethylpyrocarbonate (DEPC)
(#D5758), imidazole (#I5513), 3-morpholinopropane-1-sulfonic acid (MOPS) (#M1254),
MOPS sodium salt (#M9381), iodoacetamide (#I6125), tris(2-carboxyethyl)phosphine (TCEP)
(#C4706), were all bought from Sigma-Aldrich (St. Louis, MO). Model peptide, FmocDGHGG-NH2, was custom synthesized by GenScript USA Inc (Piscataway, NJ). Kinetensin
(#4016325.0005) was from BACHEM (Bubendorf, Switzerland). PierceTM sulfo-NHSacetate (#26777) and immobilized TPCK-trypsin (#20230) were obtained from Thermo
Scientific (Waltham, MA). Urea (#424581000) was bought from Acros Organics (Fair Lawn,
NJ). Human full-length -2 microglobulin (2m) were purchased from Lee Biosolutions
(Maryland Heights, MO). Formic acid (#A117), water (#W7), and acetonitrile (#A998) were
obtained from Fisher Scientific (Fair Lawn, NJ). Amicon centrifugal filters (#UFC501096)
were from Millipore Sigma (Burlington, MA).

4.2.2 DEPC Labeling Reactions

122

A lyophilized powder of model peptide (Fmoc-DGHGG-NH2, angiotensin II, or
kinetensin) was first reconstituted in water, and then diluted in 10 mM MOPS buffer (pH 7) to
make a final solution of the desired concentration. For angiotensin II and kinetensin, the Ntermini of the peptides were first acetylated for 1 h at room temperature using sulfo-NHSacetate (NHSA) in a 10-fold molar excess before the DEPC labeling reaction. Acetylating the
N-terminus ensured a high yield of modified His residues in these peptides. DEPC stock
solutions were prepared in dehydrated acetonitrile. Each acetylated model peptide (50 μM) was
reacted with DEPC at 37 °C for 1 min at molar excesses ranging from 1 to 18. The reaction
was then quenched by the addition of imidazole at a 1:50 DEPC to imidazole molar ratio.
Model proteins (50 μM) were prepared in 10 mM MOPS buffer (pH 7). Protein labeling
was initiated by adding DEPC at molar excesses ranging from 2 to 8. After 1 min at 37 °C, the
DEPC labeling reactions were quenched by imidazole. The final amount of acetonitrile in the
protein solution was 2% or less.
For the DEPC labeling reactions on tryptic peptides, peptides from β2m, myoglobin,
and carbonic anhydrase were first generated via proteolytic digestion with trypsin (see
Proteolytic Digestion). N-termini blocking of the peptides was achieved by reacting NHSA for
1 h at a 10:1 molar ratio of reagent to the number of potential amine groups. The acetylated
tryptic peptides were then labeled by DEPC at 37 °C for 1 min at molar excesses ranging from
50 to 150 before being quenched by imidazole.

4.2.3 Proteolytic Digestion
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The proteins, before or after a DEPC reaction, were preconcentrated and desalted in
MOPS buffer via Amicon® centrifugal filters with 10 kDa molecular weight cutoff (MWCO).
Then, 10% (v/v) acetonitrile was added to β2m and myoglobin samples respectively followed
by incubation at 50 °C for 45 min to denature the proteins. The disulfide bond of β2m was
reduced by TCEP in a 40-fold molar excess. After 3 min at room temperature, iodoacetamide
was added in an 80-fold molar excess to alkylate the resulting free Cys residues. The samples
were kept in the dark at room temperature for 30 min. To unfold carbonic anhydrase, 8 M urea
was added to the samples. After 10 min, the samples were desalted and preconcentrated again
to ensure the concentration of urea was less than 2 M. Immobilized trypsin slurry was
prewashed 3 times with MOPS buffer. The digestion was performed for 16 hours at 37 °C by
adding immobilized trypsin at a 1:4 (v/w) enzyme to substrate ratio. Finally, the enzyme was
separated by centrifugation.

4.2.4 Liquid Chromatography
Online LC-MS/MS analyses were performed on a Thermo Scientific Dionex Ultimate
3000 HPLC system (Waltham, MA) with a Thermo Scientific Acclaim™ PepMap™ RSLC
C18 column (15 cm x 300 μm, 2 μm particle size, 100 Å pore size) at a flow rate of 4 μL/min.
The mobile phases were water and acetonitrile, both containing 0.1% formic acid. For model
peptides, the mobile phase started at 5% acetonitrile for the first 5 min and was then followed
by an isocratic elution at 25% acetonitrile for 25 min. For protein digests, the mobile phase
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started at 5% acetonitrile, and after 5 min, it was increased to 50% acetonitrile over 50 min
before being changed to and held at 95% to flush the column for 5 min.

4.2.5 Mass Spectrometry
Mass spectral data of the model peptides were acquired on a Bruker AmaZon
quadrupole ion trap (Billerica, MA). The electrospray needle voltage was kept at 4.1 kV with
the capillary temperature at 250 °C. To identify the modification sites, collisional-induced
dissociation (CID) was conducted with a ramp of voltages ranging from 0.9 to 2.7 V. Data
processing was performed on Bruker Compass™ data analysis 4.0.
Mass spectral data of the protein digests were acquired on a Thermo Scientific Orbitrap
Fusion mass spectrometer (Waltham, MA). The electrospray voltage was 4 kV, and the ion
transfer tube temperature was 275 °C. Tandem MS on peptides was conducted using CID. The
precursor ions (unmodified or modified peptide ions) were selected using a quadrupole mass
filter. CID was performed in the linear quadrupole ion trap with collision energy of 35%.
Product ions were detected by the orbitrap analyzer with a resolution of 30,000. Data
processing was performed using Thermo Xcalibur.

4.2.6 Molecular Dynamics (MD) Simulations
Crystal structures of β2m (PDB ID: 1JNJ)33 and horse heart myoglobin (PDB ID:
1WLA)34 were used as the starting structures for the molecular dynamics (MD) analyses. All
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waters and other ions were removed from the structures using BioLuminate 3.5,35 and the
proteins were then energy minimized using the OPLS3e force field.36 The heme group in
myoglobin was retained. The proteins were minimized in vacuo using steepest descent
minimization for 10,000 steps prior to solvation using TIP3P water molecules. Counter ions
were added to neutralize the system charge by adding Na+ and Cl- ions to a total salt
concentration of 150 mM. Energy minimizations and later equilibration and production steps
were performed using the CHARMM36 force field37 in GROMACS 2020.4.38-39 After
solvation, the whole system was energy minimized using 10,000 steps of steepest descent
minimization.
Equilibration steps were then performed using position restraint, NPT, and NVT
conditions each for 50 ps with integration time steps of 2 fs. All bonds were constrained using
the LINCS algorithm,40 and electrostatic interactions were treated with the Particle-Mesh
Ewald algorithm.41 Under NPT conditions, the systems were then equilibrated at 300 K and 1
bar using a Berendsen thermostat. The systems were further equilibrated under NVT conditions
at 300 K with temperature coupling using velocity rescaling before starting a 100 ns production
simulation.
The trajectory output from the production simulation was then indexed to include only
the protein, and every 5th frame was written for a total of 10,000 frames sampling every 10 ps
for the solvent accessible surface area (SASA) calculations. Per-residue SASA values were
calculated over these 10,000 frames using MDTraj 1.9.542 and calibrated to a percent exposure
using the SASA values of fully exposed His residues. The fully exposed SASA of the His
residues were determined by simulating a Gly-His-Gly tripeptide for 5 ns with a similar
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procedure as written. Per-atom SASA values were also calculated using MDTraj 1.9.5. pKa
values of His residues were calculated using PROPKA 3.4.0 using the starting frame of the
trajectory.43-46
4.3 Results and Discussion
4.3.1 DEPC Labeling on Model Peptides
The histidine side chain is a heterocycle having two nitrogen atoms. The non-bonding
electron pair on one of the nitrogens (black in Figure 4.2) is part of the aromatic π-electron
system, while the nitrogen with the other electron pair is not (red in Figure 4.2). This latter
nitrogen reacts more readily with an electrophile like DEPC without disrupting the aromatic
system. The nucleophilic reaction with DEPC generates a carbethoxylated product with a mass
shift of 72.02 Da, ethanol, and carbon dioxide (Figure 4.2). Because histidine has two tautomers
and one nitrogen in each tautomer will initially react with DEPC, distinguishing the two
isomers is feasible. Longer reaction times and higher DEPC concentrations can cause a second
carbethoxylation to occur on the histidine side chain (Figure 4.2),47 but this reaction can be
avoided by controlling the labeling reaction conditions.
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Figure 4.2. a) Reaction mechanism of DEPC with histidine side chain. b) Second modification
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on histidine side chain

To test our ability to distinguish the two tautomers via DEPC labeling, we reacted
several histidine-containing model peptides. The first peptide was Fmoc-DGHGG-NH2, which
included an Fmoc group on the N-terminus to ensure that only histidine was labeled. During
the LC run, an isocratic elution was used to maximize the separation of the two isomers and to
ensure that the mobile phase composition did not impact peptide ionization efficiency, allowing
us to quantify the ratios of each tautomer. Figure 4.3 shows the extracted ion chromatograms
of the unmodified (blue trace) and modified (red trace) peptides. The peaks eluting at 11.4 and
13.6 min have identical m/z ratios and are both singly-modified species with the DEPC label
found on the histidine residue in both cases, according to the tandem MS data (Figure 4.4).
Furthermore, the tandem mass spectra of these isobaric ions are different, suggesting that these
are isomeric forms. One of the key differences in the MS/MS data is that modified species 2
has a significantly more abundant a3* ion compared to modified species 1.

Figure 4.3: Extracted ion chromatograms of the unlabeled (blue trace) and DEPC labeled (red
trace) peptide Fmoc-DGHGG-NH2. The concentration of DEPC was 10 times higher than the
concentration of the peptide, and the reaction was conducted for 1 min.
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Figure 4.4: Tandem mass spectra of two modified His isomers. a) Tandem mass spectrum of
modified species 1. b) Tandem mass spectrum of modified species 2.

Another important observation is that the abundance ratio of the two DEPC labeled
forms is 3.9 ± 0.2 based on 3 replicates labeling experiments. This result is important because
NMR studies on histidine tautomers in the free amino acid show that at neutral pH, the Nε-H
tautomer is favored ∼4:1 over Nδ-H tautomer.48-49 Thus, the ratio of peak areas of two modified
species suggests that modified species 1 has the DEPC modification on Nε2, which means
labeling occurs via the Nδ-H tautomer, while modified species 2 has the DEPC label on the Nδ1,
which means the labeling occurs via the Nε-H tautomer. Further evidence for these assignments
can be obtained by considering the peptide dissociation pathways and the effect of histidine
modification on the dissociation patterns. Modified species 2 has a more abundant a3* ion in
its tandem mass spectrum because the location of the DEPC label on the side chain presumably
facilitates dissociation via the bx-yz pathway and subsequent loss of CO by the bx-ax pathway.50
In contrast, the location of the DEPC label in modified species 1 enables the histidine
pathway50-51 and preferential formation of a more stable b3* ion because of the favorable five130

membered ring that can form (Figure 4.5). The same five-membered ring formation is
prevented in modified species 2 with the DEPC label on Nδ1. These dissociation preferences
further support the assignments of species 1 as the Nδ-H tautomer and species 2 as the Nε-H
tautomer.
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Figure 4.5. Peptide fragmentation pathway of two isomers in CID. The left pathway is
modified species 1 (Nδ-H tautomer), DEPC modification on Nε2 and the right one is modified
species 2 (Nε-H tautomer), DEPC modification on Nδ1.

To further assess the ability of DEPC labeling to distinguish the two histidine tautomers,
we investigated the histidine-containing peptides angiotensin II and kinetensin as well. The Ntermini and tyrosine residues of these two peptides were acetylated before DEPC labeling to
ensure only the histidine residue was modified in each peptide. LC-MS results indicate that the
ratios of the areas for modified species 2 to modified species 1 are 3.3 ± 0.1 and 2.3 ± 0.2,
respectively, for angiotensin II and kinetensin (Figures 4.6 and 4.8). In the case of angiotensin
II, modified species 2 has a more abundant a62+* ion compared to modified species 1 (Figure
4.7), again suggesting that modified species 2 is the Nε-H tautomer. Similarly, modified species
2 for kinetensin has a more abundant a52+* ion than modified species 1 (Figure 4.9). Together
these results, along with the results with Fmoc-DGHGG-NH2, indicate that we can identify the
two histidine tautomers, and the MS/MS data helps confirm which peak is the Nδ-H tautomer
and which is the Nε-H tautomer. The measured tautomer ratios of 3.3 and 2.3 are close to the
values expected for free histidine at neutral pH. The slight change from a value close to 4:1
might be expected, as the pKa of histidine influences the ratio of the tautomers.32 The different
amino acid sequences of these two peptides almost certainly influences the pKa of the histidine
residue in each peptide.

Figure 4.6. Extracted ion chromatogram of the unlabeled and labeled acetylated angiotensin
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II. The concentration of DEPC was 10 times higher than the concentration of the peptide. The
ratio of two histidine isomers is 3.3.

Figure 4.7. Tandem mass spectra of two modified His isomers on acetylated angiotensin. a)
Tandem mass spectrum of modified species 1. b) Tandem mass spectrum of modified species
2.

Figure 4.8. Extracted ion chromatogram of the unlabeled and labeled acetylated kinetensin.
The concentration of DEPC was 10 times higher than the concentration of the peptide. The
ratio of two histidine isomers is 2.3.
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Figure 4.9. Tandem mass spectra of two modified His isomers on acetylated kinetensin. a)
Tandem mass spectrum of modified species 1. b) Tandem mass spectrum of modified species
2.
4.3.2 DEPC Labeling on Tryptic Peptides at Different Concentrations
A prerequisite for accurately determining the ratio of the two tautomeric forms is that
both histidine tautomers react at the same rate with DEPC. It is reasonable that the reactive
nitrogens in the tautomers have similar nucleophilicity, but to test this, we reacted several
peptides at different DEPC concentrations and measured their labeling ratios. Because DEPC
hydrolyzes in water with a half-life of approximately 9 min at pH 7 and 25 °C,52 we assessed
reactivity by increasing DEPC concentrations with a constant reaction time of 1 min. Figure
4.10 displays the DEPC labeling results for select peptides. In each case, the labeling ratio does
not vary over about an order of magnitude of DEPC concentrations. For example, Figure 4.10a
indicates that the ratio of two modified forms for Fmoc-DGHGG-NH2 remains essentially
constant around a value of 4 at DEPC concentrations ranging over an order of magnitude. Other
peptides have slightly different ratios (Figure 4.10b-4.10d), but the labeling ratios stay constant
for a given peptide as the DEPC concentrations are increased. Interestingly, all the studied
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peptides show a higher abundance of the Nε-H tautomer (Table 4.1) as expected, although it
should be noted that for some peptides the LC retention order for the tautomers changes and/or
MS/MS data makes it difficult to confirm the tautomer identity (e.g. Ac-HKIPIK(Ac) in Figure
4.11 & 4.12). Overall, these results demonstrate that the two tautomeric forms are equally
reactive, allowing us to use the labeling data to determine the ratio of the two tautomers in
proteins.

Figure 4.10. The labeling ratio of two modified forms (peak area of Nε-H over peak area of
Nδ-H) at different DEPC concentrations. a) Histidine from Fmoc-DGHGG-NH2; b) His13
isomers from β2m; c) His25 isomers from myoglobin; d) and His37 from myoglobin. MS/MS
was used to confirm the identity of each tautomer by measuring the ratio of the an/bn ions.

Table 4.1. Peptides produced by tryptic digestion of the indicated protein, and the LC-MS/MS
measured tautomer ratios after acetylation and reaction with DEPC, as described in the
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experimental methods section.
β2m
Residue
Peptide sequence
H13
Ac-IQVYSRHPAENGK(Ac)
H31
SNFLNCYVSGFHPSDIEVDLLK(Ac)
H51
VEHSDLSFSK(Ac)
H84
Ac-VNHVTLSQPK
myoglobin
Residue
Peptide sequence
H25
Ac-VEADIAGHGQEVLIR
H37
Ac-LFTGHPETLEK(Ac)
H65
HGTVVLTALGGILK(Ac)
H98
Ac-HKIPIK(Ac)
H114
YLEFISDAIIHVLHSK(Ac)
H117
YLEFISDAIIHVLHSK(Ac)
H120
Ac-HPGDFGADAQGAMTK(Ac)
carbonic anhydrase
Residue
Peptide sequence
H10
Ac-HNGPEHWHK(Ac)
H64
Ac-MVNNGHSFNVEYDDSQDK(Ac)

Peak area Nε-H/Peak area Nδ-H
1.6 ± 1.0
4.9 ± 1.6
6.9 ± 1.8
5.2 ± 1.3
5.6 ± 0.9
4.7 ± 0.6
1.5 ± 0.7
-1
1.1 ± 0.2
6.1 ± 3.5
4.7 ±1.1
3.4 ± 2.1
-2

1

The tautomer identity of H98 from myoglobin is difficult to be confirmed by the change of
LC retention order and MS/MS data.
2
H64 from carbonic anhydrase only has one peak. This His tautomers cannot be separated by
LC under gradient conditions, making it impossible to assign them.

Figure 4.11. Extracted ion chromatogram of two histidine isomers on Ac-HKIPIK(Ac)
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Figure 4.12. MS2 spectra of two modified His isomers on Ac-HKIPIK(Ac)

Table 4.2. Labeling ratio of two histidine isomers in proteins and in tryptic peptides.
Protein

myoglobin

β2m

1

Residue

pKa

H25
H37
H65
H98
H114
H117
H120
H13
H31
H51
H84

5.5
6.3
4.3
5.5
5.6
6.9
5.2
6.2
6.0
6.5
6.3

Peak area Nε-H/Peak area Nδ-H
Peptide
Protein
5.6 ± 0.9
0.063 ± 0.044
4.7 ± 0.6
28 ± 6
1.5 ± 0.7
1.3 ± 0.6
2
-3
1.1 ± 0.2
3.8 ± 1.4
6.1 ± 3.5
0.52 ± 0.2
4.7 ±1.1
22 ± 5
1.6 ± 1.0
2.7 ± 1.3
4.9 ± 1.6
9.2 ± 2.1
6.9 ± 1.8
06
5.2 ± 1.3
3.4 ± 1.3

Ratio measured
by NMR
0
0.25
-4
-4
2.3
1.55
infinite
-7

1

pKa is calculated based on 10 ns MD simulation of each protein;
2 and 3
-: cannot resolve; 4 -: not directly measured by NMR;
5
1.5: This value is less confident because of ‘exchange broadening in NMR’;
6
0: only Nδ-H form was found; 7 No NMR results

4.3.3 DEPC Labeling of Proteins to Determine Histidine Tautomer Ratios
Two intact proteins, myoglobin and β2m, were separately labeled by DEPC. After
digestion, the labeling ratios of the two tautomers for various histidine residues were measured
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by LC-MS/MS analysis. Myoglobin is a good test protein because it has 11 histidine residues,
and the tautomers for many of these histidines have been previously measured by NMR.53 In
our LC-MS/MS experiments, we are able to measure the DEPC labeling of seven of these
histidine residues, and LC is able to resolve the tautomers for each of these seven histidine
residues. The ratios of the two tautomers are indicated in Table 4.2, along with a comparison
to the previous NMR data when possible. The tautomer ratios for the corresponding free
peptides are also included, as they provide context for understanding how local sequence and
three-dimensional structure influence the tautomer ratios. Many of our tautomer ratios agree
with the data from NMR. For example, His25 is primarily in the Nδ-H state (100%) according
to previous NMR data,53 which matches our data showing that the Nδ-H tautomer has a much
higher peak area than the Nε-H one. Similarly, we measure a tautomer ratio of 3.8 ± 1.4 for
His114, and by NMR the value is estimated to be 2.3. Interestingly, our labeling ratio for
His120 is 22, indicating primarily the Nε-H tautomer, whereas the NMR data indicates 100%
Nε-H. Our ability to measure a low percentage of the Nδ-H tautomer likely reflects the greater
precision of our measurements. We are also able to provide tautomer ratios for His65 and His98,
which cannot be definitively measured by NMR. Our measured tautomer ratios are inconsistent
with NMR data for His37 and His117. For His37, we measure a value of 28, indicating the NεH tautomer is dominant, whereas the NMR data suggests the opposite. It should be noted,
however, that the NMR assignment of the tautomeric state for this His residue is inferred based
on 13C resonances rather than the more direct 15N resonances, which are not measured. Perhaps
the inferred NMR data is incorrect. Another possibility is this His residue in the sperm whale
myoglobin studied by NMR has a different structure than this His in the equine myoglobin
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studied here, despite the 88% sequence homology of the two proteins. Our measured ratio for
His117 is also somewhat different from the measured NMR data, but it should be noted that
the NMR data for His117 shows significant exchange broadening, which reduces confidence
in the measured ratios. Overall, our data shows reasonable agreement with previously obtained
NMR data, suggesting that we can successfully measure the ratios of histidine tautomers in
proteins via DEPC labeling and LC-MS/MS analysis.
We also used our labeling approach to determine the tautomer ratios for the protein
β2m, which has not been studied by NMR. From our data, we find that the Nε-H tautomer is
favored for three of the four histidine residues. For His51, however, we find that only the NδH form is present in the protein, even though both tautomers are measured in the free peptide
that contains this residue (Table 4.2). The reason for the prevalence of this tautomer could be
due to the structure around His51. The Nδ is usually buried, according to MD simulations
(Figure 4.13), forcing the Nε to be the protonated site, which causes the Nδ-H form to be
dominant. In effect, the ability to determine the tautomeric states of His residues in proteins
provides more detailed structural information for proteins.
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Figure 4.13. Position of H51 from β2m. Nδ is usually buried, which forces the Nε to be the
protonated site (1JNJ).

4.4 Conclusions
In this work, we have used DEPC labeling together with LC-MS/MS analysis to
distinguish histidine tautomers in peptides and proteins. Using known preferences for the NεH tautomer in free peptides, as well as peptide dissociation patterns during CID, we are able to
distinguish the ratios of the tautomers from the extent of their reactivity with DEPC. In free
peptides, the DEPC modification ratio of the two forms is close to 4:1 (Nε-H:Nδ-H), although
the exact value of this ratio is dependent on peptide sequence. Using this DEPC labeling
strategy, we have determined the ratio of the two histidine tautomers in proteins, and where
comparisons are possible, our measurements are consistent with previous 2D NMR data. In
contrast to 2D NMR measurements, our DEPC labeling approach is simpler, faster, and is more
precise. The ability to distinguish His tautomers via DEPC labeling indicates the sensitivity of
this labeling chemistry to the local structure around the histidine residues in proteins,
essentially providing high resolution structural information.

4.5 References
1.
Limpikirati, P.; Liu, T.; Vachet, R. W., Covalent labeling-mass spectrometry with
non-specific reagents for studying protein structure and interactions. Methods 2018, 144, 7993.
2.
Liu; Zhang, M. M.; Gross, M. L., Mass Spectrometry-Based Protein Footprinting for
Higher-Order Structure Analysis: Fundamentals and Applications. Chem. Rev. 2020, 120
(10), 4355-4454.
3.
Kaur, U.; Johnson, D. T.; Chea, E. E.; Deredge, D. J.; Espino, J. A.; Jones, L. M.,
Evolution of structural biology through the lens of mass spectrometry. Anal. Chem. 2019, 91
(1), 142-155.
4.
Du, Y.; Duc, N. M.; Rasmussen, S. G. F.; Hilger, D.; Kubiak, X.; Wang, L.; Bohon,
J.; Kim, H. R.; Wegrecki, M.; Asuru, A.; Jeong, K. M.; Lee, J.; Chance, M. R.; Lodowski, D.
140

T.; Kobilka, B. K.; Chung, K. Y., Assembly of a GPCR-G Protein Complex. Cell 2019, 177
(5), 1232-1242.
5.
Manzi, L.; Barrow, A. S.; Scott, D.; Layfield, R.; Wright, T. G.; Moses, J. E.;
Oldham, N. J., Carbene footprinting accurately maps binding sites in protein-ligand and
protein-protein interactions. Nat. Commun. 2016, 7, 13288-13288.
6.
Li, K. S.; Rempel, D. L.; Gross, M. L., Conformational-Sensitive Fast Photochemical
Oxidation of Proteins and Mass Spectrometry Characterize Amyloid Beta 1–42 Aggregation.
JACS 2016, 138 (37), 12090-12098.
7.
Klinger, A. L.; Kiselar, J.; Ilchenko, S.; Komatsu, H.; Chance, M. R.; Axelsen, P. H.,
A Synchrotron-Based Hydroxyl Radical Footprinting Analysis of Amyloid Fibrils and
Prefibrillar Intermediates with Residue-Specific Resolution. Biochemistry 2014, 53 (49),
7724-7734.
8.
Liu, X. R.; Zhang, M. M.; Rempel, D. L.; Gross, M. L., A Single Approach Reveals
the Composite Conformational Changes, Order of Binding, and Affinities for Calcium
Binding to Calmodulin. Anal. Chem. 2019, 91 (9), 5508-5512.
9.
Liu, T.; Marcinko, T. M.; Vachet, R. W., Protein-Ligand Affinity Determinations
Using Covalent Labeling-Mass Spectrometry. J. Am. Soc. Mass Spectrom. 2020, 31 (7),
1544-1553.
10.
Stocks, B. B.; Konermann, L., Structural Characterization of Short-Lived Protein
Unfolding Intermediates by Laser-Induced Oxidative Labeling and Mass Spectrometry. Anal.
Chem. 2009, 81 (1), 20-27.
11.
Pan, Y.; Brown, L.; Konermann, L., Kinetic Folding Mechanism of an Integral
Membrane Protein Examined by Pulsed Oxidative Labeling and Mass Spectrometry. J. Mol.
Bio. 2011, 410 (1), 146-158.
12.
Pan, X.; Vachet, R. W., Membrane Protein Stuctures and Interactions from Covalent
Labeling Coupled with Mass Spectrometry. Mass Spectrom. Rev. 2020, n/a (n/a).
13.
Schmidt, C.; Macpherson, J. A.; Lau, A. M.; Tan, K. W.; Fraternali, F.; Politis, A.,
Surface Accessibility and Dynamics of Macromolecular Assemblies Probed by Covalent
Labeling Mass Spectrometry and Integrative Modeling. Anal. Chem. 2017, 89 (3), 14591468.
14.
Müller, A.; Langó, T.; Turiák, L.; Ács, A.; Várady, G.; Kucsma, N.; Drahos, L.;
Tusnády, G. E., Covalently modified carboxyl side chains on cell surface leads to a novel
method toward topology analysis of transmembrane proteins. Sci. Rep. 2019, 9 (1), 15729.
15.
Espino, J. A.; Mali, V. S.; Jones, L. M., In Cell Footprinting Coupled with Mass
Spectrometry for the Structural Analysis of Proteins in Live Cells. Anal. Chem. 2015, 87
(15), 7971-7978.
16.
Espino, J. A.; Jones, L. M., Illuminating Biological Interactions with in Vivo Protein
Footprinting. Anal. Chem. 2019, 91 (10), 6577-6584.
17.
Espino, J. A.; Zhang, Z.; Jones, L. M., Chemical Penetration Enhancers Increase
Hydrogen Peroxide Uptake in C. elegans for In Vivo Fast Photochemical Oxidation of
Proteins. J. Proteome Res. 2020, 19 (9), 3708-3715.
18.
Kalkum, M.; Przybylski, M.; Glocker, M. O., Structure Characterization of Functional
Histidine Residues and Carbethoxylated Derivatives in Peptides and Proteins by Mass
Spectrometry. Bioconj. Chem. 1998, 9 (2), 226-235.
141

19.
Mendoza, V. L.; Antwi, K.; Barón-Rodríguez, M. A.; Blanco, C.; Vachet, R. W.,
Structure of the preamyloid dimer of β-2-microglobulin from covalent labeling and mass
spectrometry. Biochemistry 2010, 49 (7), 1522-1532.
20.
Mendoza, V. L.; Baron-Rodriguez, M. A.; Blanco, C.; Vachet, R. W., Structural
insights into the pre-amyloid tetramer of beta-2-microglobulin from covalent labeling and
mass spectrometry. Biochemistry 2011, 50 (31), 6711-6722.
21.
Liu, T.; Marcinko, T. M.; Kiefer, P. A.; Vachet, R. W., Using covalent labeling and
mass spectrometry to study protein binding sites of amyloid inhibiting molecules. Anal.
Chem. 2017, 89 (21), 11583-11591.
22.
Marcinko, T. M.; Drews, T.; Liu, T.; Vachet, R. W., Epigallocatechin-3-gallate
Inhibits Cu(II)-Induced β-2-Microglobulin Amyloid Formation by Binding to the Edge of Its
β-Sheets. Biochemistry 2020, 59 (10), 1093-1103.
23.
Borotto, N. B.; Zhou, Y.; Hollingsworth, S. R.; Hale, J. E.; Graban, E. M.; Vaughan,
R. C.; Vachet, R. W., Investigating Therapeutic Protein Structure with Diethylpyrocarbonate
Labeling and Mass Spectrometry. Anal. Chem. 2015, 87 (20), 10627-10634.
24.
Limpikirati, P.; Hale, J. E.; Hazelbaker, M.; Huang, Y.; Jia, Z.; Yazdani, M.; Graban,
E. M.; Vaughan, R. C.; Vachet, R. W., Covalent labeling and mass spectrometry reveal subtle
higher order structural changes for antibody therapeutics. MAbs 2019, 11 (3), 463-476.
25.
Limpikirati, P. K.; Zhao, B.; Pan, X.; Eyles, S. J.; Vachet, R. W., Covalent
Labeling/Mass Spectrometry of Monoclonal Antibodies with Diethylpyrocarbonate: Reaction
Kinetics for Ensuring Protein Structural Integrity. J. Am. Soc. Mass Spectrom. 2020, 31 (6),
1223-1232.
26.
Bachovchin, W. W.; Roberts, J. D., Nitrogen-15 nuclear magnetic resonance
spectroscopy. The state of histidine in the catalytic triad of .alpha.-lytic protease. Implications
for the charge-relay mechanism of peptide-bond cleavage by serine proteases. J. Am. Chem.
Soc. 1978, 100 (26), 8041-8047.
27.
Bachovchin, W. W., Confirmation of the assignment of the low-field proton
resonance of serine proteases by using specifically nitrogen-15 labeled enzyme. Proc. Natl.
Acad. Sci. USA 1985, 82 (23), 7948-7951.
28.
Alden, R. A.; Birktoft, J. J.; Kraut, J.; Robertus, J. D.; Wright, C. S., Atomic
coordinates for subtilisin BPN′ (or Novo). Biochem. Biophy. Res. Commun. 1971, 45 (2),
337-344.
29.
Raines, R. T., Ribonuclease A. Chem. Rev. 1998, 98 (3), 1045-1066.
30.
Hass, M. A. S.; Hansen, D. F.; Christensen, H. E. M.; Led, J. J.; Kay, L. E.,
Characterization of Conformational Exchange of a Histidine Side Chain: Protonation,
Rotamerization, and Tautomerization of His61 in Plastocyanin from Anabaena variabilis. J.
Am. Chem. Soc. 2008, 130 (26), 8460-8470.
31.
Sudmeier, J. L.; Bradshaw, E. M.; Coffman Haddad, K. E.; Day, R. M.; Thalhauser,
C. J.; Bullock, P. A.; Bachovchin, W. W., Identification of Histidine Tautomers in Proteins
by 2D 1H/13Cδ2 One-Bond Correlated NMR. J. Am. Chem. Soc. 2003, 125 (28), 8430-8431.
32.
Vila, J. A.; Arnautova, Y. A.; Vorobjev, Y.; Scheraga, H. A., Assessing the fractions
of tautomeric forms of the imidazole ring of histidine in proteins as a function of pH. Proc.
Natl. Acad. Sci. USA 2011, 108 (14), 5602.
142

33.
Verdone, G.; Corazza, A.; Viglino, P.; Pettirossi, F.; Giorgetti, S.; Mangione, P.;
Andreola, A.; Stoppini, M.; Bellotti, V.; Esposito, G., The solution structure of human β2microglobulin reveals the prodromes of its amyloid transition. Protein Sci. 2002, 11 (3), 487499.
34.
Maurus, R.; Overall, C. M.; Bogumil, R.; Luo, Y.; Mauk, A. G.; Smith, M.; Brayer,
G. D., A myoglobin variant with a polar substitution in a conserved hydrophobic cluster in
the heme binding pocket. Biochim. Biophys. Acta Protein Struct. Molec. Enzym. 1997, 1341
(1), 1-13.
35.
Schrödinger Release 2019-2: BioLuminate, Schrödinger, LLC, New York, NY, 2019.
36.
Roos, K.; Wu, C.; Damm, W.; Reboul, M.; Stevenson, J. M.; Lu, C.; Dahlgren, M. K.;
Mondal, S.; Chen, W.; Wang, L.; Abel, R.; Friesner, R. A.; Harder, E. D., OPLS3e:
Extending Force Field Coverage for Drug-Like Small Molecules. J. Chem. Theory Comput.
2019, 15 (3), 1863-1874.
37.
Huang, J.; MacKerell Jr, A. D., CHARMM36 all-atom additive protein force field:
Validation based on comparison to NMR data. J. Comput. Chem. 2013, 34 (25), 2135-2145.
38.
H. Bekker, H. J. C. B., E.J. Dijkstra, S. Achterop, R. van Drunen, D. van der Spoel, A.
Sijbers, and H. Keegstra et al.,, “Gromacs: A parallel computer for molecular dynamics
simulations”; pp. 252–256 in Physics computing 92. Edited by R.A. de Groot and J.
Nadrchal. World Scientific, Singapore, 1993.
39.
Berendsen, H. J. C.; van der Spoel, D.; van Drunen, R., GROMACS: A messagepassing parallel molecular dynamics implementation. Comput. Phys. Commun. 1995, 91 (1),
43-56.
40.
Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. G. E. M., LINCS: A linear
constraint solver for molecular simulations. J. Comput. Chem. 1997, 18 (12), 1463-1472.
41.
Darden, T.; York, D.; Pedersen, L., Particle mesh Ewald: An N⋅log(N) method for
Ewald sums in large systems. J. Chem. Phys. 1993, 98 (12), 10089-10092.
42.
McGibbon, Robert T.; Beauchamp, Kyle A.; Harrigan, Matthew P.; Klein, C.; Swails,
Jason M.; Hernández, Carlos X.; Schwantes, Christian R.; Wang, L.-P.; Lane, Thomas J.;
Pande, Vijay S., MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics
Trajectories. Biophys. J. 2015, 109 (8), 1528-1532.
43.
Li, H.; Robertson, A. D.; Jensen, J. H., Very fast empirical prediction and
rationalization of protein pKa values. Proteins 2005, 61 (4), 704-721.
44.
Bas, D. C.; Rogers, D. M.; Jensen, J. H., Very fast prediction and rationalization of
pKa values for protein–ligand complexes. Proteins 2008, 73 (3), 765-783.
45.
Olsson, M. H. M.; Søndergaard, C. R.; Rostkowski, M.; Jensen, J. H., PROPKA3:
Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions. J.
Chem. Theory Comput. 2011, 7 (2), 525-537.
46.
Søndergaard, C. R.; Olsson, M. H. M.; Rostkowski, M.; Jensen, J. H., Improved
Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of
pKa Values. J. Chem. Theory Comput. 2011, 7 (7), 2284-2295.
47.
Mendoza, V. L.; Vachet, R. W., Probing protein structure by amino acid-specific
covalent labeling and mass spectrometry. Mass Spectrom. Rev. 2009, 28 (5), 785-815.

143

48.
Reynolds, W. F.; Peat, I. R.; Freedman, M. H.; Lyerla, J. R., Determination of the
tautomeric form of the imidazole ring of L-histidine in basic solution by carbon-13 magnetic
resonance spectroscopy. JACS 1973, 95 (2), 328-331.
49.
Blomberg, F.; Maurer, W.; Rueterjans, H., Nuclear magnetic resonance investigation
of nitrogen-15-labeled histidine in aqueous solution. J. Am. Chem. Soc. 1977, 99 (25), 81498159.
50.
Paizs, B.; Suhai, S., Fragmentation pathways of protonated peptides. Mass Spectrom.
Rev. 2005, 24 (4), 508-548.
51.
Bridgewater, J. D.; Srikanth, R.; Lim, J.; Vachet, R. W., The effect of histidine
oxidation on the dissociation patterns of peptide ions. J. Am. Soc. Mass Spectrom. 2007, 18
(3), 553-562.
52.
Lundblad, R. L., and Noyes, C. M., Chemical Reagents for Protein Modification.
1984, 105-126, CRC Press, Boca Raton, FL.
53.
Bhattacharya, S.; Sukits, S. F.; MacLaughlin, K. L.; Lecomte, J. T., The tautomeric
state of histidines in myoglobin. Biophysical J. 1997, 73 (6), 3230-3240.

144

CHAPTER 5
COVALENT LABELING COUPLED WITH MASS SPECTROMETRY REVEALS
STRUCTURAL CHANGES OF CHEMORECEPTOR IN A MEMBRANE COMPLEX
SYSTEM

5.1 Introduction
Membrane proteins play important roles in living organisms such as catalysis, cell
signaling, cell adhesion, and transport. They also mediate interactions between a cell’s external
and internal environment. In 2020, 60% of the drugs that have been approved by Food and
Drug Administration (FDA) target membrane proteins.1 Because of their importance in disease
treatments, it is crucial to characterize their higher order structures and to study their binding
interactions. However, in contrast to water-soluble proteins, it is generally challenging due to
their flexibility, partially hydrophobic surfaces, and lack of stability.2 Furthermore, membrane
proteins are often studied in the presence of artificial membrane such as micelles, bicelles,
amphipols, or lipid nanodiscs, which are necessary to maintain their structures but create
technical challenges in analysis.
X-ray crystallography,3 cryo-electron microscopy (cryo-EM),4 solution and solid-state
nuclear magnetic resonance (NMR),5 and single-molecule tracking with fluorescence
spectroscopy6-8 are common measurement techniques that are used to characterize membrane
protein structure. However, the co-crystallization of membrane protein with artificial
membranes is difficult, making X-ray crystallography not broadly applicable. NMR has
broader applications, but the technique has protein molecular weight limitations and cannot
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readily analyze protein mixtures. Cryo-EM is able to analyze membrane protein structures with
moderate resolution, although its resolution for intact cell studies is currently limited. Singlemolecule tracking has low structural resolution and works on one protein at a time.
Mass spectrometry (MS) has emerged as a valuable tool for studying membrane
proteins. The advantages of MS in the realm of membrane protein studies are its high sensitivity,
good structural resolution, relatively high-throughput, and ability to study proteins in complex
mixtures.9 Native MS can be used to provide membrane protein structural information and
binding stoichiometries. Ion mobility (IM)-MS, coupled with collision-induced dissociation
(CID), collision-induced unfolding (CIU), or surface-induced dissociation (SID) can report
protein stoichiometry and architecture information. Hydrogen/deuterium exchange (HDX)-MS
has been used to monitor membrane protein secondary structure and backbone dynamics via
the increase of deuterium uptake on the peptide level over time.10-12 Chemical cross-linking
(XL)-MS, can provide information about subunit connectivity of membrane protein complexes
and protein interactions using bi-functional reagents that link nearby residues.13-14
CL-MS has also been used to study membrane protein structure and interactions due to
its inherent advantages such as measurement simplicity, no back-exchange and no label
scrambling. In CL-MS, a chemical reagent covalently modifies solvent exposed residue side
chains on a protein or protein complex. The stable modification allows the use of optimized
proteomics techniques to facilitate its localization. A variety of residue non-specific reagents
(e.g. hydroxyl radicals) and residue specific reagents (e.g. diethylpyrocarbonate, DEPC, for
nucleophilic residues) are available.15-16 Residue specific methods have the advantage of
simplicity as compared to residue non-specific approaches. Upon comparing modification
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percentages of a free protein to a protein with its partner, binding interfaces and conformational
changes can be revealed with residue-level resolution.
One CL reagent that has potential for studying membrane protein structure is DEPC.
DEPC modifies the side chains of nucleophilic residues such as His, Lys, Tyr, Ser, Thr, and Nterminus with good structure resolution. Previously, Schmidt et al. used DEPC labeling, native
MS, and XL data as modeling constraints to assemble a structural model of F-type ATP
synthase.17 This protein was labeled by DEPC reagent in DDM detergent micelles. DEPC
labeling results from this previous work suggests that residue solvent accessibility can be used
to constrain structures for computational modeling, but they did not thoroughly investigate how
DEPC labeling is influenced by the artificial micelle system. In our work, we more thoroughly
investigate DEPC labeling of a membrane associated protein in the presence of artificial
membranes and associated protein in complex, using chemotaxis histidine kinase (CheA) as a
model system. CheA is part of a chemoreceptor system that controls the mobility of some
bacteria (Figure 5.1a).18 It is a monomer in solution, consisting of five domains (P1 to P5), but
a homodimer in the chemoreceptor complex.19 The P1 domain has a phosphorylation site; the
P2 domain binds to other proteins in the complex, CheB and CheY; P3 is the dimerization
domain; P4 is the catalytic domain; and P5 binds to CheW and transmembrane receptors. When
specific attractant molecules bind to the receptor complex, signals are transmitted across the
membrane to direct the swimming of the bacteria. A model complex has been built in which
CheA binds to CheW and cytoplasmic fragment (CF4Q, receptor) in the presence of vesicles
(Figure 5.1b).20 We are interested in using DEPC CL-MS to study the structural change and
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binding interactions of CheA in this membrane complex system. These results provide a better
understanding of CheA structure in the complex, helping refine the model structure.

Figure 5.1. a) Structure of the chemotaxis histidine kinase (CheA) in complex with CheW and
transmembrane receptors. Structures of the P1 and P2 domains are from separate nuclear
magnetic resonance (NMR) measurements (PDB: 2LP4), and the structures of the P3, P4, and
P5 domains with CheW and transmembrane receptors are from electron microscopy
measurements (PDB: 6S1K). b) Scheme of CheA in the membrane complex system containing
CheW, cytoplasmic fragment (CF4Q, receptor) and unilamellar vesicles.

5.2 Experimental Section
5.2.1 Materials
Human angiotensin II (#A9525), bradykinin (#B3259), diethylpyrocarbonate (DEPC)
(#D5758), imidazole (#I5513), iodoacetamide (#I6125), and trypsin from bovine pancreas
(#T1426) were all purchased from Sigma-Aldrich (St. Louis, MO). Urea (#424581000) was
bought from Acros Organics (Fair Lawn, NJ). Formic acid (#A117), water (#W7), and
acetonitrile (#A998) were obtained from Fisher Scientific (Fair Lawn, NJ). Amicon
centrifugal filters (#UFC501096 & #UFC800324) were from Millipore Sigma (Burlington,
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MA). A kinase buffer (50 mM K2HPO4, 5 mM MgCl2, 75 mM KCl, pH 7.5) and vesicles
containing 60% dipalmitoylphosphatidylcholine (DOPC) and 40% nickel chelating lipid DGSNi2+-NTA

(1,2-dioleoyl-sn-glycero-3-{[N-(5-amino-1-carboxypentyl)-iminodiacetic

acid]succinyl}) were prepared using previously described methods.21 CheA, CheW, and the
cytoplasmic fragment (CF4Q) were expressed, purified, and assembled into complexes using
previously described methods.21

5.2.2 DEPC Labeling Reactions
Bradykinin (51 μM) and angiotensin II (51 μM) were prepared in a kinase buffer at pH
7.5. DEPC labeling of these peptides were conducted without and with vesicles present. The
concentration of vesicles in the samples was 860 μM. DEPC stock solutions were freshly
prepared in dehydrated acetonitrile for each experiment. Peptides were reacted with DEPC at
37 °C for 1 min at various molar excesses ranging from 2 to 10. The reaction was then quenched
by the addition of imidazole at a 1:50 DEPC:imidazole molar ratio.
51 μM CheA or complexes containing 51 μM protein in total (3 μM CheA, 18 μM
CheW, 30 μM CF4Q) and 860 μM vesicles were reacted with DEPC at 37 °C for 5 min at
various molar excesses ranging from 4 to 10. The DEPC concentration was chosen to minimize
protein structural perturbations based on predictions from previous work (Chapter 2).22 The
DEPC labeling reactions were quenched by imidazole. To prevent protein structural
perturbation, the final amount of acetonitrile in the protein solution was kept to 3% (v/v).

5.2.3 Proteolytic Digestion
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After the DEPC reactions, 8.0 M urea was added to the protein complex sample and
incubated for 10 min to unfold the protein. Iodoacetamide was added in a molar excess of 120
to alkylate the free Cys residues. The samples were kept in the dark at room temperature for 30
min. After that, the samples were desalted and preconcentrated via Amicon® centrifugal filters
with a 10 kDa molecular weight cutoff (MWCO) to ensure the concentration of urea was less
than 2.0 M. Soluble trypsin was added into the samples at a 1:10 (w/w) enzyme:substrate ratio.
The digestion was performed for 16 hours at 37 °C, and finally the enzyme was separated by
centrifugal filters with a 3 kDa MWCO.

5.2.4 Liquid Chromatography (LC)
Online LC-MS/MS analyses were performed on a Thermo Scientific Dionex Ultimate
3000 HPLC system (Waltham, MA) with a Thermo Scientific Acclaim™ PepMap™ RSLC
C18 column (15 cm x 300 μm, 2 μm particle size, 100 Å pore size) at a flow rate of 4 μL/min.
The mobile phases were water and acetonitrile, both containing 0.1% formic acid. For the
bradykinin and angiotensin II samples, the mobile phase composition started at 5% acetonitrile
for the first 5 min, went to 50% over the next 15 min and then was followed by a flush mobile
phase of 95% acetonitrile. For protein digests, the mobile phase started at 5% acetonitrile. After
5 min, it was increased to 50% acetonitrile over 50 min and finally was elevated to and held at
95% to flush the column for 5 min. For samples containing the vesicles, an additional 45-min
flush of mobile phase was used to ensure the lipids were removed from the column.

5.2.5 Mass Spectrometry
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Mass spectra of bradykinin and angiotensin II were acquired on a Bruker AmaZon
quadrupole ion trap (Billerica, MA). The electrospray needle voltage was kept at 4.1 kV with
the capillary temperature at 250 °C. To identify the modification sites, collisional-induced
dissociation (CID) was conducted with a ramp of voltages from 0.9 to 2.7 V.
Mass spectra of protein digests were acquired on a Thermo Scientific Orbitrap Fusion
mass spectrometer (Waltham, MA). The electrospray voltage was 4.0 kV, and the ion transfer
tube temperature was 275 °C. The resolution of the orbitrap was set to 60,000, a 100 ms
maximum injection time was used. CID was conducted in the linear quadrupole ion trap with
collision energy of 35%. The width of the isolation window was 2.0 Da. Parallel reaction
monitoring (PRM) was used to measure the modified peptides from the protein digests. In these
experiments the resolution of the orbitrap was set to 30,000 and a 50 ms maximum injection
time was used. The precursor ions (unmodified or modified peptide ions) were selected, and
CID was performed with collision energy of 35%. Product ions were detected by the orbitrap
analyzer with a resolution of 30,000.

5.2.6 Peak Identification and Modification Level Quantification
The extent of modification on a given peptide was calculated as follows (Eq. 1).
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

Extent of Modification =

∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧

𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

+∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧

(1)

where 𝑧is the peptide charge state. Data processing of results on the Bruker AmaZon was
performed using Bruker Compass™ data analysis 4.0.
The percentage of labeling on a given residue was calculated as follows (Eq.2).
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𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒𝑜𝑓𝐿𝑎𝑏𝑒𝑙𝑖𝑛𝑔 =

𝑚
∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑚
∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧

𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑚
+ ∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧

× 100

(2)

where 𝑖 represents the residue of interest and 𝑧 is the charge state. In parallel reaction
monitoring, the calculations were based on the peak area of extracted ion chromatograms by
choosing the three most abundant b or y ions in the peptide tandem mass spectra. To correct
day-to-day instrument variations, labeling percentage data at 10-fold molar ratio of DEPC was
used to normalize the data points at other concentrations. Data processing of results on the
Thermo Scientific Orbitrap Fusion was performed using Thermo Xcalibur and a custom
software pipeline.23

5.2.7 HDX-MS
In brief, HDX experiments were performed on 3 μM CheA or complexes containing 3
μM CheA, 18 μM CheW, 30 μM CF4Q and 860 μM vesicles, respectively, by our collaborator
Thomas Tran, using methods previously described.21 The samples were added into a 7k
MWCO Zeba spin column, which was pre-equilibrated by deuterated kinase buffer. Then,
deuterated CheA or complexes were centrifuged and placed in a 25 °C water bath for different
incubation times. Finally, the HDX reactions were quenched with a buffer containing 20%
glycerol, 1 M GuHCl and 1% formic acid at pH 1.6 on ice. The digestions were conducted by
adding soluble pepsin into the samples, and protein digests were injected into a C18 reverse
phase column (2.1 mm × 5 cm, Higgins Analytical) for desalting and peptide separation. Mass
spectra were acquired on a Waters Synapt G2Si mass spectrometer. Data processing of results
was performed using ProteinLynx Global Server (PLGS) 3.0.1 and DynamX 3.0.
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5.3 Results and Discussion
5.3.1 DEPC Labeling on CheA in Solution Versus Complex Under One Concentration
CL-MS provides information about protein binding interactions and conformational
changes by comparing residue modification extents of a free protein to the same protein in a
complex. In this work, DEPC was used to modify the CheA monomer (71 kDa) in solution and
in complex with CheW (18 kDa) and CF4Q (33 kDa) (Figure 5.2). Because CheW and CF4Q
can also react with DEPC, we used the labeling reagent at a molar excess of 6 to label a 51 μM
CheA solution and complexes having 51 μM protein in total. Through comparing residue
modification levels of CheA in solution versus complex, we find than many residues undergo
decreases in labeling (Figure 5.3). Because vesicles and multiple proteins are present in the
complex, a simple comparison of labeling extents between free CheA and the complex is likely
insufficient to get definitive structural information. Consequently, we explored the effect of the
vesicles on DEPC reactivity to ensure the vesicles themselves do not hinder DEPC reactivity.
In addition, we measured the labeling rates of CheA residues by reacting the protein and its
complex with multiple DEPC concentrations as a way to account for the differences between
the two samples.
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Figure 5.2. Experimental workflow of DEPC CL-MS of CheA in solution and in complex

Figure 5.3. Residue labeling percentages of CheA in solution and complex after labeling at a
DEPC concentration of 306 µM. Asterisks on the x-axis indicate modified residues that
undergo significant changes in reactivity based on student t-test with a 95% confidence interval.
5.3.2 DEPC Labeling on Model Peptides/CheA Without and With Vesicles
To study the effect of the vesicles on DEPC reactivity, the peptides bradykinin and
angiotensin II were labeled by DEPC at three different concentrations either without or with
vesicles composed of 60% DOPC with 40% DGS-NTA(Ni2+) (Figure 5.4a). Figure 5.4b shows
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that the modification level of each peptide does not significantly change across all DEPC
concentrations even when the vesicles are added to a concentration of 860 µM, indicating that
the influence of vesicles on DEPC labeling is minor.

Figure 5.4. a) Chemical structure of the lipids that comprise the vesicles. b) Modification
extent of bradykinin (BK) and angiotensin II (Ang II) without and with vesicles (860 µM).

Furthermore, we used an 8-fold molar ratio of DEPC to label free CheA without and
with 860 µM vesicles. Figure 5.5 demonstrates that the majority (67%) of the residues do not
undergo significant changes in labeling suggesting that the presence of the vesicles does not
have a major impact on DEPC reactivity. The 33% of the residues that do undergo labeling
changes may interact with the abundant vesicles that are present everywhere in the sample. It
should be noted, though, that when CheA is in complex with the other proteins in the
chemoreceptor complex, all the vesicles are associated with the cytoplasmic fragment, and
CheA is not expected to interact with free vesicles.
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Figure 5.5. Residue labeling percentages of CheA in solution and vesicles. Asterisks on the xaxis indicate modified residues that undergo significant labeling changes in the presence of the
vesicles based on student t-test with 95% confidence interval. The majority of the CheA
residues do not undergo any significant change in labeling.
5.3.3 DEPC Labeling on CheA in Solution Versus Complex Under Different
Concentrations
In addition to the effect of the vesicles, the effect of other proteins in the complex on
DEPC reactivity must be considered as well. To account for the presence of these other proteins
that undoubtedly react to different extents with DEPC, we measured the rate of labeling on
individual residues rather than absolute amount of labeling. Changes in the labeling rate of a
CheA residue in complex would suggest a change in the location of that residue in the complex,
with a decrease suggesting burial in the complex. To obtain good quantitative information at
the different DEPC concentrations, we used PRM measurements to monitor the labeling rate
of 20 residues. Five experimental replicates were conducted at each DEPC concentrations.
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Figure 5.6. Labeling percentages for residues of CheA in solution and in complex at different
DEPC molar equivalent ratios.

Figure 5.6 shows the labeling percentage of 20 modified residues of CheA in solution
and in complex at different DEPC concentrations. The slopes in each plot are related to the
labeling rate of each residue. Two-way ANOVA tests were used to determine whether the
labeling rate of a given residue in CheA changed significantly upon complex formation.
Overall, we find five residues have decreased labeling upon complex formation, including
Thr134/Ser136/Thr139 (these three residues cannot be resolved), Ser258, Tyr331,
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Ser381/His384, and His543. The labeling rates of 14 residues have no change, and one residue
(His181) has an increased labeling rate (Table 5.1).
Table 5.1. Summary of CL-MS and HDX-MS data.

Location

Modified
residue

Changes in CL

HDX of CheA in
solution- CheA in
complex

Model results

H48/K51
P1

Y105

None

No change

Decrease

On the loop, no
change

S142

None

No change

H181

Increase

K131
L121

T134/S136/T139

None

P2
T183/T184

More accessible
in complex

None

K239

No change
None

L232

P3

T247
S258

Decrease

On the loop, no
change

H300

None

No interface,
change of SASA

Y331

Decrease
No change

T375/H376

None

S381/H384

Decrease

Decrease
P4

Packing
interactions in
complex

S399
No change
K479

None

None

H488
H543
P5

Decrease
Decrease

/

Y614
None

Decrease

K616
1
2

No interface,
change of SASA

Linker between P1 and P2.
Linker between P2 and P3.
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At CheA/CheW
interface

5.3.4 Structural Interpretation of CL-MS Data
CL-MS provides structural information about residue side chains, while HDX-MS
reports on protein backbone information. Because the intrinsic reaction rate of HDX is around
two orders of magnitude faster than that of DEPC labeling at pH 7, HDX measurements
typically can measure protein dynamics in solution while CL does not. When it comes to
protein interactions, CL-MS measurements typically indicate binding sites when modification
extents of given residues decrease upon protein complex formation. HDX can report on binding
interfaces and provide information about protein dynamics. Hence, when the results from these
two techniques are combined, clearer information about protein binding sites and changes in
protein dynamics are provided. To facilitate comparisons of the CL-MS data with model of the
CheA complex, we calculated the solvent accessible surface areas (SASA) of each modified
residue in CheA with and without CheW or CF4Q. We also conducted a PISA (Proteins,
Interfaces, Structures and Assemblies) analysis of the protein interfaces in the complex model
(Table 5.1). A hexagonal array is formed in the complex, consisting of trimers of
transmembrane receptor dimers, two CheW molecules, and two P5 domains from CheA
(Figure 5.7).19
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Figure 5.7. Structure of CheA in complex with CheW and CF4Q. The structure of P1 and P2
domains are not shown.

Based on our CL-MS results and HDX-MS results acquired by our collaborators
(Figure 5.8), the 20 modified residues can be classified into 5 categories. In the first category,
nine residues have no change in labeling rate and no change in HDX (His48/Lys51, Tyr105,
Lys131, Ser142, Thr183/Thr184, Lys239, Thr247, His300 and Lys479, see Table 5.1). These
residues are not involved in any binding interface, and the protein regions in which they are
found do not undergo any changes in conformation and dynamics. The results of these nine
residues are consistent with the PISA analysis and SASA calculations of the model, which
indicate no change in structure or accessibility. As an example, Lys479, which is part of the P4
domain, does not interact with CheW or CF4Q (Figure 5.9). All of the nine residues, except
His300 and Lys479, are found in the P1 or P2 domains, which are not expected to be involved
in binding interactions. Interestingly, SASA calculations suggest that His300 should be
partially buried in the complex, but because both the CL-MS and HDX-MS results indicate no
change, we speculate that the protein structure model may be incorrect around this residue
(Figure 5.9).
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Figure 5.8. Summary of the HDX-MS data. Difference in the deuterium uptake of CheA in
complex from CheA in solution at different labeling times. Figure used permission from
Thomas Tran.

Figure 5.9. Position of His300 and Lys479 in the CheA structure (circled). His300 sits on the
top of P3 domain while Lys479 sits on the top of P4 domain, having no interactions with CF4Q
and CheW.

A second category of the data includes three residues (Tyr331, Ser381/His384, and
His543) that decrease in CL and are found in peptides that decrease in HDX in the complex.
Together, these data suggest a decrease in the solvent exposure of these residues. Tyr331 is
located in the P4 domain, although the model does not report a decrease of SASA of this residue,
because both the CL-MS and HDX-MS results indicate a decrease, we speculate that the protein
structure model may be incorrect around this residue. His384 is in ATP binding pocket,
opposite to the ATP lid (Figure 5.10), and decreased CL indicates that this residue undergoes
a change in packing interactions in the complex, which is something that the model would not
indicate. No peptide containing His543 is detected during HDX-MS, so the data from the two
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techniques cannot be directly compared. However, the decreased labeling of this residue
matches the structure model that indicates that this residue sits at the CheA and CheW interface.

Figure 5.10. Position of Ser381/His384 in the CheA structure (circled).

The third category includes two modified residues (Thr134/Ser136/Thr139 and Ser258)
that show a decrease in CL but no change in HDX. Thr134, Ser136, and Thr139 are all located
in the unstructured linker that connects the P1 and P2 domain. This linker region is not expected
to be buried upon complex formation, but it is reasonable that these residues would experience
a change in microenvironment upon complex formation (Figure 5.11), which is known to
change the DEPC reactivity of Ser and Thr residues.24 Ser258, which is located in the flexible
linker that connects the P2 and P3 domains, also likely undergoes a decrease in labeling for the
same reason.
The fourth category of data includes two residues (Thr375/His376 and Ser399) that
have no change in CL but decrease in HDX, suggesting a decrease in protein dynamics in these
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regions spanned by these residues. These residues are not near the predicted binding interface,
but they are present in an α-helix that could undergo stabilization upon complex formation
(Figure 5.12). The fifth and final category of data includes His181 that increases in CL but
undergoes no change in HDX. In the model, this residue is near the site where CheA forms an
interface with CheY.25 CheY is not present in the complex that we studied, but the CL-MS
results suggests that the CheY binding interface on the P2 domain of CheA is more accessible
in the complex (Figure 5.13), which could have implications for how CheY interacts with the
overall chemoreceptor complex.

Figure 5.11. Position of Thr134/Ser136/Thr139 in the CheA structure (circled).
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Figure 5.12. Position of Thr375/His376 in the CheA structure (circled).

Figure 5.13. Position of His181 in the CheA structure (circled).

Considering the CL-MS results as a whole, we find that 17 of the 20 residues undergo
labeling that is consistent with the model of the CheA complex (Figures 5.1 and 5.7). The
labeling results for the other three residues might suggest that the model needs to be refined.
His488 undergoes no change in CL, despite the model suggest that it would have a decrease in
SASA. Interestingly, the HDX data indicate a decrease in the 13-residue peptide that spans
His488, but exchange of this peptide in CheA and the complex converge after 16 h, indicating
166

a change in dynamics rather than a change of solvent accessibility. It is possible that parts of
this region of the protein interact with CF4Q, but a structural reorganization occurs such that
His488 is not buried as suggested by the model (Figure 5.14). Lys616 behaves in a similar
fashion to His488, and this residue is predicted to be near the CheA/CheW binding interface
(Figure 5.15). The positively-charged nature of Lys residues makes it difficult to bury such
residues, so it is likely that the CheA rearranges upon complex formation to avoid burying this
residue. Alternatively, perhaps CL is not sensitive enough to report the change of solvent
exposure. Tyr614 is predicted to be in the middle of the CheA/CheW binding interface, so the
lack of a labeling change for this residue is more difficult to explain. Previously we found that
weak nucleophilic residues are labeled when they are in a “sweet spot” in which there are
enough nearby hydrophobic sites and moderate solvent accessibility.23-24, 26-27 We propose that
this residue has higher SASA with less hydrophobic environment in free CheA. When CheW
binds to it, it has smaller SASA with more hydrophobic environment, which could explain its
no change in labeling percentage.

Figure 5.14. Position of His488 in the CheA structure (circled).
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Figure 5.15. Positions of Tyr614 and Lys616 in the CheA structure (highlighted in magenta).
The model predicts that Lys616 would be in close contact with Leu158 from CheW but burying
the side chain of Lys residues is not favorable.

5.4 Conclusions
In this work, CL-MS has been applied to study a membrane-associated protein which
is a class of proteins that are difficult to investigate by other techniques. We chose CheA as a
model system to study the structural and binding interactions of this protein in a membraneassociated chemoreceptor complex system. We find that DEPC labeling chemistry is not
significantly altered by the presence of vesicles, allowing it to be used to study proteins in the
presence of artificial membranes. Comparing the DEPC labeling results of free CheA and
CheA in complex required measurements of the DEPC labeling rate to account for the effect
of the other proteins, CheW and CF4Q, on DEPC reactivity. Using PRM, we measured the
labeling rate of 20 residues in CheA and found that the results for 17 of the residues are
consistent with the chemoreceptor model complex. Three of the residues are found to be
inconsistent with the model, but the labeling results of two of these residues (His488 and
Lys616) strongly suggest that the model needs to be refined in the regions near these residues.
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CHAPTER 6
UNDERSTANDING POLYMER-PROTEIN NON-COVALENT INTERACTIONS IN
COMPLEXES USING COVALENT LABELING MASS SPECTROMETRY

6.1 Introduction
The past several decades have witnessed increased development of protein therapeutics
in the pharmaceutical industry. Biological drugs such as antibodies have many advantages over
small molecules such as higher specific binding and more complex functions. In 2020, 53 novel
drugs were approved by Food and Drug Administration (FDA), and 12 of them were antibodybased therapies.1 However, the delivery efficiency of protein into the cells is low due to the
barrier of cell membrane. To solve this issue, a commonly-used method is to incorporate cellpenetrating proteins and peptides (CPPs) in the delivery system. Some CPPs consist of a high
percentage of positively charged residues while the others are amphipathic. These peptides can
covalently or non-covalently interact with proteins. Inspired by these CPPs, polymeric protein
transduction domain mimics (PTDMs) have been synthesized. These non-covalent carriers
bind with proteins through a variety of electrostatic, hydrophobic, and hydrogen bonding
interactions and can enable protein intracellular delivery.2
To understand how these carriers specifically interact with proteins, many traditional
analytical techniques have been used. Fluorescence quenching assays have been used to
measure dissociation constants (Kd), which represent the binding affinity of protein with
PTDMs. Dynamic light scattering (DLS) provides information about the size of the polymerprotein complex and their zeta potential.3 Circular dichroism (CD) detects the change of protein
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secondary structure upon interacting with the PTDM. In general, these techniques are
straightforward but have low-resolution. They are also only able to provide ensemble averages
of protein conformations rather than indicating specific sites of interactions between the
polymer and protein of interest.
Mass spectrometry (MS) is a powerful technique to study protein interactions due to its
moderate structural resolution, analysis speed, high sensitivity, and high specificity.4 Partial
proteolysis methods have been effectively coupled with MS to study how proteins interact with
binding partners. In this technique, the digestion of a given protein is compared with and
without the binding partner. The prevention of peptide bond cleavage at potential digestion
sites indicates the binding interfaces with the partner. Partial proteolysis is the most common
approach

for

epitope

mapping

for

antibodies.5-7

Labeling

approaches

such

as

hydrogen/deuterium exchange (HDX), chemical cross-linking (XL), and covalent labeling (CL)
have advantages over partial proteolysis methods because they provide better resolution. In
HDX, protein secondary structure and dynamics are monitored via the increase of deuterium
uptake on the peptide level over time. Upon binding, the change of protein backbone
accessibility to D2O leads to less deuterium uptake compared to free protein. In XL-MS, bifunctional chemical linkers form new covalent bonds between close residues in one protein or
between two proteins.8 After proteolytic digestion and liquid chromatography (LC) MS/MS
analysis, peptides that are linked reflect their relative positions in the 3-dimensional space.
In CL-MS, a free protein or a protein with its binding partner is reacted with chemical
reagents that modify the side chains of residues exposed to solvent. These reagents can be
residue non-specific ones (e.g., hydroxyl radical, carbenes and trifluoromethyl radical) or
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residue specific ones (e.g., 2,3-butanedione (BD), diethylpyrocarbonate (DEPC), and
dimethyl(2-hydroxy-5-nitrobenzyl) sulfonium bromide (HNSB)).9 Residue specific methods
have the advantage of simplicity as compared to residue non-specific approaches. Upon
comparing modification percentages of a free protein to a protein with its partner, binding
interfaces and conformational changes can be revealed with residue-level resolution (Figure
6.1). CL-MS has inherent advantages over HDX-MS and XL-MS that include no back
exchange or label scrambling, and straightforward data interpretation. In this work, we show
that DEPC-CL-MS can be used to identify the surface residues on a protein that interact with
a PTDM. DEPC modifies the side chains of nucleophilic residues such as His, Lys, Tyr, Ser,
Thr, and N-terminus,10 providing good resolution to determine the sites on the protein with
which the PTDM binds. Superfolder green fluorescent protein (sfGFP) has been chosen as
model protein because it has high binding affinity with PTDMs, and its delivery into cells can
readily be measured. Our results show that an amphipathic PTDM with phenyl and
guanidinium groups binds with many different surface residues in sfGFP via hydrophobic and
electrostatic interactions. These results help us to understand the binding of a polymer and
protein with better resolution than previously possible and should facilitate the design of better
protein carriers.
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Figure 6.1: Experimental workflow of DEPC labeling of sfGFP without and with the polymer
(PDB: 2B3P)
6.2 Experimental Section
6.2.1 Materials
Human angiotensin II (#A9525), bradykinin (#B3259), diethylpyrocarbonate (DEPC)
(#D5758), imidazole (#I5513), sodium chloride (#S5886), guanidine thiocyanate (GTC,
#G6639), and iodoacetamide (#I6125) were all purchased from Sigma-Aldrich (St. Louis, MO).
Immobilized TPCK-trypsin (#20230) was obtained from Thermo Scientific (Waltham, MA).
Potassium phosphate monobasic (#P285), sodium phosphate dibasic anhydrous (#S374),
formic acid (#A117), water (#W7), and acetonitrile (#A998) were obtained from Fisher
Scientific (Fair Lawn, NJ). Amicon centrifugal filters (#UFC501096 & #UFC800324) were
from Millipore Sigma (Burlington, MA). Polymeric protein transduction domain mimics
(PTDM), which have a hydrophobic block and a hydrophilic guanidinium block (MePh10block-dG5, 5899.5 g/mol) were synthesized by Prof. Tew group in PSE department at UMass
using previously described methods,11-13 and superfolder green fluorescent protein (sfGFP) was
expressed and purified by Prof. Thayumanavan’s group in chemistry department at UMass
using approaches described previously.14
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6.2.2 DEPC Labeling Reactions
Bradykinin (50 μM) and angiotensin II (50 μM) were prepared in a phosphate buffered
saline (PBS) solution at pH 7.2. The PBS solution contained 1.5 mM KH2PO4, 155 mM NaCl,
and 2.7 mM Na2HPO4. A lyophilized powder of the PTDM was reconstituted in acetonitrile to
make a 10 mM stock solution. In the experiment of DEPC labeling of peptides in the presence
of polymers, the final concentration of PTDM in the samples is 500 μM. DEPC stock solutions
were freshly prepared in dehydrated acetonitrile in each experiment. Peptides were reacted
with DEPC at 37 °C for 1 min at various molar excesses ranging from 2 to 10. The reaction
was then quenched by the addition of imidazole at a 1:50 DEPC to imidazole molar ratio.
sfGFP was first buffer exchanged into PBS, and its final concentration was determined
by a Thermo Scientific NanoDrop™ 2000c spectrophotometer. Depending on the experiments,
0, 0.6, 4, or 8 μM PTDM was added into the samples. After incubation at room temperature for
30 min, 200 nM of the protein was reacted with 200 μM DEPC for 5 min at 37 °C. The DEPC
concentration was chosen to minimize protein structural perturbations based on predictions
from previous work.15 The DEPC labeling reactions were quenched by imidazole. To avoid
protein structural perturbation, the final amount of acetonitrile in the protein solution upon
DEPC addition was only 2% (v/v).

6.2.3 Proteolytic Digestion
After the DEPC reactions, the labeled sfGFP was preconcentrated to 8 µM and desalted
in a PBS buffer via Amicon® centrifugal filters with either 3 or 10 kDa molecular weight
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cutoffs (MWCO). Then, 2.0 M GTC was added and allowed to incubate with the protein at
50 °C for 1 h to unfold the protein. Iodoacetamide was added in a molar excess of 40 to alkylate
the free Cys residues. The samples were kept in the dark at room temperature for 30 min. After
that, the samples were desalted and preconcentrated again to ensure the concentration of GTC
was around 1.2 M. An immobilized trypsin slurry was prewashed 3 times with PBS buffer. The
digestion was performed for 16 hours at 37 °C by adding immobilized trypsin at a 1:4 (v/w)
enzyme to substrate ratio. Finally, the enzyme was separated by centrifugation.

6.2.4 Liquid Chromatography
Online LC-MS/MS analyses were performed on a Thermo Scientific Dionex Ultimate
3000 HPLC system (Waltham, MA) with a Thermo Scientific Acclaim™ PepMap™ RSLC
C18 column (15 cm x 300 μm, 2 μm particle size, 100 Å pore size) at a flow rate of 4 μL/min.
The mobile phases were water and acetonitrile, both containing 0.1% formic acid. For the
peptides bradykinin and angiotensin II, the gradient started at 5% acetonitrile for the first 5 min,
went to 50% over the next 15 min and then was followed by a flush mobile phase of 95%
acetonitrile. For protein digests, the gradient initiated at 5% acetonitrile. After 5 min, it
increased to 50% acetonitrile over 50 min and finally was elevated to and held at 95% to flush
the column for 5 min. For samples containing the polymers, additional 45-min flush method
was followed.

6.2.5 Mass Spectrometry
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Mass spectra of bradykinin and angiotensin II were acquired on a Bruker AmaZon
quadrupole ion trap (Billerica, MA). The electrospray needle voltage was kept at 4.1 kV with
the capillary temperature at 250 °C. To identify the modification sites, collisional-induced
dissociation (CID) was conducted with a ramp of voltages from 0.9 to 2.7 V.
Mass spectra of protein digests were acquired on a Thermo Scientific Orbitrap Fusion
mass spectrometer (Waltham, MA). The electrospray voltage at a positive mode was 4 kV, and
the ion transfer tube temperature was 275 °C. The resolution of the orbitrap was set to 60,000
with 100 ms maximum injection time. Collision-induced dissociation (CID) was conducted in
the linear quadrupole ion trap with collision energy of 35%. The width of the isolation window
was 2.0 Da.

6.2.6 Peak Identification and Modification Level Quantification
The extent of modification on a given peptide was calculated as follows (Eq. 1).
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

Extent of Modification =

∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧

𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

+∑𝑛
𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑧

(1)

where 𝑧stands for the peptide charge state. Data processing of results on the Bruker
AmaZon was performed using Bruker Compass™ data analysis 4.0.
The percentage of labeling on a given residue was calculated as follows (Eq.2).
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑃𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒𝑜𝑓𝐿𝑎𝑏𝑒𝑙𝑖𝑛𝑔 =

𝑚
∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧
𝑀𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑚
∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧
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𝑈𝑛𝑚𝑜𝑑𝑖𝑓𝑖𝑒𝑑

𝑚
+ ∑𝑛
𝑖=1 ∑𝑧=1 𝑃𝑒𝑎𝑘𝑎𝑟𝑒𝑎𝑖,𝑧

× 100

(2)

where 𝑖represents the residue of interest and 𝑧stands for charge state. Data processing
of results on the Thermo Scientific Orbitrap Fusion was performed using Thermo Xcalibur and
a custom software pipeline.16

6.2.7 Distance Measurements
The distances of each modified residue from an anionic surface region of sfGFP were
determined using PyMOL.17 Qualitative electrostatic potentials were created by averaging the
charges over the protein's surface using a quasi-Coulombic shaped convolution function in
PyMOL.18 The distance of the modified residue was measured from the edge of the nearest
atom in the anionic surface potential. In addition, hydrophobic moment plots were created in
PyMOL using the Eisenberg hydrophobicity scale.19 The distances of each modified residue
from a hydrophobic surface region were determined by measuring from the DEPC modification
site to the atom at the edge of the nearest hydrophobic region.

6.3 Results and Discussion
6.3.1 DEPC Labeling on Model Peptides without and with PTDMs
CL-MS can report on protein binding interactions by comparing residue modification
levels under one condition (sfGFP alone) to that of the same protein under another condition
(with polymers). To accurately conduct this comparison, we first investigated whether the
presence of the PTDMs affects DEPC reactivity, even though these polymers (Figure 6.2a) do
not contain functional groups that would be expected to react with DEPC. To identify any
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interfering reactions, the peptides bradykinin and angiotensin II were labeled by DEPC at 3
different concentrations either without or with PTDMs. Figure 6.2b shows that the modification
level of each peptide does not significantly change across all DEPC concentrations even when
the polymers are added to a concentration of 500 µM, indicating that the polymer does not
significantly affect DEPC reactivity.

Figure 6.2: a) Chemical structure of MePh10-b-dG5. b) Modification extent of bradykinin (BK)
and angiotensin II (Ang II) without and with PTDMs (500 µM).

6.3.2 DEPC Labeling on sfGFP Alone and with Different PTDM Concentrations
sfGFP has 63 residues that could be modified by DEPC, and upon reacting with the
protein (200 nM) with a 1000-fold molar excess of DEPC, we find that up to 38 of these
residues can be modified. Because sfGFP has a very stable β-barrel structure, which makes
enzymatically digesting this protein difficult, we used GTC as a denaturant due to its strong
denaturing capabilities. Before adding trypsin for digestion, the protein was incubated with 2.0
M GTC at 50 °C for 1 h, and during the digestion, the concentration of GTC was kept at 1.2 M
to prevent protein refolding while maintaining trypsin activity. The sequence coverage from
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these digestion conditions was found to be over 90%. Together with the 38 residues modified
by DEPC, we are able to probe up to 20% of the protein’s structure (Figure 6.3).

Figure 6.3: Modified residues mapped onto the sfGFP crystal structure (PDB: 2B3P). The
residues that are found to be modified by DEPC are colored in red.

PTDM binding to sfGFP was studied using three different PTDM:sfGFP concentration
ratios that are known to influence intracellular delivery of the protein. The cell delivery
experiments were performed by our collaborator, Hazel Davis. Delivery efficiencies ranging
from 20% to > 90% can be achieved using PTDM:sfGFP concentration ratios of 3:1 to 40:1
(Figure 6.4). CL-MS experiments were performed without the PTDM and at PTDM:sfGFP
ratios of 3:1, 20:1, and 40:1. Upon comparing the labeling of sfGFP alone and sfGFP with 3fold excess of the PTDM, we find that there are three residues (Lys140, Tyr143, and His217)
that undergo a significant decrease in labeling, one residue (Thr9) that increases in labeling,
and 15 residues that undergo no change (Figure 6.5). When the concentration of the PTDM is
further increased, more residues decrease in modification (Figure 6.6). At a 20:1 PTDM:sfGFP
ratio, 15 residues decrease in labeling, 5 increase, and 10 have no change. At a 40:1
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PTDM:sfGFP ratio, 26 residues decrease in labeling, one increases, and three have no change.
It should be noted that the number of residues that were labeled by DEPC in the 3:1
PTDM:sfGFP ratio and 20:1 and 40:1 ratios are different due to different batches of DEPC and
different MS analysis conditions used in these sets of experiments. In all cases, the comparisons
shown in Figures 6.5 and 6.6 were from experiments done on the same day with the same batch
of DEPC and same MS conditions, so the individual comparisons are valid. Table 1
summarizes the residues that are labeled by DEPC at different PTDM concentrations.
Considering the data as a whole, it is clear that higher concentrations of the PTDM result in
more of the protein’s surface being protected from DEPC labeling. This trend indicates that the
presence of more PTDM leads to more complete coating of the protein by the polymer
molecules, which is consistent with a model that has the polymer packaging the protein for
delivery. In addition, 6 residues were observed to have increase in labeling. We speculate that
their side chains have hydrogen bonding or salt bridges with some negatively charged residues
(Ser28-Asp19, Lys140-Asp133, and Lys162-Tyr182 in Figure 6.7). When polymers bind, they
probably break the salt bridges and cause the increase of labeling.

Figure 6.4: Delivery of polymer-protein complexes into Jurkat T cells. a) Percentage of cells
positive for sfGFP (normalized to the control). b) Median fluorescence intensity, which is
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proportional to the amount of protein delivered to cell population. Figure used permission from
Hazel Davis.

Figure 6.5: Residue labeling percentage in the absence of the PTDM and in the presence of a
3:1 PTDM:sfGFP ratio. Asterisks on the x-axis indicate modified residues that undergo
significant changes in labeling in the presence of the PTDM based on student t-test with 95%
confident interval.

Figure 6.6: Residue labeling percentage a) above 6% and b) below 6% in the absence of the
PTDM and in the presence of 20:1 and 40:1 PTDM:sfGFP ratios. Asterisks on the x-axis
indicated modified residues that undergo significant changes in labeling in the presence of the
PTDM based on student t-test with 95% confident interval.
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Table 6.1: Summary of the DEPC labeling changes in sfGFP at different PTDM:sfGFP
concentration ratios with modified residues having a decrease in the present of PTDM
highlighted in blue, residues having an increase highlighted in red, and residues undergoing no
change highlighted in grey.
DEPC position
K3
T9
H25
K26
S28
T38
K41
H81
K85
S86
Y92
S99
K101
T105
K107
T108
K113
T118
K126
K131
H139
K140
Y143
S147
H148
Y151
T153
K156
K158
K162
K166
H217
H231

3:1
None
Decrease

None
None
None
None
None
None
None
None
None

Increase
Decrease
None
None
None
None
None
Decrease
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20:1
Decrease

40:1
Decrease

Increase
Decrease
Increase
Increase
Decrease
None
None
Decrease
Decrease
Decrease
Increase
None
None
None
None

Increase
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
Decrease
None
None
Decrease

None
Decrease
None
Decrease
Decrease
Decrease

Decrease
Decrease
Decrease
Decrease
Decrease
Decrease

Decrease
Decrease
Decrease
None
Increase
None
Decrease
Decrease

Decrease
Decrease
Decrease
None
Decrease
Decrease
Decrease
Decrease

Figure 6.7: The polar interaction of increase residues with other residues in protein.

6.3.3 Mapping Modified Residues onto Protein Surfaces
By mapping the modified residues on the surface structure of sfGFP, we can obtain
insight into the PTDM binding interfaces. The results from the three different concentration
ratios indicate that the polymer interacts with negatively-charged and hydrophobic patches on
the protein. The conclusion is evident by looking at the positions of the residues that change in
labeling relative to electrostatic and hydrophobic patches on the protein (Figures 6.8-6.10). For
example, at the 3:1 PTDM:sfGFP ratio, Tyr143 decreases in labeling and is both close to
negatively-charged regions and hydrophobic regions in sfGFP (Figure 6.8). Similarly, His217
also decreases in labeling and is close to an anionic patch. Ser86, Lys131, and Lys140, which
decrease in labeling at the 20:1 PTDM:sfGFP ratio, are close to anionic and hydrophobic
regions as well (Figure 6.9). At the 40:1 PTDM:sfGFP ratio, Thr153 and Lys156 are examples
of residues that decrease and are close to both anionic and hydrophobic regions, while Ser99
and Lys131 are close to anionic regions (Figure 6.10). Presumably, the phenyl groups on the
184

PTDM have preferential interactions with hydrophobic regions on the protein surface, and the
guanidinium groups tend to bind with anionic patches on the protein surface. Those interactions
cause the burial of residues nearby, resulting in decreased labeling percentages.

Figure 6.8: sfGFP surface maps showing the locations of residues that decrease in labeling and
nearby anionic and hydrophobic patches. (Left) An indication of the position of residues that
change in labeling at the 3:1 PTDM:sfGFP concentration ratio. Magenta indicates an increase
in labeling, cyan indicates a decrease in labeling, and grey means no change. (Middle)
Electrostatic surface maps with regions having positive charges shown in blue and ones with
negative charges shown in red. (Right) Hydrophobicity maps showing hydrophobic regions.
The deeper red color indicates greater hydrophobicity.
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Figure 6.9: sfGFP surface maps showing the locations of residues that decrease in labeling and
nearby anionic and hydrophobic patches. (Left) An indication of the position of residues that
change in labeling at the 20:1 PTDM:sfGFP concentration ratio. Magenta indicates an increase
in labeling, cyan indicates a decrease in labeling, and grey means no change. (Middle)
Electrostatic surface maps with regions having positive charges shown in blue and ones with
negative charges shown in red. (Right) Hydrophobicity maps showing hydrophobic regions.
The deeper red color indicates greater hydrophobicity.

Figure 6.10: sfGFP surface maps showing the locations of residues that decrease in labeling
and nearby anionic and hydrophobic patches. (Left) An indication of the position of residues
that change in labeling at the 40:1 PTDM:sfGFP concentration ratio. Magenta indicates an
increase in labeling, cyan indicates a decrease in labeling, and grey means no change. (Middle)
Electrostatic surface maps with regions having positive charges shown in blue and ones with
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negative charges shown in red. (Right) Hydrophobicity maps showing hydrophobic regions.
The deeper red color indicates greater hydrophobicity.

The role of hydrophobic and electrostatic interactions on PTDM binding can be further
demonstrated by considering the average distances between hydrophobic and anionic patches
and residues that decrease in labeling. For each modified residue, we measured its distance
from the closest hydrophobic or anionic patche using Pymol, as described in the experimental
section. For example, in the CL-MS experiments at the 40:1 PTDM:sfGFP ratio, Lys126 shows
a decrease in labeling percentage, and to acquire its distance from an anionic region, we
measured the distance of the nitrogen on the Lys126 side chain to the closest atom in a
negatively-charged patch (Scheme 1). Similarly, the distance of the nitrogen on Lys126 from
the closest atom in a hydrophobic patch was also measured. A summary of these distance
measurements for all modified residues at different PTDM concentration ratios is listed in
Tables 2-4.

Scheme 6.1: Illustration of distance measurements from modified residues to anionic or
hydrophobic regions.
Table 6.2a: The distance of modified residues at the 3:1 PTDM:sfGFP ratio to anionic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
T9
0
K140
0
K3
5.3
187

Y143
H217

8.6
0

T38
K41
K85
Y92
K101
K107
K113
T118
K126
H148
Y151
K156
K162
K166

6.3
6.6
9.5
>10
7.7
9.6
8.1
3.7
8.2
7.7
>10
0
7.2
8.9

Table 6.2b: The distance of modified residues at the 3:1 PTDM:sfGFP ratio to hydrophobic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
T9
0
K140
4.8
K3
5.9
Y143
0
T38
4.1
H217
6.2
K41
5.1
K85
4.5
Y92
0
K101
4.4
K107
10.0
K113
3.8
T118
6.1
K126
4.9
H148
10.8
Y151
0
K156
4.6
K162
7.3
K166
5.8
Table 6.3a: The distance of modified residues at the 20:1 PTDM:sfGFP ratio to anionic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
K3
5.3
H25
>10
H81
3.2
K26
7.6
S28
0
K85
9.5
188

K41
S86
Y92
S99
K131
K140
Y143
S147
Y151
T153
K156
H217
H231

6.6
4.6
>10
0
0
0
8.6
>10
>10
0
0
0
0

T38
K101
K162

6.3
7.7
7.2

T105
K107
T108
K113
K126
H139
K158
K166

0
9.6
9.9
8.1
8.2
0
7.0
8.9

Table 6.3b: The distance of modified residues at the 20:1 PTDM:sfGFP to hydrophobic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
K3
5.9
H25
4.8
H81
5.0
K26
6.9
S28
3.3
K85
4.5
K41
5.1
T38
4.1
T105
0
S86
4.3
K101
4.4
K107
10.0
Y92
0
K162
7.3
T108
6.1
S99
0
K113
3.8
K131
5.3
K126
4.9
K140
4.8
H139
3.8
Y143
0
K158
7.0
Y151
0
K166
5.8
T153
3.0
S147
0
K156
4.6
H217
6.2
H231
4.0
Table 6.4a: The distance of modified residues at the 40:1 PTDM:sfGFP ratio to anionic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
K3
K26
S28
T38

5.3
7.6
0
6.3

H25

>10

189

K107
T108
K158

9.6
9.9
7.0

K41
H81
K85
S86
Y92
S99
K101
T105
K113
K126
K131
H139
K140
Y143
S147
Y151
T153
K156
K162
K166
H217
H231

6.6
3.2
9.5
4.6
>10
0
7.7
0
8.1
8.2
0
0
0
8.6
>10
>10
0
0
7.2
8.9
0
0

Table 6.4b: The distance of modified residues at the 40:1 PTDM:sfGFP ratio to hydrophobic
patches.
Decrease
Increase
No change
residue distance (Å) residue distance (Å) residue distance (Å)
K3
K26
S28
T38
K41
H81
K85
S86
Y92
S99
K101
T105
K113
K126
K131
H139
K140

5.9
6.9
3.3
4.1
5.1
5.0
4.5
4.3
0
0
4.4
0
3.8
4.9
5.3
3.8
4.8

H25

4.8
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K107
T108
K158

10
6.1
7.0

Y143
S147
Y151
T153
K156
K162
K166
H217
H231

0
0
0
3.0
4.6
7.3
5.8
6.2
4.0

Because the length of a DEPC molecule is approximately 11 Å, we used a distance of
5.5 Å to define if a residue is close to anionic or hydrophobic regions. Considering the data
from the 20:1 and 40:1 PTDM:sfGFP concentration ratios as a whole, we find that 18 of the 41
(44%) residues that decrease in labeling are close to both anionic and hydrophobic patches on
the sfGFP surface, whereas only 1 of the 6 (17%) residues that increase and 3 of the 13 (23%)
residues that do not change are close to these regions (Figure 6.11). The 3:1 PTDM:sfGFP data
is not included in this analysis, as so few residues change in labeling under this condition.
These results are consistent with the idea that the positively-charged and hydrophobic groups
on the PTDM bind to anionic and hydrophobic sites on sfGFP, causing decreases in the labeling
of the nearby residues. Given the size of the polymer, it is likely that the PTDM is anchored by
these electrostatic and hydrophobic interactions, while other parts of the PTDM settle at
additional sites on the protein surface, causing labeling decreases elsewhere. Figure 6.12
presents the locations of residues that change in labeling at the 20:1 PTDM:sfGFP
concentration ratio. One face (left) of the protein has more residues decrease in labeling than
the adjacent face (right), which might result from more accessibility of these residues to large
polymers.
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Figure 6.11: Venn diagrams showing the number of modified residues that are close to anionic
or hydrophobic regions. Numbers in the circles indicate the number of modified residues
meeting the given criterion (e.g. close to an anionic patch). The numbers in the overlapping
parts of the circle correspond the number of residues that meet both criteria.

Figure 6.12: sfGFP surface maps showing the locations of residues that change in labeling at
the 20:1 PTDM:sfGFP concentration ratio. Magenta indicates an increase in labeling, cyan
indicates a decrease in labeling, and grey means no change.
6.4 Conclusions
In summary, we demonstrate that CL-MS can probe surface interactions in polymerprotein complexes and provides residue-level structural information that has never before been
obtained for PTDM-protein interactions. DEPC is shown to be a valuable labeling reagent for
these studies because the PTDMs do not substantially impact its reactivity. From the labeling
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experiments at increasing polymer concentrations, we find that residues near negativelycharged and hydrophobic patches on sfGFP decrease in labeling, which is consistent with a
model in which PTDM binding is mediated via electrostatic and hydrophobic interactions on
the protein surface. Because the success of polymer-based protein carriers depends on cargo
and protein surface properties, the understanding of binding interfaces at the residue level could
be useful in enhancing the design of polymer carriers by designing mechanisms of protein
release in the intracellular space.
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CHAPTER 7
SUMMARY AND FUTURE DIRECTIONS

7.1 Summary
This dissertation has described the technique of DEPC covalent labeling integrated
with MS to study protein higher-order structure. Due to the fact that DEPC experiments can be
conducted very readily and the identification of labeled sites is simple, this method has been
successfully applied for studying protein-protein interactions, probing protein aggregation,
evaluating ligand binding sites and affinities, and characterizing protein therapeutics. In
addition, research has found that DEPC reactivity depends on protein structural factors such as
residue intrinsic reactivity, solvent accessibility and the effect of secondary and tertiary
structures. Owing to the advantages of DEPC labeling-MS and the lack of knowledge in the
aspect of reaction kinetics, my dissertation shows that we have better understanding the
influence of protein and peptide structural properties on labeling reactivity, and how labeling
chemistry reflects the local structure around the histidine residues in proteins. Moreover, my
works further broaden its applications in membrane-associated protein study and the study of
polymer-protein complexes interactions.
In Chapter 2, we have found that the solvent accessible surface areas of histidine and
lysine residues in proteins are the primary factors that determine a protein’s reactivity towards
DEPC. Based on that, a statistics model has been established to predict the reactivity of a
protein based on its structure and sequence, which is supported by accurately predicting of the
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reactivity of five test proteins. Although some Tyr, Ser, and Thr residues in protein react with
DEPC as well, their impact is not significant enough to affect overall protein reactivity.
In Chapter 3, we have determined the reaction order of DEPC with peptides,
demonstrating that it is a second-order reaction by using kinetic isolation method. We have
also determined the intrinsic rate coefficients of nucleophilic residues and the N-terminus via
second-order kinetics equation. Their reactivity order matches the order of their side chain
nucleophilicity. In addition, we have shown that the reactivity of histidine residues in peptides
is affected by the number of charged residues and peptide net charge at neutral pH. However,
their reactivity in protein is not only influenced by their SASA but also other structural
properties in a complicated way.
In Chapter 4, we have been able to distinguish the two sidechain tautomers of histidine
residues by DEPC and LC-MS/MS. Based on the distinct peptide dissociation patterns and LC
retention times, we can differentiate two different products modified by DEPC. Furthermore,
the ratios of histidine tautomers that we measured in myoglobin are consistent with previously
published 2D NMR results. We have validated that this technique helps us to have further
understanding about histidine residue structure and function in proteins by identifying the
tautomers.
In Chapter 5, given the fact that DEPC can report the change of residue solvent
accessibility, we have applied DEPC labeling-MS to study the structural and binding
interactions of a membrane-associated protein (CheA) in a complex system, which is difficult
to study by other techniques. DEPC molecule is applicable because it does not interfere with
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artificial membranes., By measuring the labeling rate of 20 residues in CheA when this protein
was in solution and in complex system separately, we have found that a mass majority of our
results matches HDX-MS results and protein model. The inconsistency of some results
indicates the necessity of model refinement.
In Chapter 6, we also have applied this method to probe surface interactions in polymerprotein complexes. DEPC also presents good performance because the polymers do not
substantially impact its reactivity. Because this technique can provide residue-level structural
information, we have found that residues near anionic and hydrophobic patches on sfGFP
decrease in labeling with the increase of polymer concentrations. It indicates polymers
preferentially bind to electrostatic and hydrophobic interactions on the protein surface. The
finding could be useful in the design of polymer carriers.

7.2 Future Directions

The following sections discuss possible future improvements to the covalent labeling
method and applications of this method.

7.2.1 Influence of Protein Structural Properties on DEPC Labeling Reactivity

In Chapter 3, we have found that the reactivity of histidine residues in protein only has
weak correlation with its SASA. This conclusion points out that the reactivity of nucleophilic
residues in protein is determined by many structural properties in a complicated way. In order
to figure out the correlation between different structural factors and residue rate coefficients,
we need to classify them based on the residue type and consider each type differently. For
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histidine and lysine, we still think solvent accessibility is a key factor because not only me but
also other colleagues in our lab have found that their reactivity has semi-quantitative correlation
with SASA. However, it seems that other factors should be taken into account as well, such as
polar contact, pKa of residues, as well as hydrophobic environment around these residues. If
we still prefer to use statistical models to express the relationship, one of the biggest difficulties
is describing residue local environment mathematically. To solve this problem, we can
probably get some insights from computational modeling field. As far as I know, classical
mechanics functions have been used in the establishment of force-field. Among them, there are
equations which describe van de Waals interactions and electrostatic interactions. They may
help us to describe the hydrophobic environment and polar contact of the residues. For Tyr,
Ser, and Thr, their reactivity is predominately determined by their microenvironment,
especially the hydrophobic environment. In this case, the proper way to describe interactions
is more crucial. Similarly, I think classical mechanics functions will help us in certain extent.

7.2.2 The Application of CL-MS in the Study of Membrane-associated Protein and
Polymer-protein Complexes

In Chapter 5, we used CL-MS method to investigate membrane-associated protein. The
promising results present that DEPC labeling-MS technique is applicable in the study of
membrane protein. In my work, the labeling rate of only 20 residues in CheA were monitored.
In the future, more residues can be detected by reasonably decreasing the resolution of orbitrap
mass analyzer and shortening the retention time window of each peptide. Since DEPC molecule
is hydrophobic, it may have the potency to penetrate artificial membrane. It means that this
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method can be applied to other model systems, and even DEPC labeling in cells or in vivo. We
can discover the binding interfaces of the extracellular domain of some membrane proteins
when they bind to receptors. If DEPC can penetrate cell membrane with high efficiency, we
can even look at the change of intracellular domain of some membrane proteins. In addition,
the usage of chemical penetration enhancers can be a good way to facilitate DEPC penetration.
Although the amount of membrane proteins expressed on the cell surface is low, we can add
immunoaffinity tag to the proteins that we are interested in and then enrich them from the cell
lysis.
In Chapter 6, we used CL-MS technique to find the surface interactions of polymerprotein complexes on the residue level. We chose sfGFP as our first model protein because it
strongly binds to PTDMs. Our collaborators have found that the binding affinity of polymers
and proteins depends on protein pIs. Higher pI the proteins are, weaker binding of these
proteins with polymers. In the future, other proteins which have higher pI than sfGFP such as
lysozyme and avidin can be used as model proteins. By comparing how differently these
proteins interact with polymers, we will have further understanding of their binding interactions.
Moreover, trying different polymers with different hydrophobic groups is another way that
might be interested to study whether they will bind with the same protein differently.

7.2.3 The Usage of Isotopic Labeling Reagents in CL-MS

In CL-MS field, using isotopic labeling reagents is another common method to study
protein higher-order structure. For example, one reagent can be used to modify a given protein
under one condition and its isotopically encoded reagent can be used to label the same protein
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under another condition. After mixing, the samples will be treated in the same condition to
prevent digestion inconsistencies and thus improve data quality. This method also largely
shortens the detection time on LC-MS/MS. In fact, our lab has isotopically encoded DEPC
(iDEPC) in which all of the 12C atoms were replaced by 13C. The mass shift of residues after
modification is 75.02 Da instead of 72.02 Da. In the future, we might use normal DEPC to
label a model protein under one scenario and use iDEPC to label the same protein under another
scenario. Comparing the modification percentage on the residue, we are able to find the change
of protein higher-order structures.
In another way, we can use DEPC to label an intact model protein. In this case, only
nucleophilic residue exposed to the solvent will be labeled. Then we unfold this protein, digest
it into peptides and use iDEPC to label tryptic peptides. Residues which are previously buried
in the protein will be labeled by iDEPC. The labeling extent of each residue may partially
reflect its solvent accessibility. This method can work as experimental constraints for protein
modeling. However, before applying this method, we need to have further understanding how
structural properties affect residue reactivity in proteins.
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